Development of Organocatalytic Direct Aldol Transformations, Total Syntheses of Brasoside and Littoralisone, and Progress Toward the Total Synthesis of Diazonamide A by Mangion, Ian Kyle
 Development of Organocatalytic Direct Aldol Transformations, 
Total Syntheses of Brasoside and Littoralisone, 
and Progress Toward the Total Synthesis of Diazonamide A 
 
 
 
Thesis by 
Ian Kyle Mangion 
 
In Partial Fulfillment of the Requirements for the 
Degree of 
Doctor of Philosophy 
 
 
             California Institute of Technology 
Pasadena, California 
2006 
(Defended May 25, 2006)
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2006 
Ian Kyle Mangion 
All Rights Reserved 
 
 iii 
Acknowledgements 
 First and foremost I would like to thank my friend and fiancée Erin Guidry for all 
her support during long nights I chose to spend in lab, and for being the reason I started 
choosing otherwise.  I look forward to our new life together outside of Caltech.  I would 
also like to thank my family for their support during my graduate career, especially my 
mother who almost did not survive to see it come to an end, but who is now back to 
drinking wine and railing against the president.   
 I would like to thank my advisor David MacMillan, who took me into his lab for 
reasons I do not know.  He was on my case more than I would have thought, but ultimately 
he put faith in me to work on my own and for that I am grateful.  He also supported me as 
much as I could have asked for to start a new career.  In a similar way I appreciate my 
thesis committee for their help in guiding my graduate career and the outstanding level of 
interest they have taken in the progress of my research, particularly Jonas Peters and Robert 
Grubbs for their scientific curiosity.  I would like to give a special thanks to Brian Stoltz 
who has never hesitated to give me advice from his own experience, and who stood out as 
someone who takes an interest in the development of people as well as science. 
 I would also like to thank my roommates Jacob and Nick for being friends for all 
these years.  Jacob for introducing us to Hollywood, Las Vegas, and Sunday baseball, and 
Nick for accompanying me to Ireland for Guinness, Smithwick’s, and Graeme Early 
Dennis (should he ever be found).  Also, thanks to all Fuzzie Bunnies of Death members 
past and present: Eifler, Mohan, Josh, Mollner, Rafael, Andy, Justin, Jeff “Zone buster” 
Byers, and apartment 402 (who showed up to practice). 
 iv 
 Finally, I would like to thank the wide variety of colleagues who have influenced 
me in a positive way, in no particular order.  First, my baymates and deskmates: Wendy 
Jen, who tolerated everything I did and taught me how to work happy.  Vy Dong, who 
brought the best combination of optimism, humor, and scientific excellence day after day.  
Sandy Lee made a stressful year easier to deal with, and for that I am thankful.  Crystal 
Shih almost converted me to an irrepressibly happy person, since I failed to make her bitter 
and tired.  Masa and JB have been the most easygoing co-workers I could have ever asked 
for, and have never faulted me for anything. 
 Nikki Goodwin has been my lone classmate these many years, and has been a good 
friend and selfless individual in an environment that does not always reward those things.  Joel  
Austin (now at the Dung-Flinging Monkey Institute of Chemical Research) is a priceless, 
unique human being who embiggens our lives.  Jamie Tuttle continues to bring joy and 
cynicism from the bow of his yacht, and is the most avid participant of The Game.  Thanks 
to Dr. Abbas Walji for being so generous with his encyclopedic knowledge of chemistry 
and good wit.  Joe Carpenter and Bryon Simmons are two first-years I have had the 
pleasure of getting to know and who I can only imagine from their enthusiasm will do great 
things in the future, apart from being good people.   
 I also thank Jake Wiener and Brian Kwan for their very thoughtful variety of 
friendship; I consider them scholars of the first rate.  Dr. Christopher Sinz and Dr. Steven 
Goldberg were two individuals who were remarkably willing to teach me and talk to me 
about chemistry and all things, despite how bad at chess Chris really is.  And basketball.  
Tristan Lambert and Mike Brochu are thanked for being really nice people and killer 
basketball players when needed. 
 v 
 I want to thank a variety of people in the Stoltz, Grubbs, and Bercaw labs who had 
an exceptionally positive influence on my growth as a scientist, including Dan Caspi, Mike 
Krout, Jon Owen, Jeff Byers, Jacob Berlin, Raissa Trend, Chris Douglas, J. T. Mohr, Greg 
Beutner, Eric Ferreira, Uttam Tambar, Jeremy May, Eric Ashley, Richmond Sarpong, and 
Neil Garg.  I cannot begin to recall all the random interactions and discussions we have 
shared about chemistry, but above all else I consider them not just good colleagues but 
good people.   
 A big thanks to those who have worked with me most closely: Alan Northrup and 
Frank Hettche who pushed back the boundaries of science through aldol chemistry.  
Amanda Reider, who had the patience to work with me on whatever came up.  Simon 
Blakey and especially Rob Knowles, the precocious young graduate student who does and 
will continue to do great things, and whose devotion to the craft of synthesis is virtually 
unmatched in my experience. 
 Finally, I would like to thank the California vineyards; Hair of the Dog, Rogue, 
North Coast, and Stone breweries; Coachella, and Meatwad.  
 vi 
ABSTRACT 
 The enantioselective amine-catalyzed direct aldol reaction of aldehdyes has been 
accomplished for the first time using an imidazolidinone organocatalyst.  That 
imidazolidinone catalyst, initially developed for LUMO-lowering activation of α, β-
unsaturated aldehydes, provides new insight into amine-mediated aldol transition states.  
The concepts developed in this study have been applied toward the development of an 
unprecedented enantioselective Type II direct aldol.  In the course of these studies the 
amino acid proline was also found to be a highly effective catalyst for this transformation.  
These catalyst systems form the basis for a novel approach to polyketide and polyglycolate 
architectures, structural motifs having broad representation amongst natural product 
isolates. 
 This enamine catalysis strategy was then applied towards the total synthesis of the 
iridoid natural products brasoside and littoralisone.  Direct aldol chemistry was applied 
towards the synthesis of a substituted carbohydrate structure, and a recently developed 
enantioselective oxyamination reaction installed a key stereocenter.  Stereocontrolled 
synthesis of the bicyclic core common to the iridoid class of natural products required the 
development of a new, kinetically controlled organocatalytic intramolecular Michael 
reaction.  A [2+2] photocycloaddition completed the first total synthesis of littoralisone, 
and demonstrated a likely biosynthetic link to brasoside, which may well be a natural 
precursor.  
 An iminium-mediated addition-cyclization cascade reaction has been applied 
toward the total synthesis of the marine natural product diazonamide A.  This strategy has 
provided stereoselective, catalytic access to the crucial C-10 quaternary carbon stereocenter 
for the first time.  A novel intramolecular soft enolization aldol macrocyclization formed a 
precursor to the A-ring oxazole, which was subsequently completed in a newly discovered 
DAST-mediated cyclodehydration.  Closure of the fourteen-membered biaryl macrocycle 
has been accessed through an unusual Suzuki macrocyclization, and completion of 
diazonamide A should be accessible in four further steps. 
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1 
C h a p t e r  1  
The Imidazolidinone-Catalyzed Direct Aldol Reaction* 
  
Enantioselective Enamine-Based Catalysis 
 Much of the early work accomplished in the MacMillan lab has focused on 
LUMO-lowering iminium activation of carbonyls.1  In analogy to Lewis acid chemistry, 
the activation imparted by iminium formation provides the mechanistic basis for 
enantioselective amine catalysis of cycloaddition and conjugate addition processes 
(figure 1).  In principle one could access a broad range of other enantioselective 
transformations by taking advantage of the enamine intermediate generated by the 
equilibrium between a secondary amine and a saturated aldehyde.  Enamines are well 
known for their nucleophilic properties,2 and have found use in reactions with a variety of 
electrophiles.  In particular, they have been recently demonstrated in enantioselective 
aldol catalysis.3 
Figure 1:  Iminium and Enamine Intermediates are Targets for Enantioselective Catalysis
substrate catalyst HOMO–activation
O
R
N
H
R
•HX
N
R
R
O
R
N
H
R
N
R
R
+•HX
substrate catalyst LUMO–activation
  
                                                
For a communication of this work, see: Mangion, I. K.; Northrup, A. B.; MacMillan, D. W. C.  Angew. Chem. Int. 
Ed. 2004, 43, 6722. 
1 Austin, J. F.; Kim, S-G.; Sinz, C. J.; Xiao, W-J.; MacMillan, D. W. C. Proc. Nat. Acad. Sci. U.S.A. 2004, 101, 5482, 
and references therein. 
2 For a comprehensive review see: Hickmott, P. W. Tetrahedron 1982, 38, 1975.   
3 List, B.; Lerner, R. A.; Barbas, C. F., III J. Am. Chem. Soc. 2000, 122, 2395. 
 
 
2 
The MacMillan lab has focused on new methods for accessing structural motifs 
that have broad representation amongst natural products.  Two such ubiquitous motifs are  
Figure 2: Direct Aldehyde-Aldehyde Aldol Reaction Generates Common Motifs
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those of polypropionates and polyglycolates (figure 2).  These structures can be reduced 
in a retrosynthetic sense as simply being the products of iterative, stereocontrolled aldol 
additions of aldehydes.  In particular, one may think of carbohydrates as being the 
product of consecutive additions of hydroxyacetaldehydes.  We hope to develop a direct 
aldehyde-aldehyde aldol reaction mediated by a chiral amine source to provide rapid 
access to these structures. 
The basis for this work lies in literature precedent such as the Hajos-Parrish 
reaction,4 in which a catalytic intramolecular aldol reaction presumably goes through an 
enamine intermediate (eq 1).  Intermolecular aldol reactions between ketones and 
aldehydes have also been recently demonstrated by Barbas, List and Lerner.3  A catalytic 
(1)
3 mol% L-Proline
DMF
100% yield, 98% ee
O
OMe
OH
O
O
Me
O
Me
 
                                                
4 (a) Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615.  (b) Eder, U.; Sauer, G.; Wiechert, R. Angew. Chem. 
1971, 10, 496.  (c) Agami, C.; Platzer, N.; Sevestre, H. Bull. Chim. Soc. Fr. 1987, 2, 358. 
 
 
3 
enantioselective aldehyde-aldehyde aldol, however, remained unknown at the time these 
studies began.  One reason we thought this might be is that the product of this reaction 
should be, like the starting materials, an aldehyde.  Therefore chemoselectivity will be a 
critical issue in this aldol process in order to avoid oligomerization (figure 3). 
Figure 3:  Chemoselectivity Will Be a Critical Issue in Direct Aldehyde Aldol
H
O
Me
R2NH•HX
H
O
Me
OH
Me
OH
Me
OH
Me
OH
Me
H
O
Me
OH
Me  
 We were particularly interested in work developed in the Wong lab,5 which 
demonstrated the ability of an aldolase enzyme to mediate a direct double aldol addition of 
acetaldehyde (eq 2).  The sequential aldol process creates a cyclic acetal, which is inert 
towards further aldol reaction under the reported conditions.  This shows that a second 
aldol event can provide a self-termination step that allows isolation of a useful, discrete 
product. Further, the aldolase in question was demonstrated by Wong to perform chemistry 
by an enamine mechanism.  If this same enamine chemistry can apply to small molecule 
catalysis, then oligomerization should not be an issue in the direct aldehyde aldol.   
(2)
H
O
Me H
O
Me
aldolase
H
O OH
Me
H
O
Me
OMe
OH
OH 20% yield
78% ee
6 days
 
 It had been observed previously in the MacMillan lab6 that exposure of hexenal to 
imidazolidinone catalyst 1 under certain conditions will lead to an apparent vinylogous 
Michael addition process (eq 3).  It is envisioned that this product might arise from a 
dienamine conjugate addition.  The moderate level of enantiocontrol is a promising entry  
                                                
5 Gijsen, H. J. M.; Wong, C.-H. J. Am. Chem. Soc. 1994, 116, 8422. 
6 Northrup, A. B.; Goodwin, N. C.; Brown, S. P.; MacMillan, D. W. C.  unpublished results 
 
 
4 
(3)Me O
N
H
N
OMe
Bn
Me
Me
Me
• TfOH
20%
10% DMPU in DMF, –30 °C
O
n-Pr
Et
O
2:1 d.r. 77% ee
1
 
into enamine catalysis, and suggests that 1 can perhaps mediate the direct aldol event we 
wish to investigate, functioning as a small molecule aldolase. 
 
Imidazolidinone Catalysis: Applications to Enamine-Based Reactions 
 There was good reason to believe that the imidazolidinone catalyst architecture, 
which had been carefully optimized to provide enantiodiscrimination in reactions involving 
iminium ion intermediates, might prove effective as an enamine catalyst.  In particular, 
computational work performed in the Houk group7 demonstrated that in the transition state 
of aldol reactions mediated by enamines, formation of the iminium π-bond is very 
advanced relative to carbon-carbon bond formation (figure 4).  Imidazolidinone catalyst 1  
Me
Figure 4:  Houk's Calculated Transition State for Amine-Mediated Aldol Reactions
O
N
H
Me
Me!
+
!
–Me
O
H
N
Me
Me
H2O
Me
OH O
H
Iminium-like T.S.  
has been designed to provide steric control for iminium-like transition states, and in this 
instance may enforce a single enamine geometry and provide facial coverage for that olefin 
(figure 5).  The tert-butyl group should enforce enamine geometry in this late transition 
state through nonbonding interactions (in the same fashion as for iminium ions), while the 
benzyl group should control selective facial blockage.  If successful, this enamine catalysis 
                                                
7 Bahmanyar, S.; Houk, K. N. J. Am. Chem. Soc. 2001, 123, 11273. 
 
 
5 
would be a mechanistic platform from which other enantioselective reactions could be 
derived (e.g., α-oxidation, α-halogenation, etc.) 
Figure 5:  Benzyl Group of Imidazolidinone Provides Clear Rationale for Stereocontrol
N
N
H
O Me
Me
Me
Me
Ph
O
Me
H
Si–face exposed
 
 With these design parameters taken into account, propionaldehyde was subjected to 
a catalytic amount of 1 in conditions similar to those in which the vinylogous Michael 
reaction was first observed (eq 4).  An unexpected product (2) was observed that results 
from a carbon-carbon bond forming event and that appears to contain a latent β-hydroxy 
aldehyde motif expected from an aldol event.  However, a third equivalent of aldehyde has 
also incorporated itself into this product.   
O
H
Me
10 mol% 1•TfOH
10% DMPU/DMF
O O
HO
Me
Me
Me
3 (4)
75% yield
3:1 anti:syn
78% ee
2  
 One can imagine this product arising from a transient iminium intermediate (3) that 
is activated towards attack by the excess of aldehyde in solution (figure 6).  Cyclization 
completes the hemiacetal that is observed, providing the self-termination step that is 
required to avoid a oligomerization process.  Unlike Wong’s aldolase, the trapping event 
reported here occurs after a single aldol event. 
 
 
6 
Figure 6:  Interception of Iminium Intermediate Provides Self-Termination
N
N
MeO
Ph Me
Me
Me
Me
H
O
O O
HO
Me
Me
Me
Me
N
Me
Me
R R
OH
H
H
O
Me
3  
 The promising enantioselectivity (78% ee) suggested this reaction warranted further 
development.  Solvent was examined for its effect on enantio- and diastereoselectivity in 
the direct aldol reaction of propionaldehyde (table 1).  To increase the utility of the aldol 
product, methanol and an acid resin (Amberlyst-15) are added to liberate the extraneous 
equivalent of aldehyde and protect the β-hydroxy aldehyde as its dimethyl acetal when 
conversion is complete.  This creates a bench-stable product that is also simpler to analyze. 
Hexanes
CH2Cl2
CHCl3
Toluene
EtOAc
THF
Et2O
Dioxane
entry
1
2
3
4
5
6
7
8
anti:syn
3:1
4:1
4:1
3:1
2:1
2:1
4:1
4:1
89
66
42
80
91
22
85
92
yield %ee (anti)
90
93
91
87
93
90
90
94
solvent
Me
O
H
OH
Me
MeO
MeO
Me
 10 mol% 1, 4 °C, 24 h;
Amberlyst-15, MeOH
Table 1:  Effect of Solvent on Imidazolidinone-Catalyzed Direct Aldol
 
Dioxane was found to provide the optimal mix of reactivity and selectivity (table 1, entry 8) 
and was chosen for further study, though a range of solvents proved amenable to our direct 
aldol. 
 Further optimization studies focused on the effect of the acid co-catalyst on 
reactivity and selectivity (table 2).  Ultimately, cocatalysts of intermediate (pKa ~0–1) 
 
 
7 
acidity proved to provide the best reactivity.  Perhaps by out-competing background 
reaction this also had the effect of maximizing stereocontrol.  Optimal rate should require 
balance between greater acidity that promotes iminium ion formation and lesser acidity that 
favors tautomerization to the corresponding enamine.  
TfOH
HCl
pTSA
TCA
TFA
DFA
DBA
Salicylic
AcOH
pKa (H2O)
-10
-6.1
-1.34
0.51
0.52
1.34
1.48
2.98
4.76
anti:syn
3:1
4:1
4:1
3:1
3:1
3:1
0
0
56
98
97
80
54
49
0
yield %ee (anti)
--
--
86
94
92
90
86
82
--
acid
Me
O
H
OH
Me
MeO
MeO
Me
 10 mol% 1, 4 °C, Dioxane;
Amberlyst-15, MeOH
Table 2:  Effect of Cocatalyst on Imidazolidinone-Catalyzed Direct Aldol
--
--
--
 
 The key issue in developing a truly useful direct aldol is the ability to perform cross 
aldol reactions (reactions between structurally discrete aldehydes) in a regioselective 
manner.  Reaction between two different aldehydes could create as many as four 
regioisomeric products.  To partition between these possible pathways, there must be a 
preference for one aldehyde to act as the nucleophilic aldol donor while the other aldehyde 
acts as the electrophilic aldol acceptor.  This was first explored in the addition of 
propionaldehyde to isobutyraldehyde, where it was hoped that the increased steric 
encumbrance of the latter would force it to act as the aldol acceptor (eq 5).  This proved to 
be true, though slow syringe pump addition of propionaldehyde was required to avoid 
competing homodimerization. 
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H
O
Me Me
Me
H
O MeO
MeO
Me
OH
Me
Me
   10 mol% 1•TCA;
 Amberlyst-15, MeOH
90% yield
5:1 anti:syn; 95% ee
(5)
 
 With optimal conditions in hand for cross aldol reactions, a scope study was 
undertaken to test the limitations of this new process (table 3).    It was found that a range 
of different aldehydes could be applied with complete regiocontrol and high (>90%) 
enantiomeric excess.8  In particular, α-alkyl, α-aromatic and α-oxy functionality can all be 
incorporated into the acceptor component (Entries 1-7, 90% to 97% ee).  In an example of 
electronic rather than steric substrate differentiation, an α-oxy aldehyde was shown to act 
exclusively as the acceptor in a cross aldol with propionaldehyde (Entry 7, 90% ee).  This 
is presumably because of its greater electrophilicity and also the greater instability of its 
corresponding iminium that may inhibit the catalyst from condensing with it. 
 We next examined the capacity of imidazolidinone 1 to catalyze the 
homodimerization of α-heterosubstituted aldehydes.  As shown in entries 8 and 9, exposure 
of 1 to α-benzyloxy and α-benzylsulfide aldehydes provides the erythrose aldol adduct 
with high levels of enantiocontrol (92%-97% ee).  Silyl protecting groups proved not to be 
amenable to the acidic conditions of methanolysis, so a new method for opening the 
intermediate hemiacetals was required.  It was observed that purification of the triisopropyl 
silyloxy hemiacetal on silica gel pretreated with triethylamine led to hydrolysis to the 
corresponding β-hydroxy aldehyde and one equivalent of free aldehyde.  This result proved 
irreproducible, so further investigation (eq 6) proved that the active agent was actually 
                                                
8 Mangion, I. K.; Northrup, A. B.; MacMillan, D. W. C.  Angew. Chem. Int. Ed. 2004, 43, 6722. 
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Et
i-Pr
c-C6H11
Ph
i-Pr
i-Pr
CH2OPiv
CH2OBn
CH2SBn
CH2OTIPS
entry
1
2
3
4
5
6
7
8
9
10
anti:syn
4:1
5:1
5:1
3:1
6:1
5:1
4:1
4:1
11:1
1:4
86
90
81
61
72
80
58
64
84
84
% yield % ee
94
95
97
83
91
91
90
92
97
92
productR1
R2
O
H
R1
O
H
 10-20 mol% 1, Et2O, 4 °C;
Amberlyst-15, MeOH
R2
OH
R1
MeO
MeO
OH
Me
MeO
MeO
Me
OH
Me
MeO
MeO
OH
Me
MeO
MeO
Me
Me
Me
Me
n-Bu
Bn
Me
OBn
SBn
OTIPS
R2
OH
Bu
MeO
MeO
Me
Me
OH
Bn
MeO
MeO
Me
Me
donor acceptor
OH
OBn
MeO
MeO
OBn
OH
OTIPS
O
H
OTIPS
OH
Me
MeO
MeO
Me
Me
OH
Me
MeO
MeO
OPiv
OH
SBn
MeO
MeO
SBn
Table 3:  Imidazolidinone-Catalyzed Direct Aldol: Substrate Scope
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H
O
OTIPS
O
H
OTIPS
OH
OTIPS
SiO2, Et2NH
4:1 syn:anti; 92% ee
(6)
O
HO
OTIPS
O
OTIPS
OTIPS
5:1 anti:syn; 94% ee  
diethylamine (which likely existed in small amounts in the original sample of 
triethylamine).  Interestingly, this opening occurred with epimerization to provide the 
threose aldol product (Entry 10, 4:1 syn:anti, 92% ee), which could well serve as a 
precursor to the threose hexoses (idose, gulose, galactose, and talose).  Though this 
chemistry is without direct precedent, the hemiacetal hydrolysis is almost certainly an 
equilibrium process that is driven by chromatographic separation of the two aldehyde 
components.  This fits well with the fact that silica gel and diethyl amine do not induce 
hydrolysis in solution, as well as with data from the Rychnovsky lab that show the reverse 
reaction (formation of hemiacetals from β-hydroxy aldehydes) is facile in the presence of 
an amine base.9 
 
Stereochemical Rationale 
 Both the absolute and relative sense of stereochemistry can be rationalized by the 
stereochemical model shown in figure 5.  Taking into account the theoretical work of Houk 
(figure 4), a computational approach was taken towards a locating a transition state.  While 
Houk predicts this reaction to be barrierless in the gas phase, a transition state energy can 
be found for both syn and anti aldol products given the assumption of a solvated late 
                                                
9 Rychnovsky, S. D.; Vaidynathan, R.; Beauchamp, T.; Lin, R.; Farmer, P. J.  J. Org. Chem. 1999, 64, 6849. 
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transition state (figure 7).  These transition structures resemble the Houk model’s envelope-
type pseudo-cyclic orientation.10  Though the transition state is nominally acyclic,  
Figure 7:  Calculated Transition State for Imidazolidinone-Catalyzed Aldol
N
N
O
Me
Me
MeMe
O
Me
H
XH
Me
H
O
Me
OH
Me syn
N
N
O
Me
Me
MeMe
O
Me
Me
XH
H
H
O
Me
OH
Me anti
0.91 kcal/mol!+
!" !"
!+
 
the dipole attraction of the developing iminium ion for the developing alkoxide simulates a 
five-membered ring.  Theoretical prediction is for a 0.91 kcal/mol preference for an anti-
selective aldol, which matches well with experimental observation.  This prediction does 
not vary much with increased steric bulk of the aldol acceptor, perhaps reflective of the 
torsional flexibility of this open (Type III)11 transition state.   
 Absolute enantioselectivity can be predicted from facial coverage provided by the 
benzyl group.  Control of the enamine geometry can be thought of as arising from allylic 
strain in the developing iminium ion (figure 8).12  The steric bulk of the tert-butyl group of 
the imidazolidinone creates a strong non-bonding interaction that favors orientation of the 
enamine toward the benzyl group.  This control is crucial to high enantiocontrol since 
exposure of the opposite face of the enamine leads to the opposite enantiomer. 
                                                
10 Gaussian 03™ calculation, B3LYP/3-21G(d,p) 
11 Mahrwald, R. Chem. Rev. 1999, 99, 1095. 
12 Figure from Northrup, A. B.; “Design and Development of New Enantioselective Organocatalytic 
Transformations, A Two-Step Synthesis of Carbohydrates, and Progress Toward the Total Synthesis of 
Callipeltoside C”, PhD thesis, California Institute of Technology, 2005. 
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Figure 8:  Allylic Strain Predicts Control of Enamine Geometry
N
N
O Me
Bn
Me
Me
Me
Me
O H
N
N
O Me
Bn
Me
Me
Me
H
Me
O
TCA TCA
Si-face exposed Re-face exposed  
 
Application Towards a Syn-Selective Direct Aldol 
 Despite the wealth of aldol chemistry described in the literature,13 there is no known 
enantioselective, syn-selective direct aldol reaction.  This is presumably a consequence of 
the fact that known direct aldol chemistry3, 14 typically proceeds via an E-enamine or E-
enolate, and in the context of a chair or chair-like transition state this will favor anti 
selectivity.  However, the open transition state postulated for the imidazolidinone-catalyzed 
aldehyde-aldehyde aldol suggests the possibility of perturbation into a syn-selective 
manifold.  Increasing steric encumbrance around the catalyst might drive orientation of the 
incoming aldehyde such that the oxygen-cocatalyst complex will lie away from this added 
bulk (figure 9).  Doing this will expose the opposite face of that aldehyde to attack, leading  
Figure 9: Possible Model For a Syn-Selective Direct Aldol Reaction
Me
H
O
HR
N
N
Bn
O Me
Me
Me
Me
HX
O
H
Me
OH
R
anti
Me
H
H
OR
N
N
Bn
O Me
O
H
Me
OH
R
syn
R1
R2
HX
Increased
steric repulsion  
                                                
13 Evans, D. A.; Nelson, J. V.; Taber, T. R. “Stereoselective Aldol Condensations,” in Topics in Stereochemistry New 
York: Wileyy, 1982; vol. 13, p. 2. 
14 (a) Yoshikawa, N.; Yamada, Y. M. A.; Das, J.; Sasai, H.; Shibasaki, M. J. Am. Chem. Soc. 1999, 121, 4168; (b) 
Trost, B. M.; Ito, H. J. Am. Chem. Soc. 2000, 122, 12003. 
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to the syn diastereomer.  This was observed to a modest extent for imidazolidinone 2, the 
first generation catalyst developed for iminium catalysis (eq 7).  Use of this catalyst in a 
reaction with propionaldehyde led to aldol reactivity with a small syn preference (2:1) and 
modest yield but high enantioselectivity.  This proved true for cross aldol reactions as well, 
with no loss in enantiocontrol (eq 8, 9). 
N
H
N
OMe
• TFA20%
Et2O, 4 °C, 24 h;
MeOH, Amberlyst-15
2
H
O
Me
MeO
MeO
Me
OH
Me
2:1 syn:anti; 90% ee
BnMe
Me
(7)
23% yield  
 Attempts to increase either diastereoselectivity or reaction efficiency by 
optimization of solvent, cocatalyst or temperature were unsuccessful.  Efforts were then 
devoted toward optimization of the catalyst structure.  In general, catalysts with the gem-
disubstituted frameworks were the only ones that demonstrated any syn selectivity, but 
H
O
Me Me
Me
H
O MeO
MeO
Me
OH
Me
Me
   20 mol% 2•TFA;
Amberlyst, MeOH
16% yield
2:1 anti:syn; 94% ee
(8)
H
O
Me
H
O MeO
MeO
Me
OH
   20 mol% 2•TFA;
Amberlyst, MeOH
22% yield
2:1 anti:syn; 92% ee
(9)
 
also tended to have only trace reactivity.  At this point, catalyst 3 was demonstrated to be 
highly effective in the hydride reduction of enals (eq 10).15  While it was only a marginal  
                                                
15 Ouellet, S. G.; Tuttle, J. B.; MacMillan, D. W. C.  J. Am. Chem. Soc. 2005, 127, 32. 
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Me
Ph O
N
H
MeMe
CO2EtEtO2C
H H N
N
H
Me
Me
Me
Me
O
•TFA
20 mol%
CHCl3, –45 °C
Me
Ph O
3 (10)
91% yield, 93% ee  
catalyst for the dimerization of propionaldehyde (83% ee, 3:1 anti:syn, 76% yield), it 
proved an inspiration for a catalyst structure (4)16 that incorporates both the tert-butyl 
group and a trans-methyl substituent (as in first-generation 2).  On exposure of 4 to 
propionaldehyde, the aldol adduct was isolated in 45% yield as a 5:1 syn:anti mixture and 
98% ee (eq 11).17  While demonstrating that, in principle, high selectivities can be 
obtained in this new syn aldol process, this result proved to be the best in a series of 
optimization studies.  Further, reactivity dropped off severely when tested in cross aldol  
N
H
N
OMe
• TFA20%
Et2O, 4 °C, 24 h;
MeOH, Amberlyst-15
2
H
O
Me
MeO
MeO
Me
OH
Me
5:1 syn:anti; 98% ee
Bn
(11)
45% yield
Me
 
reactions.  For these reasons studies were abandoned, but they may provide a suggestive 
lead as to how to approach a more general syn-selective direct aldol process.18  
 
 
 
 
                                                
16 The synthesis of this catalyst has been reported: DeMico, A.; Margarita, R.; Parlanti, L.; Vescovi, A.; Piancatelli, 
G.; J. Org. Chem. 1997, 62, 6974; see also: Brown, S. B.; “Iminium and Enamine Activation: Methods for 
Enantioselective Orgnaocatalysis”, PhD thesis, California Institute of Technology, 2005. 
17 Work performed with Crystal Shih. 
18 For a syn-selective decarbonylative aldol reaction see: (a) Magdziak, D.; Lalic, G.; Lee, H. M.; Fortner, K. C.; 
Aloise, A. D.; Shair, M. D.  J. Am. Chem. Soc. 2005, 127, 7284; for a syn-selective reductive aldol see: (b) Russell, 
A. E.; Fuller, N. O.; Taylor, S. J.; Aurisset, P.; Morken, J. P.  Org. Lett. 2004, 6, 2309, and references therein. 
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Conclusions and Future Directions 
 The first method for the direct enantioselective aldol coupling of aldehydes has 
been reported using imidazolidinone catalyst 1.  This catalyst was optimized to provide 
enantiocontrol for reactions involving iminium ion intermediates, but that appears to be a 
design principle that is ideal for controlling the transition state of reactions involving 
nucleophilic enamines.  This methodology has proven general for a range of substrates in 
regioselective cross aldol reactions, and provides a new concept for rapid polyketide or 
polyglycolate synthesis.  These studies have also provided a foundation for development of 
an unprecedented syn-selective direct aldol methodology that would rapidly access 
valuable threo stereochemical motifs.  The following chapters will detail the extension of 
this methodology in the context of proline catalysis, and the application of organocatalytic 
methods towards the synthesis of natural products. 
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Supporting Information 
 
 General Information.  Commercial reagents were purified prior to use following 
the guidelines of Perrin and Armarego.19 Dioxane and diethyl ether were obtained from 
EM Science and used as supplied.  Non-aqueous reagents were transferred under nitrogen 
via syringe or cannula.  Organic solutions were concentrated under reduced pressure on a 
Büchi rotary evaporator using an ice-water bath.  Chromatographic purification of 
products was accomplished using forced-flow chromatography on ICN 60 32-64 mesh 
silica gel 63 according to the method of Still.20 Thin-layer chromatography (TLC) was 
performed on EM Reagents 0.25 mm silica gel 60-F plates.  Visualization of the 
developed chromatogram was performed by fluorescence quenching or by anisaldehyde 
stain. 
1H and 13C NMR spectra were recorded on a Varian Mercury 300 (300 MHz and 
75 MHz) Spectrometer as noted, and are internally referenced to residual protio solvent 
signals.  Data for 1H NMR are reported as follows: chemical shift (δ ppm), multiplicity (s 
= singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration, coupling 
constant (Hz) and assignment.  Data for 13C NMR are reported in terms of chemical shift.  
IR spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported 
in terms of frequency of absorption (cm-1).  Mass spectra were obtained from the 
California Institute of Technology Mass Spectral Facility.  Gas liquid chromatography 
(GLC) was performed on Hewlett-Packard 6850 and 6890 Series gas chromatographs 
equipped with a split-mode capillary injection system and flame ionization detectors 
using a Bodman β-DM (30 m x 0.25 mm) column or an ASTEC Chiraldex γ-BP (30 m x 
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0.25 mm) or β-PH (30 m x 0.25 mm) column as noted.  High performance liquid 
chromatography (HPLC) was performed on Hewlett-Packard 1100 Series 
chromatographs using a Chiralcel AD column (1.6 x 25 cm) and AD guard (1.6 x 5 cm), 
a Chiralcel OJ column (1.6 x 25 cm) and OJ guard (5 cm), or a Chiralcel ODH column 
(1.6 x 25 cm) and ODH guard (1.6 x 5 cm), as noted. 
 
 
(2R, 3R)-1,1-Dimethoxy-2-methyl-pentan-3-ol (table 3, entry 1). Freshly 
distilled propionaldehyde (621 µL, 8.61 mmol) was added to a stirring 4 ºC solution of 
(2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (70.7 mg, 0.287 mmol) and 
trichloroacetic acid (46.9 mg, 0.287 mmol) in dioxane (8.6 mL).  After 36 h methanol 
(14.4 mL) and Amberlyst-15 (359 mg) were added in one portion.  The solution was 
stirred until the reaction was judged complete by TLC analysis (1 h).  The Amberlyst-15 
resin was removed by filtration through a fritted filter, and the filtrate was concentrated in 
vacuo.  Flash chromatography (85:15 pentane:Et2O) afforded the title compound as a 
clear, colorless oil in 86% yield (400 mg, 2.46 mmol), 94% ee and 4:1 anti:syn. IR (film) 
3457, 2966, 2934, 2868, 1463, 1432, 1382, 1099, 1069, 977.5, 945.6 cm-1; 1H NMR (300 
MHz, CDCl3) δ 4.28 (d, 1H, J = 6.3 Hz, CH(OCH3)2); 3.50 (m, 1H, CHOH); 3.42 (s, 3H, 
OCH3); 3.35 (s, 3H, OCH3); 1.84 (m, 1H, CHCH3); 1.59 (m, 1H, CH2CH3); 1.37 (m, 1H, 
CH2CH3); 0.95 (t, 3H, J = 7.2 Hz, CH2CH3); 0.86 (d, 3H, J = 6.6 Hz, CHCH3); 13C NMR 
(75 MHz, CDCl3) δ 109.0, 74.1, 55.9, 53.5, 40.6, 27.4, 12.0, 9.7; HRMS (CI) exact mass 
calculated for [M + H]+ (C8H19O3) requires m/z 163.1334, found m/z 163.1340. [α]D = 
34.06 (c = 1.0, CHCl3).  The product ratios were determined by GLC analysis of the tert-
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butyl carbonate derived from the product alcohol by the method of Hassner3 using a 
Bodman Chiraldex β-PH (30 m x 0.25 mm) column (80 ºC isotherm, 14 psi); (2R, 3R) 
anti isomer tr = 85.8 min, (2S, 3S) anti isomer tr = 90.8 min, (2R, 3S) and (2S, 3R) syn 
isomers tr = 82.9, 104.5 min. 
 
 (2R, 3R)-1,1-Dimethoxy-2,4-dimethyl-pentan-3-ol (table 3, entry 2). A 4 ºC 
solution of freshly distilled propionaldehyde (76.8 µL, 1.06 mmol) in 0.88 mL Et2O was 
added slowly over the course of 36 h to a stirring suspension of isobutyraldehyde (976 
µL, 10.6 mmol), (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (52.4 mg, 
0.213 mmol) and trifluoroacetic acid (16.4 µL, 0.213 mmol) in Et2O (1.2 mL) at 4 ºC.  
After  37 h methanol (5.32 mL) and Amberlyst-15 (133 mg) were added in one portion.  
The solution was stirred until the reaction was judged complete by TLC analysis (4 h).  
The Amberlyst-15 resin was removed by filtration through a fritted filter, and the filtrate 
was concentrated in vacuo.  Flash chromatography (4:1 pentane:Et2O) afforded the title 
compound as a clear, colorless oil in 90% yield (181 mg, 0.961 mmol), 95% ee and 5:1 
anti:syn. IR (film) 3504, 2961, 2923, 2871, 1457, 1387, 1105, 1073, 996.3 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 4.30 (d, 1H, J = 5.7 Hz, CH(OCH3)2); 3.49 (d, 1H, J = 2.1 Hz, 
CHOH); 3.42 (s, 3H, OCH3); 3.36 (m, 4H, CHOH, OCH3); 1.88 (m, 1H, CHCH3); 1.76 
(m, 1H, CH(CH3)2); 0.98 (d, 3H, J = 6.6 Hz, CH3); 0.85 (d, 6H, J = 7.8 Hz, CH(CH3)2); 
13C NMR (75 MHz, CDCl3) δ 109.3, 77.2, 56.2, 53.6, 38.8, 30.2, 20.6, 14.9, 11.9; HRMS 
(CI) exact mass calculated for [M + H]+ (C9H21O3) requires m/z 177.1492, found m/z 
177.1487. [α]D = 20.4 (c = 1.0, CHCl3). The product ratios were determined by GLC 
analysis using a Bodman Chiraldex β-DM (30 m x 0.25 mm) column (70 ºC isotherm, 12 
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psi); (2R, 3R) anti isomer tr = 62.0 min, (2S, 3S) anti isomer tr = 59.0 min, (2R, 3S) and 
(2S, 3R) syn isomers tr = 65.0 min. 
 
(1R, 2R)-1-Cyclohexyl-3,3-dimethoxy-2-methyl-propan-1-ol (table 3, entry 3). A 4 ºC 
solution of freshly distilled propionaldehyde (76.6 µL, 1.06 mmol) in 0.92 mL Et2O was 
added slowly over the course of 36 h to a stirring suspension of 
cyclohexanecarboxaldehyde (1.28 mL, 10.6 mmol), (2S, 5S)-5-benzyl-2-tert-butyl-3-
methyl-imidazolidin-4-one (52.2 mg, 0.212 mmol) and trifluoroacetic acid (16.3 µL, 
0.212 mmol) in Et2O (1.00 mL) at 4 ºC.  After 44 h methanol (5.30 mL) and Amberlyst-
15 (130 mg) were added in one portion.  The solution was stirred until the reaction was 
judged complete by TLC analysis (6 h).  The Amberlyst-15 resin was removed by 
filtration through a fritted filter, and the filtrate was concentrated in vacuo.  Flash 
chromatography (97:3 pentane:Et2O) afforded the title compound as a clear, colorless oil 
in 81% yield (186 mg, 0.860 mmol), 97% ee and 5:1 anti:syn. 1H NMR, 13C NMR, and 
IR data are consistent with those already reported.21 [α]D = 14.0 (c = 1.0, MeOH); lit: [α]D 
= 0.5 (c = 1.12, MeOH); 19% ee. The product ratios were determined by GLC analysis of 
the acetate derived from the product alcohol by the method of Khorana4 using a Bodman 
Chiraldex β-DM (30 m x 0.25 mm) column (105 ºC isotherm, 12 psi); (1R, 2R) anti 
isomer tr = 103.8 min, (1S, 2S) anti isomer tr = 103.4 min, (1R, 2S) and (1S, 2R) syn 
isomers tr = 106.0 min. 
 
(1R, 2R)-3,3-Dimethoxy-2-methyl-1-phenyl-propan-1-ol (table 3, entry 4). A 4 
ºC solution of freshly distilled propionaldehyde (66.7 µL, 0.925 mmol) in 0.83 mL Et2O 
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was added slowly over the course of 36 h to a stirring suspension of benzaldehyde (940 
µL, 9.25 mmol), (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (45.6 mg, 
0.185 mmol) and trichloroacetic acid (30.2 mg, 0.185 mmol) in Et2O (0.95 mL) at 4 ºC.  
After 48 h methanol (4.60 mL) and Amberlyst-15 (240 mg) were added in one portion.  
The solution was stirred until the reaction was judged complete by TLC analysis (1 h).  
The Amberlyst-15 resin was removed by filtration through a fritted filter, and the filtrate 
was concentrated in vacuo.  Flash chromatography (4:1 pentane:Et2O) afforded the title 
compound as a clear, colorless oil in 61% yield (109 mg, 0.518 mmol), 83% ee and 3:1 
anti:syn. 1H NMR, 13C NMR, and IR data are consistent with those already reported.21 
[α]D = –13.06 (c = 1.0, MeOH); lit: [α]D = –16.20 (c = 1.06, MeOH).  The product ratios 
were determined by GLC analysis using a Bodman Chiraldex β-DM (30 m x 0.25 mm) 
column (120 ºC isotherm, 12 psi); (1R, 2R) anti isomer tr = 75.6 min, (1S, 2S) anti isomer 
tr = 80.6 min, (2R, 3S) and (2S, 3R) syn isomers tr = 86.1 min. 
 
(3R, 4R)-4-Dimethoxymethyl-2-methyl-octan-3-ol (table 3, entry 5). A 4 ºC 
solution of freshly distilled hexanal (165 µL, 1.37 mmol) in 0.80 mL Et2O was added 
slowly over the course of 36 h to a stirring suspension of isobutyraldehyde (1.18 mL, 
13.7 mmol), (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (67.5 mg, 0.274 
mmol) and trifluoroacetic acid (21.1 µL, 0.274 mmol) in Et2O (1.0 mL) at 4 ºC.  After 40 
h methanol (6.9 mL) and Amberlyst-15 (171 mg) were added in one portion.  The 
solution was stirred until the reaction was judged complete by TLC analysis (4 h).  The 
Amberlyst-15 resin was removed by filtration through a fritted filter, and the filtrate was 
concentrated in vacuo.  Flash chromatography (5:1 pentane:Et2O) afforded the title 
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compound as a clear, colorless oil in 72% yield (202 mg, 0.801 mmol), 91% ee and 6:1 
anti:syn. IR (film) 3520, 2956, 2932, 2872, 1467, 1379, 1365, 1200, 1188, 1101, 1074, 
996.5 cm-1; 1H NMR (300 MHz, CDCl3) δ 4.42 (d, 1H, J = 3.9 Hz, CH(OCH3)2); 3.42 (s, 
3H, OCH3); 3.40 (s, 3H, OCH3); 3.34 (m, 2H, CHOH, CHOH);  1.76 (m, 2H, 
CHCH(OCH3)2, CH(CH3)2); 1.48-1.18 (m, 6H, CH(CH2)3CH3); 0.94-0.85 (m, 9H, 
CH(CH3)2, (CH2)3CH3); 13C NMR (75 MHz, CDCl3) δ 108.2, 76.2, 56.5, 55.0, 42.3, 31.3, 
29.6, 25.9, 23.5, 20.2, 17.6, 14.4; HRMS (CI) exact mass calculated for [M – H]+ 
(C12H25O3) requires m/z 217.1804, found m/z 217.1805; [α]D = 6.40 (c = 1.0, CHCl3). The 
diastereomeric ratio was determined by 1H NMR integration of the crude product (300 
MHz, CDCl3): δ 4.42 (d, 1H, major), 4.39 (d, 1H, minor).  The enantiomeric purity was 
determined by conversion to the (R)-MTPA ester derivative and 1H NMR integration 
(300 MHz, CDCl3): δ 4.07 (d, 1H, major), 4.10 (d, 1H, minor). 
 
(2R, 3R)-2-Benzyl-1,1-dimethoxy-4-methyl-pentan-3-ol (table 3, entry 6). A 4 
ºC solution of freshly distilled hydrocinnamaldehyde (132 µL, 1.00 mmol) in 0.86 mL 
Et2O was added slowly over the course of 36 h to a stirring suspension of 
isobutyraldehyde (908 µL, 10.0 mmol), (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-
imidazolidin-4-one (49.3 mg, 0.200 mmol) and trifluoroacetic acid (15.4 µL, 0.200 
mmol) in Et2O (1.0 mL) at 4 ºC.  After 40 h methanol (5.0 mL) and Amberlyst-15 (188 
mg) were added in one portion.  The solution was stirred until the reaction was judged 
complete by TLC analysis (4 h).  The Amberlyst-15 resin was removed by filtration 
through a fritted filter, and the filtrate was concentrated in vacuo.  Flash chromatography 
(4:1 pentane:Et2O) afforded the title compound as a clear, colorless oil in 80% yield (202 
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mg, 0.801 mmol), 91% ee and 5:1 anti:syn. IR (film) 3517, 2958, 2873, 2834, 1495, 
1453, 1366, 1207, 1111, 1068, 1032, 964.4, 747.5, 700.6 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 7.31-7.16 (m, 5H, C6H5); 4.30 (d, 1H, J = 3.3 Hz, CH(OCH3)2); 3.45 (s, 3H, 
OCH3); 3.39 (s, 3H, OCH3); 3.28 (m, 2H, CHOH, CHOH); 2.77 (d, 2H, J = 7.8 Hz, 
CH2C6H5); 2.16 (m, 1H, CHCH(OCH3)2); 1.78 (m, 1H, CH(CH3)2); 0.94 (d, 3H, J = 6.9 
Hz, CH(CH3)2); 0.86 (d, 3H, J = 6.9 Hz, CH(CH3)2); 13C NMR (75 MHz, CDCl3) δ 129.3, 
128.6, 128.5, 126.1, 107.9, 75.8, 57.0, 56.1, 44.6, 32.2, 31.7, 19.9, 18.0; HRMS (CI) 
exact mass calculated for [M]+ (C15H24O3) requires m/z 252.1726, found m/z 252.1724. 
[α]D = –10.78 (c = 1.0, CHCl3). The diastereomeric ratio was determined by 1H NMR 
integration of the crude product (300 MHz, CDCl3): δ 4.30 (d, 1H, major), 4.08 (d, 1H, 
minor).  The enantiomeric purity was determined by conversion to the (R)-MTPA ester 
derivative and 1H NMR integration (300 MHz, CDCl3): δ 4.05 (d, 1H, major), 4.10 (d, 
1H, minor). 
 
2,2-Dimethyl-propionic acid (2S, 3R)-2-hydroxy-4,4-dimethoxy-3-methyl-
butyl ester (table 3, entry 7).   A 4 ºC solution of freshly distilled propionaldehyde (290 
µL, 4.02 mmol) and 2,2-dimethyl-propionic acetoxyacetaldehyde (116 mg, 0.805 mmol) 
in 0.60 mL Et2O was added slowly  over the course of 36 h to a stirring solution of (2S, 
5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (40.0 mg, 0.161 mmol) and 
trifluoroacetic acid (12.4 µL, 0.161 mmol) in Et2O (0.60 mL).  After 36 h methanol (4.0 
mL) and Amberlyst-15 (200 mg) was added in one portion.  The solution was stirred until 
the reaction was judged complete by TLC analysis (8 h).  The Amberlyst-15 resin was 
removed by filtration through a fritted filter, and the filtrate was concentrated in vacuo.  
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Flash chromatography (95:5 hexanes:acetone) afforded the title compound as a clear, 
colorless oil in 58% yield (116 mg, 0.467 mmol), 90% ee and 4:1 anti:syn. IR (film) 
3469, 2961, 2929, 1729, 1482, 1462, 1393, 1367, 1286, 1163, 1107, 1071, 945.4 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 4.35 (d, 1H, J = 5.7 Hz, CH(OCH3)2); 4.22 (dd, 1H, J = 11.4, 
3.3 Hz, CH2OC(O)C(CH3)3); 4.09 (dd, 1H, J = 11.4, 5.4 Hz, CH2OC(O)C(CH3)3); 3.81 
(m, 1H, CHOH); 3.44 (s, 3H, OCH3); 3.40 (s, 3H, OCH3); 2.01 (m, 1H, CHCH3); 1.21 (s, 
9H, C(CH3)3); 0.93 (d, 3H, J = 7.2 Hz, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 108.4, 
71.8, 67.1, 56.3, 54.5, 39.1, 38.8, 27.6, 11.7; HRMS (CI) exact mass calculated for [M + 
H]+ (C12H25O5) requires m/z 249.1702, found m/z 249.1690. [α]D = 4.20 (c = 1.0, CHCl3).  
The product ratios were determined by GLC analysis of the product using a Bodman 
Chiraldex β-PH (30 m x 0.25 mm) column (120 ºC isotherm, 14 psi); (2R, 3S) anti isomer 
tr = 107.8 min, (2S, 3R) anti isomer tr = 114.7 min, (2R, 3S) and (2S, 3R) syn isomers tr = 
127.3, 142.4 min. 
 
(2R, 3R)-1,3-Bis-benzyloxy-4,4-dimethoxy-butan-2-ol (table 3, entry 8). 
Freshly distilled benzyloxyacetaldehyde (621 µL, 8.61 mmol) was added to a –20 ºC 
stirring solution of (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (81.8 mg, 
0.332 mmol) and trichloroacetic acid (54.2 mg, 0.332 mmol) in Et2O (0.35 mL).  After 72 
h methanol (2.8 mL) and Amberlyst-15 (138 mg) were added in one portion.  The 
solution was stirred until the reaction was judged complete by TLC analysis (2 h).  The 
Amberlyst-15 resin was removed by filtration through a fritted filter, and the filtrate was 
concentrated in vacuo.  Flash chromatography (3:2-2:3 pentane:Et2O, linear gradient) 
afforded the title compound as a clear, colorless oil in 64% yield (134 mg, 0.387 mmol), 
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91% ee and 4:1 anti:syn. IR (film) 3468, 2927, 2862, 1454, 1365, 1325, 1202, 1075, 
736.6, 698.2 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.43-7.22 (m, 10H, C6H5);  4.82-4.43 
(m, 5H, CH(OCH3)2, CH2C6H5); 4.00 (s, 1H, CHOH); 3.65-3.41 (m, 10H, OCH3, CHOH, 
CH2OBn, CHOBn); 13C NMR (75 MHz, CDCl3) δ 128.6, 128.4, 128.2, 128.1, 128.0, 
127.9, 127.8, 106.2, 78.9, 78.3, 74.6, 73.6, 71.2, 69.7, 56.6, 56.2; HRMS (CI) exact mass 
calculated for [M – H]+ (C20H25O5) requires m/z 345.1702, found m/z 345.1691. [α]D =      
–2.48 (c = 1.0, CHCl3).  The product ratios were determined by HPLC using a Chiracel 
OJ and OJ guard column (6% ethanol/hexanes, 1 mL/min): (2R, 3R) anti isomer tr = 41.7 
min, (2S, 3S) anti isomer tr = 31.4 min, (2R, 3S) and (2S, 3R) syn isomers tr = 22.1, 24.8 
min. 
 
Determination of the absolute stereochemistry of (2R, 3R)-1,3-Bis-benzyloxy-
4,4-dimethoxy-butan-2-ol.  (2S, 3S)-3-Hydroxy-2,3-bis-(benzyloxy)-propionaldehyde 
(20 mg, 0.067 mmol) was prepared as reported previously24 and dissolved in MeOH (0.33 
mL).  Amberlyst-15 (8 mg) was added in one portion with stirring.  After 6 h, the 
Amberlyst-15 resin was removed by filtration through a fritted filter, and the filtrate was 
concentrated in vacuo. Flash chromatography (1:1 pentane:Et2O) afforded (2S, 3S)-1,3-
bis-benzyloxy-4,4-dimethoxy-butan-2-ol as a clear, colorless oil in 64% yield (14 mg, 
0.043 mmol); 1H NMR, 13C NMR, and IR data match those reported above, but with an 
opposite rotation: [α]D = 2.61 (c = 1.0, CHCl3).    
 
(2R, 3R)-1,3-Bis-benzylsulfanyl-4,4-dimethoxy-butan-2-ol (table 3, entry 9). 
Freshly distilled benzylsulfanylacetaldehyde (300 mg, 1.80 mmol) was added to a 4 ºC 
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stirring solution of (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one (14.8 mg, 
0.060 mmol) and trifluoroacetic acid (4.6 µL, 0.060 mmol) in Et2O (0.60 mL).  After 48 h 
methanol (2.8 mL) and Amberlyst-15 (138 mg) were added in one portion.  The solution 
was stirred until the reaction was judged complete by TLC analysis (2 h).  The 
Amberlyst-15 resin was removed by filtration through a fritted filter, and the filtrate was 
concentrated in vacuo.  Flash chromatography (4:1 pentane:Et2O) afforded the title 
compound as a clear, colorless oil in 84% yield (192 mg, 0.504 mmol), 97% ee and 11:1 
anti:syn. IR (film) 3464, 3058, 3026, 2918, 2820, 1606, 1582, 1494, 1453, 1117, 1070, 
1030, 765.8, 701.8 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.40-7.18 (m, 10 H, C6H5);  4.37 
(d, 1H, J = 3.3 Hz, CH(OCH3)2);  3.93 (m, 1H, CHOH); 3.78 (s, 2H, CH2C6H5); 3.72 (s, 
2H, CH2C6H5);   3.35 (s, 6H, OCH3); 3.18 (m, 1H, CHCH(OCH3)2); 2.87 (dd, 1H, J = 7.2, 
4.2 Hz, CH2SBn); 2.54 (dd, 1H, J = 13.8, 7.2 Hz, CH2SBn) 13C NMR (75 MHz, CDCl3) δ 
138.3, 138.2, 129.4, 129.2, 129.1, 128.7, 127.4, 127.2, 107.7, 70.4, 56.5, 56.4, 51.3, 37.5, 
36.7; HRMS (CI) exact mass calculated for [M – H]+ (C20H25O3S2) requires m/z 377.1245, 
found m/z 377.1253. [α]D = 15.54 (c = 1.0, CHCl3).  The product ratios were determined 
by HPLC using a Chiracel AD and AD guard column (4% isopropanol/hexanes, 1 
mL/min): (2R, 3R) anti isomer tr = 31.2 min, (2S, 3S) anti isomer tr = 27.1 min, (2R, 3S) 
and (2S, 3R) syn isomers tr = 43.5 min. 
 
(2S, 3R)-3-Hydroxy-2,3-bis-triisopropylsilanoxy-propionaldehyde (table 3, 
entry 10).  Freshly prepared triisopropylsilanoxy-acetaldehyde (900 mg, 4.17 mmol) was 
added to a 4 ºC stirring solution of (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-imidazolidin-
4-one (34.2 mg, 0.138 mmol) and trifluoroacetic acid (10.8 µL, 0.138 mmol) in Et2O 
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(1.38 mL).  After 36 h, the reaction was diluted in Et2O, and then successively washed 
with saturated aqueous solutions of NH4Cl, NaHCO3, and brine.  The organic layer was 
dried over anhydrous Na2SO4 and concentrated in vacuo.  Flash chromatography (40:1 
pentane:Et2O) was performed on a silica column prewashed with a solution of diethyl 
amine (150 mL) in pentane (900 mL), followed by 300 mL of the eluent to remove 
excess amine.  The title compound was obtained from this column as a clear, colorless oil 
in 84% yield (504 mg, 1.17 mmol), 92% ee, 4:1 syn:anti. IR (film) 3559, 2944, 2867, 
1729, 1464, 1384, 1248, 1119, 1068, 1015, 996.0, 882.3, 785.8, 683.1 cm-1.  1H NMR and 
13C NMR data are consistent with those already reported,24 [α]D = 0.60 (c = 1.0, CHCl3). 
 
Determination of the absolute stereochemistry of (2S, 3R)-3-Hydroxy-2,3-bis-
triisopropylsilanoxy-propionaldehyde. (2S, 3R)-3-Hydroxy-2,3-bis-triisopropylsilano-
xy-propionaldehyde was reduced and converted to the corresponding benzylidene acetal 
as reported previously for stereochemical proof.25  Removal of the silyl groups with 
TBAF furnished 1,3-(R)-O-benzylidine-D-threitol, whose IR, 1H NMR and 13C NMR data 
are consistent with those already reported.25 [α]D = –3.75 (c = 0.7, MeOH); lit: [α]D = –6 
(c = 1.0, MeOH) 
 
19 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed. Pergamon Press, Oxford, 1988. 
20 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
21 Basel, Y.; Hassner, A., J. Org. Chem.  2000, 65, 6368. 
22 Weber, H.; Khorana, H. G.  J. Mol. Biol.  1972, 72, 219. 
23 Denmark, S.; Ghosh, S. K.  Angew. Chem. Int. Ed. 2001, 40, 4759. 
24 Northrup, A. B.; Mangion, I. K.; Hettche, F.; MacMillan, D. W. C. Angew. Chem., Int. Ed. 2004, 43, 2152. 
25 Lehmann, J.; Wagenknecht, H.-A.  Carbohydrate Res.  1995, 276, 215. 
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C h a p t e r  2  
Proline-Catalyzed Direct Aldol Chemistry: 
Application to Carbohydrates*  
 
Introduction 
 Central to the growing interest in organocatalysis has been the renaissance of 
proline as an enantioselective catalyst.  Beginning with the Hajos-Parrish reaction1 (see 
Chapter 1), there has been a high standard for proline catalysis for thirty years.  
Remarkably, there had been few real advances in proline chemistry until recent work by 
Barbas, List, and Lerner that demonstrated high enantioselectivities in direct 
intermolecular aldol reactions between ketones and aldehydes (eq 1).2  This strategy was 
(1)
20 mol% L-Proline
DMSO
97% yield, 96% ee
Me
O
Me
20 vol%
O
H
Me
Me
Me
O OH
Me
Me
 
subsequently applied towards a variety of other reactions, including Mannich, conjugate 
addition, and cycloaddition processes.3  Despite these advances, we noted that a direct 
aldehyde-aldehyde aldol had not been reported for proline.  This seemed unusual given 
that proline has proven so effective for other direct aldol events.   
                                                
* For a communication of this work, see: Northrup, A. B.; Mangion, I. K.; Hettche, F.; MacMillan, D. W. C. 
Angew. Chem. Int. Ed. 2004, 43, 2152. 
1 (a) Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615.  (b) Eder, U.; Sauer, G.; Weichert, R. Angew. Chem. 
Int. Ed., Eng. 1971, 10, 496. 
2 List, B.; Lerner, R. A.; Barbas, C. F. III J. Am. Chem. Soc. 2000, 122, 2395. 
3 See: (a) List, B.; Pojarliev, P.; Biller, W. T.; Martin, H. J. J. Am. Chem. Soc. 2002, 124, 827; (b) Ramachary, D. B.; 
Chowdari, N. S.; Barbas, C. F. III Angew. Chem. Int. Ed. 2003, 42, 4233. 
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 Given that imidazolidinone catalysts had proven successful in the direct aldehyde 
aldol, it was perhaps a logical effort to employ proline as a catalyst for the same 
transformation.  A graduate student in our labs, Alan Northrup, attempted to do so using 
propionaldehyde as a substrate (eq 2).  The initial result (96% ee) was exceptional, and   
(2)H
O
Me
H
O
Me
10 mol% L-Proline
10% DMPU/DMF
O
H
Me
Me
OH
3:1 anti:syn
96% ee
23 °C  
was improved yet further with slight modification of conditions (4:1 anti:syn, 99% ee).4  
This method proved amenable to regioselective cross aldol reactions, including the 
remarkable example shown below in which propionaldehyde can be effectively 
differentiated from isobutyraldehyde through careful syringe pump addition (eq 3). 
(3)
H
O
Me
H
O O
H
Me
OHMe
Me
Me
Me
88% yield
3:1 anti:syn
99% ee
10 mol% L-Proline
DMF, 4 °C
 
              Notably these proline-catalyzed reactions provided β-hydroxy aldehydes directly 
rather than the hemiacetal trimers observed for imidazolidinone catalysis.5  There are few 
points of direct evidence to demonstrate why this is the case.  However, Alan made the 
intriguing observation that the resting state of proline in the direct aldehdye aldol (as 
identified by 1H NMR) is N, O-acetal 56 (figure 1).7  He subsequently proposed that such 
an acetal is the product of a side equilibrium from the catalytic cycle of proline shown 
                                                
4 Northrup, A. B.; MacMillan, D. W. C.  J. Am. Chem. Soc. 2002, 124, 6798. 
5 Mangion, I. K.; Northrup, A. B.; MacMillan, D. W. C.  Angew. Chem. Int. Ed. 2004, 43, 6722. 
6 Observation of a similar proline acetal has been reported: Orsini, F.; Pelizzoni, F.; Forte, M.; Sisti, M.; Bombieri, 
G.; Benetollo, F.  J. Heterocyclic Chem. 1989, 26, 837. 
7 A more extensive review of this and other proline aldol work has already been presented: Northrup, A. B.; PhD 
thesis, California Institute of Technology, 2005. 
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Figure 1:  Proposed Catalytic Cycle for Proline–Catalyzed Aldehyde Aldol
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here.  Most of the cycle resembles that which is predicted for imidazolidinone catalysis 
(intermediacy of an enamine, etc.), but if one makes the assumption that a similar N, O-
acetal (6) forms from product iminium 7, then catalyst turnover will be dependent on the 
ability of a nucleophile to turn over 6 or the small equilibrium content of 7.  This acetal 
should be less reactive than a discrete iminium (as in the imidazolidinone aldol), and 
therefore might require a stronger nucleophile for turnover than an aldehyde (which 
would lead to the hemiacetal).  Ambient water is assumed to provide that function, with 
hydrolysis of 6 leading to catalytic turnover. 
 The advantage of direct access to β-hydroxy aldehydes is that, in concept, they 
can be applied in further aldol reactions to try to build polypropionate arrays such as 
those present in the erythronolides (figure 2).  In a similar fashion, one could build 
carbohydrates enantioselectively in a two-step fashion if protected hydroxyacetaldehydes 
could be used as substrates in a proline-catalyzed direct aldol.  Herein is described studies 
on precisely such a methodology, performed in collaboration with Alan Northrup and Dr. 
Frank Hettche. 
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Figure 2: Sequential Aldol Can Access Carbohydrates Enantioselectively
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Direct Synthesis of Protected Erythrose Derivatives 
Applying the optimal conditions derived from the previous proline aldol studies in 
the MacMillan lab,4 we investigated a range of protected hydroxyacetaldehydes in 
dimerization reactions (table 1).  Preliminary studies revealed that the proposed 
enantioselective aldol union is indeed possible, however, the electronic nature of the 
oxyaldehyde substituent has a pronounced effect on the overall efficacy of the process.  
For example, substrates that possess an electron-withdrawing substituent, such as α-
acetoxyacetyaldehyde (Entry 1, 0% yield), do not participate in this transform, while 
aldehydes bearing relatively electron-rich oxyalkyl groups provide useful levels of 
enantiocontrol and reaction efficiency (Entry 2, R = Bn, 73% yield, 98% ee; Entry 3, R = 
PMB, 85% yield, 97% ee). Some of the best results were achieved with aldehydes 
bearing bulky α-silyloxy substituents (Entry 4, PG = TBS, 50% yield, 88% ee; Entry 5 R 
= TBDPS, 61% yield, 96% ee) with the TIPS protected glycoaldehyde (Entry 6) 
affording exceptional reaction efficiency (92%), enantioselectivity (95% ee), and a 
readily separable 4:1 mixture of anti and syn diastereomers.  It should be noted that all of 
the dimeric aldol adducts shown in Table 1 constitute protected forms of the naturally 
occurring sugar erythrose, which we hope to apply as the basis for a two-step synthesis of   
 
 
31 
Table 1.  Proline–Catalyzed Aldol Dimerization of Glycoaldehydes
entry
1
2
3
4f
5f
6
7
anti:synb
--
4:1
4:1
3:1
9:1
4:1
4:1
0  
86e
85e
50
 
61 
92
42
% yielda % eec,d
--
98
97
88
96
95
96
solventproduct
OPG
O
H
10 mol% L-Proline
solvent, rt, 24-48h
OH
OPG
O
H2
OPG
DMF
DMF
DMF
CH3CN
DMSO
DMF
OH
OBn
O
H
OBn
OH
OPMB
O
H
OPMB
OH
OTBS
O
H
OTBS
OH
OTBDPS
O
H
OTBDPS
OH
OTIPS
O
H
OTIPS
OH
OAc
O
H
OAc
DMF/
Dioxane
aYield represents the combined yield of diastereomers. bRelative
stereochemistry assigned by correlation to a known compound.
cDetermined by chiral HPLC, see supporting information for details.
dAbsolute stereochemistry assigned by correlation to a known compound.
eBased on recovered starting aldehyde.  f20 mol% catalyst was employed.
OH
OMOM
O
H
OMOM
 
erythro hexoses. More importantly, the α-oxyaldehyde products of this new aldol 
protocol are apparently inert to further proline-catalyzed enolization or enamine addition, 
a central requirement for controlled stereodifferentiation in the second step of our 
proposed two-step iterative-aldol carbohydrate synthesis (eq 4). 
(4)
Aldol 2Aldol 1
O OH
XO
XO
OH
OY
O
H
OX OX
OHO
H
OX
O
H
OY
O
H
OX
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Regioselectivity in Proline-Catalyzed Cross-Aldol Reactions 
If this aldol technology can be successfully applied toward carbohydrate 
synthesis, a key development would be the direct synthesis of unnatural erythrose 
derivatives by way of regioselective cross-aldols.  When incorporated into hexose 
architectures, these novel structures could potentially serve as probes for biological 
studies focused on carbohydrates, or could enable the synthesis of unusual and elaborate 
sugars.  As such, we examined the capacity of proline to catalyze the enantioselective 
cross-coupling of α-oxy- and α-alkyl-substituted aldehydes (table 2).  As in the 
imidazolidinone aldol described in chapter 1, the principal issue in this reaction is that the  
Table 2.  Proline–Catalyzed Cross Aldol Reactions of Glycoaldehydes
productentry anti:synb
8:1
% yielda
43
% eec,d
99
OX
O
H
OX
O
H
OH
R(OX)
O
H
OH
Me
O
H
OR
OHO
H
OR
!-alkyl
OH
RO
O
H
Me
Me
10 mol% L-Proline
DMF, rt
role = donor or acceptor
5
1
O
Me
Me
H
O
Me
H
O
H
acceptor
OTIPS
2
acceptor
OTBDPS
75 4:1 99
84 5:1 99
3
acceptor
OTIPS
4
acceptor
OBn
54 4:1 99
64 4:1 94
R
donor
acceptor
donor
i-Pr
aldehyde
OX(R)
Me Me
donor
OTIPS
donor
OBn 7:145 956
aYield represents the combined yield of diastereomers. bRelative
stereochemistry assigned by correlation to a known compound.  cDetermined 
by chiral HPLC, see supporting information for details. dAbsolute
stereochemistry assigned by correlation to a known compound.  
non-equivalent aldehydes must selectively partition into two discrete components, a 
nucleophilic donor and an electrophilic acceptor.  Given that most α-oxy- and α-alkyl 
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aldehydes we chose to employ bear enolizable protons, we anticipated that such catalyst-
controlled substrate partitioning could only function on the basis of electronic, rather than 
steric, discrimination. Contrary to expectation, the glycoaldehyde invariably acts as the 
electrophile in the presence of alkyl aldehydes that contain α-methylene protons (Entries 
1-4, 94% to 99% ee).  Surprisingly, even the sterically demanding isovaleraldehyde 
assumes the role of nucleophile when exposed to proline and α-benzyloxyacetaldehyde 
or α-silyloxyacetaldehyde (Entries 3 and 4).  However, both triisopropylsilyl and benzyl 
protected oxyaldehydes can function as aldol donors in the presence of aldehydes that do 
not readily participate in enamine formation (Entries 5 and 6, 7-8:1 anti:syn, 96% to 99% 
ee).  It should be noted, however, that significant quantities of glycoaldehyde 
homodimers are generated in these cases, indicating that homodimerization is a 
competing process even with concentration control. 
While the exquisite ability of proline to select alkyl aldehydes to act as aldol 
donors in these cross-aldol reactions was gratifying, it remained to determine the 
mechanistic origins of this selectivity.  These organocatalytic results stand in marked 
contrast to metal-mediated direct aldol technologies where the increased acidity and 
nucleophilicity afforded by α-oxygenated aldol donors greatly enhances their reaction 
efficiency relative to their all-alkyl counterparts.8  Based on these results one might 
expect the α-oxygenated aldehydes to act exclusively as the donor.  But in general, the 
reactivity of these aldehydes generally proves to be slower than those of alkyl aldehydes: 
                                                
8 For examples of metal-mediated direct aldol reactions see: (a) Yamada, Y. M. A.; Yoshikawa, N.; Sasai, H.; 
Shibasaki, M. Angew. Chem. Int. Ed. Engl. 1997, 36, 1871.  (b) Yoshikawa, N.; Kumagai, N.; Matsunaga, S.; Moll, 
G.; Oshima, T.; Suzuki, T.; Shibasaki, M. J. Am. Chem. Soc. 2001, 123, 2466. (c) Trost, B. M.; Ito, H. J. Am. Chem. 
Soc. 2000, 122, 12003.  (d) Evans, D. A.; Tedrow, J. S.; Shaw, J. T.; Downey, C. W. J. Am. Chem. Soc. 2002, 124, 
392.  (e)  Evans, D. A.; Downey, C. W.; Shaw, J. T.; Tedrow, J. S. Org. Lett. 2002, 4, 1127. 
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the proline-catalyzed dimerization of benzyloxyacetaldehyde requires 42 hours and still 
fails to go to completion, while the dimerization of propionaldehyde requires only 11 
hours. 
 To rationalize these observations, we returned to consideration of the catalytic 
cycle shown in figure 1 of this chapter.  Qualitatively, one might expect the parasitic 
equilibrium that produces 5 would be driven further to the right if the aldehyde in 
question has an electron withdrawing group α to the carbonyl (eq 5).  This effect should 
(5)
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O
R
O
5
R = OP
Greater acetal contentGreater iminium content  
be especially pronounced for the case of R = OAc, and indeed the complete lack of aldol 
reactivity of acetoxyacetaldehyde on exposure to proline is consistent with trapping of the 
catalyst as 5.  We have since observed this acetal by 1H NMR in DMF-d7 as a substantial 
(≥50%) fraction of soluble proline for a range of aldehydes.6  One can then explain the 
poorer reactivity of glycoaldehydes as a consequence of the greater electronic instability 
of their corresponding iminium ions, and therefore greater propensity to exist in an 
inactive form.  One might then predict that electron-releasing protecting groups such as 
silicon protecting groups might mitigate this destabilizing effect, and therefore allow for 
a greater iminium character which then leads to higher active enamine content.  Their 
superior reactivity relative to other glycoaldehydes provides circumstantial evidence for 
this idea.  In a similar way, one would predict a greater donor reactivity for the more 
electron-rich alkyl aldehydes, as is observed. 
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Stereochemical Rationale for Proline Aldol 
 There have been many models created for the purpose of predicting the 
stereochemical outcome of reactions mediated by proline.  Because it is well supported 
through ab initio computation and matches experimental results closely, I have chosen 
the Houk model for presentation here (figure 3).9  This model predicts a closed transition  
Figure 3:  Stereochemical Model for Proline-Catalyzed Direct Aldehyde Aldol
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state linked through a nine-membered hydrogen bonding ring.  The relative geometries of 
the enamine and aldehyde simulate a chair-type transition state that favors orientation of 
the R group of the aldol acceptor into a pseudo-equatorial conformation (pseudo-axial 
leading to the disfavored syn diastereomer).  This model correctly predicts both absolute 
and relative stereochemistry in the aldol reaction, and highlights the remarkable ability of 
proline to dictate exceptional levels of stereocontrol through its lone chiral center by way 
of a hydrogen bond activation. 
 
Development of the Second Step of a Two-Step Carbohydrate Synthesis 
 Having secured a direct enantioselective glycoaldehyde aldol reaction, the 
MacMillan lab began to pursue an iterative aldol approach to carbohydrates.  As shown 
above in equation 4, this now requires the development of an aldol addition of a 
glycoaldehyde (or its equivalent) to a protected erythrose derivative.  However, in the 
course of our proline studies we had observed only trace reactivity in attempts to add 
                                                
9 Allemann, C.; Gordillo, R.; Clemente, F. R.; Cheong, P. H.-Y; Houk, K. N. Acc. Chem. Res. 2004, 101, 5482. 
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aldehydes directly to β-hydroxy aldehyde aldol products (figure 4).  We supposed the 
poor reactivity of β-hydroxy aldehydes under conditions that seem well suited for α-
branched aldehydes (i.e. isobutyraldehyde, Figure 4) meant that these aldol products 
might engage in an internal hydrogen bond that gives the carbonyl a partial positive 
charge and renders its free lone pair unreactive towards hydrogen-bond donors (i.e. 
proline).  Given that proline’s ability to use hydrogen bonding as an activation method is 
critical to its reactivity, these observations can make perfect sense.  
Figure 4: !-Hydroxy Aldehydes are Poor Substrates in Direct Aldol
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 To overcome this limitation, a new method was envisioned for completing a 
sequential aldol approach.  Alan Northrup developed the use of silyl enol ether 
equivalents of protected glycoaldehydes in a Lewis acid-mediated aldol reaction with the 
erythrose derivatives derived from our proline aldol method (eq 6).  This approach not 
only overcomes the poorer reactivity of β-hydroxy aldehydes through metal activation, 
but also does so in a stereocontrolled fashion that allows selective synthesis of the 
glucose, mannose, and allose stereochemical arrays through judicious choice of reaction  
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O
TIPSO OAc
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Et2O, 4 °C
(6)
 
conditions.10  While this chemistry has not yet been successfully applied towards the 
synthesis of other stereochemical arrays, it demonstrates the possibility of eventually 
accessing all natural hexoses in a differentially protected form in two chemical steps. 
 
Conclusions   
 We have completed the development of a new proline-catalyzed direct aldehyde-
aldehyde aldol method.  This approach allows a one-step, enantioselective synthesis of 
protected erythrose derivatives from glycoaldehydes for the first time.  Completely 
regioselective cross aldol reactions can also be performed between alkyl and oxygenated 
aldehydes taking advantage of a mechanism-based electronic differentiation imparted by 
proline.  These erythroses can then be applied in a second, Lewis acid-mediated aldol 
reaction with silyl enol ether equivalents of aldehydes.  This reaction produces 
differentially protected carbohydrates in a stereocontrolled fashion.  Subsequent work 
shown in chapter 3 will detail efforts to take advantage of this and other applications of 
enamine catalysis toward the synthesis of natural products.  
                                                
10 Northrup, A. B.; MacMillan, D. W. C.  Science 2004, 305, 1753. 
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Supporting Information 
 
General Information.  Commercial reagents were purified prior to use following the 
guidelines of Perrin and Armarego.11  Non-aqueous reagents were transferred under 
nitrogen via syringe or cannula.  Organic solutions were concentrated under reduced 
pressure on a Büchi rotary evaporator using an ice-water bath.  Chromatographic 
purification of products was accomplished using forced-flow chromatography on ICN 60 
32-64 mesh silica gel 63 according to the method of Still.12  Thin-layer chromatography 
(TLC) was performed on EM Reagents 0.25 mm silica gel 60-F plates.  Visualization of 
the developed chromatogram was performed by fluorescence quenching or by 
anisaldehyde stain. 
1H and 13C NMR spectra were recorded on a Mercury 300 (300 MHz and 75 
MHz) as noted, and are internally referenced to residual protio solvent signals.  Data for 
1H NMR are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant (Hz) and 
assignment.  Data for 13C NMR are reported in terms of chemical shift.  IR spectra were 
recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in terms of 
frequency of absorption (cm-1).  Mass spectra were obtained from the California Institute 
of Technology Mass Spectral facility or from the UC Irvine Mass Spectral facility.  Gas 
liquid chromatography (GLC) was performed on Hewlett-Packard 6850 and 6890 Series 
gas chromatographs equipped with a split-mode capillary injection system and flame 
ionization detectors using a Bodman Chiraldex β-DM (30 m x 0.25 mm) column or an 
                                                
11Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed., Pergamon Press, Oxford, 1988. 
12Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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ASTEC Chiraldex β-BP (30 m x 0.25 mm) as noted.  High performance liquid 
chromatography (HPLC) was performed on Hewlett-Packard 1100 Series 
chromatographs using a Chiralcel AD column (25 cm) and AD guard (5 cm), a Chiralcel 
OJ column (25 cm) and OJ guard (5 cm) or a Chiralcel ODH column (25 cm) and ODH 
guard (5 cm) as noted. 
 
(2S, 3S)-3-Hydroxy-2,3-bis-(benzylyloxy)-propionaldehyde (table 1, entry 2).  A 
suspension of benzyloxyacetaldehyde (1.0 g, 6.66 mmol) and L-proline (38.3 mg, 0.33 
mmol) in dimethylformamide (13.3 mL) was stirred for 42 h at room temperature.  The 
resulting solution was diluted with water, extracted with ethyl acetate and washed with 
brine, dried over anhydrous Na2SO4.  Flash chromatography (1:19 ether: 
dichloromethane) afforded the title compound as a clear, colorless oil in 52% yield (518 
mg, 0.31 mmol), 98% ee (anti), and 4:1 anti:syn.  Recovered starting material (442 mg) 
was resubjected to the above conditions to afford and additional 21% yield (210 mg) for a 
combined yield of 73%.  IR (film) 3438, 3064, 3031, 2868, 1957, 1879, 1813, 1732, 
1497, 1454, 1094, 738.9, 698.7 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.72 (d, 1H, J = 1.8 
Hz, CHO); 7.33 (m, 10H, Ar-H); 4.73 (d, 1H, J = 12.3 Hz, CH2Ar); 4.56 (d, 1H, J = 12.3 
Hz, CH2Ar); 4.54 (d, 1H, J = 12.0 Hz, CH2Ar); 4.49 (d, 1H, J = 12.0 Hz, CH2Ar); 4.14 
(m, 1H, CHOH); 3.93 (dd, 1H, J = 5.7, 1.8 Hz, CHCHO); 3.62 (m, 2H, CH2OBn); 2.39 
(d, 1H, J = 6.6 Hz, OH);  13C NMR (75 MHz, CDCl3): δ 202.1, 137.7, 137.1, 128.8, 
128.7, 128.5, 128.4, 128.1, 128.0, 83.7, 73.7, 73.6, 71.1, 69.9; [α]D = –30.6  (c = 0.47, 
CHCl3);  HRMS (CI) exact mass calcd for [M+H]+ (C19H21O4) requires m/z 301.1434, 
found m/z 301.1432.  The enantiomeric purity was determined after reduction (NaBH4) 
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by HPLC analysis using a Chiracel AD and AD guard column (10% ethanol/hexanes, 1 
mL/min): (2S, 3S)-enantiomer: tr = 23.7 min, (2R, 3R)-enantiomer: tr = 32.3 min, syn 
isomers tr = 27.2, 28.8 min.  The diastereomer ratio was determined by 1H NMR analysis 
of the crude title compound and verified by HPLC analysis after NaBH4 reduction. 
 
(2S, 3S)-3-Hydroxy-2,3-bis-(4-methoxybenzylyloxy)-propionaldehyde (table 1, entry 
3).  A suspension of 4-methoxybenzyloxyacetaldehyde (180 mg, 1.0 mmol) and L-proline 
(5.8 mg, 0.05 mmol) in dimethylformamide (1.33 mL) was stirred for 48 h at room 
temperature.  The resulting solution was diluted with water, extracted with ethyl acetate 
and washed with brine, dried over anhydrous Na2SO4.  Flash chromatography (40% to 
60% ethyl acetate: hexanes, linear gradient) afforded the title compound as a clear, 
colorless oil in 64% yield (116 mg, 0.32 mmol), 97% ee (anti), and 4:1 anti:syn along 
with 41 mg recovered starting material (83% yield based on recovered starting material).  
IR (film) 3445, 2915, 2838, 1723, 1613, 1514, 1250, 1174, 1098, 1033, 820.0, 516.5 cm-
1; 1H NMR (300 MHz, CDCl3): δ 9.67 (d, 1H, J = 1.5 Hz, CHO); 7.21 (m, 4H, Ar-H); 
6.88 (m, 4H, Ar-H); 4.63 (d, 1H, J = 10.8 Hz, CH2Ar); 4.48 (d, 1H, J = 11.4 Hz, CH2Ar); 
4.45 (d, 1H, J = 11.1 Hz, CH2Ar); 4.41 (d, 1H, J = 11.4 Hz, CH2Ar); 4.08 (m, 1H, 
CHOH); 3.88 (dd, 1H, J = 5.4, 2.1 Hz, CHCHO); 3.80 (s, 6H, OMe); 3.57 (m, 2H, 
CH2OPMB); 2.47 (d, 1H, J = 6.6 Hz, OH); 13C NMR (75 MHz, CDCl3): δ 202.2, 159.5 
(2), 132.1 (2), 130.1, 129.7, 114.2, 114.0, 83.3, 73.4, 73.2, 71.0, 69.5, 55.6 (2); [α]D =     
–29.2  (c = 1.00, CHCl3);  HRMS (CI) exact mass calcd for [M+NH4]+ (C20H26O5N) 
requires m/z 360.1811, found m/z 360.1827.  The enantiomeric purity was determined 
after reduction (NaBH4) by HPLC analysis using a Chiracel AD and AD guard column 
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(15% ethanol/hexanes, 1 mL/min): (2S, 3S)-enantiomer: tr = 25.9 min, (2R, 3R)-
enantiomer: tr = 35.5 min, syn isomers tr = 29.6, 29.6 min.  The diastereomer ratio was 
determined by 1H NMR analysis of the crude title compound and verified by HPLC 
analysis after NaBH4 reduction. 
 
(2S, 3S)-3-Hydroxy-2,3-bis-(tert-butyl-dimethyl-silanyloxy)-propionaldehyde (table 
1, entry 4).  A suspension of (tert-butyl-dimethyl-silanoxy)-acetaldehyde (176 mg, 1.0 
mmol) and L-proline (11.6 mg, 0.1 mmol) in 1,4-dioxane (2.0 mL) was stirred for 48 h at 
room temperature.  The resulting solution was diluted with diethyl ether, passed through 
a plug of silica and concentrated.  Flash chromatography (15:1 pentane: diethyl ether) 
afforded the title compound as a clear, colorless oil in 62% yield (109 mg, 0.31 mmol), 
88% ee (anti), and 3:1 anti:syn.  IR (film) 3455, 2956, 2930, 2897, 2886, 2859, 1736, 
1473, 1362, 1256, 1117, 838, 780 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.63 (d, 1H, J = 
1.6 Hz, CHO); 4.07 (dd, 1H, J = 5.5, 1.6 Hz, CHCHO); 3.95-3.84 (m, 1H, CHOH); 3.80-
3.55 (m, 2H, CH2OR); 2.39 (d, 1H, J = 7.1 Hz, OH); 0.94-0.86 (m, 18H, 2 C(CH3)3); 
0.12-0.02 (m, 12H, 2 Si(CH3)2); (syn-isomer): δ 9.67 (d, 1H, J = 1.0 Hz, CHO); 4.19 (dd, 
1H, J = 3.8,  1.1 Hz, CHCHO); 3.95-3.84 (m, 1H, CHOH); 3.80-3.55 (m, 2H,  CH2OR); 
2.57 (d, 1H, J = 9.3 Hz, OH); 0.94-0.86 (m, 18H, 2 C(CH3)3); 0.12-0.02 (m, 12H, 2 
Si(CH3)2);  13C NMR (75 MHz, CDCl3): δ 201.7, 78.2, 72.8, 62.2, 25.9 (3C), 25.8 (3 C), 
18.3 (2C), –3.8, –4.4, –4.8 (2C); (syn-isomer): δ 203.3, 76.7, 73.1, 62.1, 25.9 (3C), 25.8 
(3 C), 18.3 (2C), –3.9, –4.4, –4.7, –4.8; the optical rotation was determined after 
converting the product mixture into its 1,3-acetonide acetal (by NaBH4-reduction 
followed by ketalization) and isolation of the anti-isomer by flash chromatography (60:1 
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pentane: diethyl ether): [α]D = –33.6  (c = 2.7, CHCl3);  HRMS (CI) exact mass calcd for 
[M–CH3]+ (C18H39O4Si2) requires m/z 375.2387, found m/z 375.2387.  The enantiomeric 
purity of the acetal and thereby the title compound was determined by GLC analysis 
using a Bodman Chiraldex β-DM (30 m x 0.25 mm) column (110 ºC hold 120 min, ramp 
1ºC/min to 150ºC, 23 psi): (2S, 3S)-enantiomer: tr = 141.8 min, (2R, 3R)-enantiomer: tr = 
142.7 min.  The diastereomer ratio was determined by 1H NMR analysis of the crude title 
compound.  
 
(2S, 3S)-3-Hydroxy-2,3-bis-(tert-butyl-diphenyl-silanyloxy)-propionaldehyde (table 
1, entry 5).  A suspension of (tert-butyl-diphenyl-silanoxy)-acetaldehyde (298 mg, 1.0 
mmol) and L-proline (11.5 mg, 0.1 mmol) in a mixture of 1,4-dioxane (1.0 mL) and DMF 
(1.0 mL) was stirred for 48 h at room temperature.  The resulting solution was diluted 
with ethyl acetate and washed successively with water and brine.  The organic layer was 
dried over anhydrous Na2SO4 and concentrated in vacuo.  Flash chromatography (10:1 
pentane: diethyl ether) afforded the title compound as a clear, colorless oil in 61% yield 
(182 mg, 0.31 mmol), 93% ee (anti-diastereomer) and 9:1 anti:syn. IR (film) 3510, 2958, 
2932, 2892, 2859, 1734, 1472, 1428, 1113, 823, 702 cm-1; 1H NMR (300 MHz, CDCl3) : 
δ 9.61 (d, 1H, J = 1.5 Hz, CHO); 7.70-7.56 (m, 8H, CHar); 7.48-7.30 (m, 12H, CHar); 
4.23 (dd, 1H, J = 3.9,  1.2 Hz, CHCHO); 4.08-3.98 (m, 1H, CHOH); 3.80 (dd, J = 10.2, 
6.9 Hz, 1H,  CH2OR); 3.62 (dd, 1H, J = 10.2, 6.3 Hz, CH2OR); 2.13 (d, J = 5.4 Hz, 1H, 
OH); 1.10 (s, 9 H, C(CH3)3); 1.01 (s, 9H, C(CH3)2); 13C NMR (75 MHz, CDCl3) δ 201.4, 
135.7, 135.6, 135.4 (2C), 132.6, 132.5, 132.4 (2C), 130.0 (4C), 129.7 (4C), 127.8 (2C), 
127.7 (6C), 79.5, 73.9, 63.2, 19.5, 19.2; HRMS (CI) exact mass calcd for [M+NH4]+ 
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(C36H48NO4Si2) requires m/z 614.3122, found m/z 614.3123; [α]D = +0.5  (c = 1.1, 
CHCl3).  The enantiomeric purity was determined by HPLC analysis of the crude title 
compound using a Chiracel OD-H and OD-H guard column (3.0% isopropanol/hexanes, 
1 mL/min): (2S, 3S) anti isomer tr = 14.5 min, (2R, 3R) anti isomer tr = 12.1 min, (2R, 3S) 
and (2S, 3R) syn isomers tr = 10.7, 20.0 min.  The 1,3-acetonide-acetal was prepared and 
the anti-isomer was isolated by flash chromatography (40:1 pentane: diethyl ether) to 
obtain a optical rotation more suitable for comparison: [α]D = –6.1  (c = 2.2, CHCl3); 
HRMS (ESI) exact mass calcd for [M+Na]+ (C39H50NaO4Si2) requires m/z 661.3145, 
found m/z 661.3134.  
 
(2S, 3S)-3-Hydroxy-2,3-bis-triisopropylsilanoxy-propionaldehyde (table 1, entry 6).  
A suspension of trisisopropylsilanoxy-acetaldehyde (224 mg, 1.0 mmol) and L-proline 
(11.7 mg, 0.1 mmol) in DMF (6.7 mL) was stirred for 24 h at room temperature.  The 
resulting solution was diluted with diethyl ether and washed successively with water and 
brine.  The organic layer was dried over anhydrous Na2SO4 and concentrated in vacuo.  
Flash chromatography (40:1 pentane:diethyl ether) afforded the title compound as a clear, 
colorless oil in 75% yield (169 mg, 0.39 mmol), 95% ee (anti-diastereomer) and 4:1 
anti:syn.  Repeated chromatographic purification afforded a 51% yield (115 mg, 0.27 
mmol) of the anti-isomer. IR (film) 3483, 2945, 2892, 2868, 1734, 1464, 1385, 1117, 
1069, 883, 683 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.68 (d, 1H, J = 2.1 Hz, CHO); 4.25 
(dd, 1H, J = 3.9, 2.1 Hz, CHCHO); 4.10-3.94 (m, 1H, CHOH); 3.84 (dd, 1H,  J  = 9.9, 
6.6 Hz, CH2OR); 3.79 (dd, 1H, J  = 9.6, 6.3 Hz, CH2OR); 2.40 (d, 1H, J = 5.4 Hz, OH); 
1.16-1.00 (m, 42H, 6 CH(CH3)2); (syn-isomer): δ 9.74 (d, 1H, J = 1.5 Hz, CHO); 4.28 
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(dd, 1H, J = 4.9, 1.5 Hz, CHCHO); 3.97 (dd, 1H, J  =  9.9, 2.7 Hz, CH2OR); 3.89 (m, 1H, 
CHOH); 3.77 (dd, 1H, J = 9.9, 4.5 Hz, CH2OR); 2.73 (d, 1H, J = 9.9 Hz, OH); 1.16-1.00 
(m, 42H, 6 CH(CH3)2); 13C NMR (75 MHz, CDCl3) δ 202.1, 78.9, 74.3, 62.7, 18.0 (12C), 
12.4 (3C), 11.9 (3C); (syn-isomer): δ 203.8, 74.4, 62.2, 18.0 (12C), 12.3 (3C), 11.9 (3C), 
one signal obscured by solvent; HRMS (CI) exact mass calcd for [M+H]+ (C22H49O4Si2) 
requires m/z 433.3169, found m/z 433.3176; [α]D = –3.6  (c = 4.0, CHCl3).  The 
diastereomer ratio was determined by 1H NMR of the crude product.  The enantiomeric 
purity of the anti-diastereomer was determined after conversion of the isolated anti-
isomer to the 1-hydroxy-3-p-nitrobenzoate-derivative as follows: To a solution of the title 
compound (40 mg, 0.09 mmol) in dichloromethane (0.6 mL), p-nitro-benzoylchloride 
(42.9 mg, 0.23 mmol), 4-dimethylaminopyridine (2.8 mg, 0.02 mmol) and triethylamine 
(0.06 mL, 0.46 mmol) were added at +4 ºC.  The resulting mixture was stirred at +4 ºC 
for 3.5 h, before methanol (0.6 mL) and NaBH4 (0.04g, 0.94 mmol) were added, which 
led to a vigorous gas evolution.  After an additional 35 minutes, the mixture was warmed 
to room temperature and diluted with 5 mL dichloromethane.  The resulting solution was 
washed with saturated NaHCO3 solution, passed through a plug of silica and 
concentrated.  HRMS (ESI) exact mass calcd for [M + Na]+ (C29H53NNaO7Si2) requires 
m/z 606.3258, found m/z 606.3253.  The product ratios were determined by HPLC using 
a Chiracel OD-H and OD-H guard column (0.16% isopropanol/hexanes, 1 mL/min): (2S, 
3S) enantiomer tr = 46.5 min, (2R, 3R) enantiomer tr = 41.4 min. 
 
Triisopropylsilanoxy-acetaldehyde. (1f)  A solution of (Z)-1,4-bis-triisopopylsilanoxy-
but-2-ene (6.70 g, 16.7 mmol) and triethylamine (3.5 mL, 25.2 mmol) in 
 
 
45 
dichloromethane/methanol (100 mL/10 mL) was cooled to –78ºC. Ozone was bubbled 
through the solution until a pale blue color developed.  At this time triphenylphosphine 
(5.70 g, 21.7 mmol) was added and the resulting mixture was stirred for 3 h allowing it to 
reach 0ºC.  After concentration, the residue was treated with pentane (30 mL) causing 
precipitation of triphenylphosphine oxide. The resulting suspension was poured directly 
onto a wet column of silica gel (20:1 pentane:diethyl ether). Flash chromatography (20:1 
pentane:diethyl ether) afforded the title compound as a clear, colorless oil in 86% yield 
(6.2 g, 28.6 mmol). IR (film) 2945, 2893, 2868, 1741, 1464, 1133, 883, 685 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 9.73 (bs, 1H, CHO); 4.26 (d, J = 1.1 Hz, 2H, CH2OR); 1.20-
1.02 (m, 21H, 3 CH(CH3)2); 13C NMR (75 MHz, CDCl3) δ 203.0, 69.7, 18.1 (6C), 12.1 
(3C); HRMS (CI) exact mass calcd for [M+H]+ (C11H25O2Si) requires m/z 217.1624, 
found m/z 217.1615.  
 
(2S, 3S)- 3-Hydroxy-2,4-bis-methoxymethoxy-butyraldehyde (table 1, entry 7).  A 
suspension of methoxymethoxyacetaldehyde (78 mg, 0.75 mmol) and L-proline (4.3 mg, 
0.038 mmol) in dimethylformamide (0.75 mL) was stirred for 20 h at room temperature.  
The resulting solution was diluted with water, extracted with ether and washed with 
brine, dried over anhydrous Na2SO4.  Flash chromatography (3:1 ether:pentane) afforded 
the title compound as a clear, colorless oil in 42% yield (33 mg, 0.16 mmol), 96% ee 
(anti), and 4:1 anti:syn. IR (film) 3364, 2978, 2938, 1715.9, 1555, 1446, 1379, 1343, 
1101, 1039, 837.9, 713.8 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.70 (d, 1H, J = 1.8 Hz, 
CHO); 4.81-4.61 (m, 4H, 2 CH2OMe); 4.12 (m, 1H, CHOH); 4.04 (dd, 1H, J =  5.1, 1.2 
Hz, CHCHO); 3.69 (m, 2H, CH2OMOM); 3.38 (s, 6H, 2 OMe); 3.15 (d, 1H, J = 7.2 Hz, 
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OH); 13C NMR (75 MHz, CDCl3): δ 200.9, 97.8, 97.3, 84.0, 71.0, 68.7, 56.6, 56.0; [α]D = 
+2.4  (c = 1.00, CHCl3);  HRMS (CI) exact mass calcd for [M+H]+ (C9H17O6) requires 
m/z 209.1020, found m/z 209.1020.  The enantiomeric purity was determined after 
reduction (NaBH4) and 1,3 acetonide formation as below (see Table 1, entry 7) by GLC 
analysis using a Bodman Chiraldex β-DM (30 m x 0.25 mm) column (120 ºC, 23 psi): 
(2S, 3S)-enantiomer: tr = 26.7 min, (2R, 3R)-enantiomer: tr = 25.7 min, syn isomers tr = 
29.7, 29.8 min.  The diastereomer ratio was determined by 1H NMR analysis of the crude 
title compound. 
 
Determination of the absolute stereochemistry of the silanoxy-acetaldehyde-dimers. 
Each dimer was converted into its 1,3-acetonide acetal as described above for Table 1, 
entry 7. Where necessary the isomers were separated (TBS, TBDPS).  The isolated anti-
isomer was then deprotected to furnish (4S, 5R)-4-hydroxymethyl-2,2-dimethyl-
[1,3]dioxane-5-ol.  This compound was purified by flash chromatography and compared 
to a sample, which had been prepared from  β-D-glucose by a known procedure. HRMS 
(CI) exact mass calcd for [M + H]+ (C7H15O4) requires m/z 163.0970, found m/z 
163.0976).  In every case (TBS, TBDPS, TIPS), the 1H- and 13C-NMR spectra were 
identical to the natural sample and the specific optical rotation was identical in sign and 
close to the magnitude of the natural sample: [α]D = –28.4  (c = 0.2, CHCl3); TBS: [α]D = 
–22.4  (c = 1.2, CHCl3); TBDPS: [α]D = –25.4  (c = 0.4, CHCl3); TIPS: [α]D = –26.3  (c = 
1.0, CHCl3).       
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(2S, 3R)-4-Triisopropyl-silanyloxy-3-hydroxy-2-methylbutanal (table 2, entry 1).  A 
solution of freshly distilled propionaldehyde (263 µL, 3.64 mmol) in 0.73 mL DMF pre-
cooled to 4 ºC was added slowly over the course of 12 h to a stirring suspension of 
triisopropylsilanoxy-acetaldehyde (158 mg, 0.73 mmol), L-proline (8.2 mg, 0.073 mmol) 
and 0.73 mL DMF at 4 ºC.  After 18 h, the resulting solution was diluted with diethyl 
ether and washed successively with water and brine.  The combined aqueous layers were 
back extracted with 3 portions of dichloromethane.  The organic layers were combined, 
dried over anhydrous Na2SO4, and concentrated in vacuo.  Flash chromatography (9:1 
pentane:diethyl ether) afforded the title compound as a clear, colorless oil in 75% yield 
(150 mg, 0.55 mmol), 99% ee and 4:1 anti:syn.  IR (film) 3435, 2943, 2867, 1725, 1463, 
1384, 1107, 996.0, 882.2, 778.5, 682.7 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.82 (d, J = 
2.1 Hz, 1H, CHO); 3.90-3.65 (m, 3H, CHOH, CH2CHOH); 2.87 (d, 1H, J = 4.8 Hz, 
OH); 2.51 (m, 1H, CHCH3); 1.18-0.95 (m, 24H, SiCH(CH3)2, CHCH3); 13C NMR (75 
MHz, CDCl3) δ 204.4, 73.0, 65.2, 49.0, 18.1, 12.1, 10.3; HRMS (CI) exact mass calcd for 
[M + H]+ (C14H31O3Si) requires m/z 275.2043, found m/z 275.2041; [α]D = + 8.46 (c = 
1.0, CHCl3).  The product ratios were determined by HPLC analysis following reduction 
to the corresponding alcohol (obtained by NaBH4 reduction) and bis-acetylation with p-
nitrobenzoyl chloride, using a Chiracel OD-H and OD-H guard column (2% 
isopropanol/hexanes, 1 mL/min) column; (2R, 3S) anti isomer tr = 33.0 min, (2S, 3R) anti 
isomer tr = 35.4 min, (2R, 3R) and (2S, 3S) syn isomers tr = 41.0, 44.9 min. 
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(2S, 3R)-4-tert-Butyldiphenyl-silanyloxy-3-hydroxy-2-methylbutanal (table 2, entry 
2).  A solution of freshly distilled propionaldehyde (361 µL, 5.0 mmol) in 1.0 mL 
dioxane pre-cooled to 4 ºC was added slowly over the course of 24 h to a stirring 
suspension of tert-butyl-diphenylsilanyloxyacetaldehyde (298 mg, 1.0 mmol), L-proline 
(11.5 mg, 0.10 mmol) and 1.0 mL dioxane at 4 ºC.  After 25 h, the resulting solution was 
diluted with diethyl ether and washed successively with water and brine.  The combined 
aqueous layers were back extracted with 3 portions of dichloromethane.  The organic 
layers were combined, dried over anhydrous Na2SO4, and concentrated in vacuo.  Flash 
chromatography (9:1 hexanes:ethyl acetate) afforded the title compound as a clear, 
colorless oil in 84% yield (300 mg, 0.84 mmol), 99% ee and 5:1 anti:syn.  IR (film) 3434, 
3050, 2929, 2856, 1725, 1590, 1462, 1428, 1113, 996.6, 823.4, 740.3, 702.1 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 9.79 (d, J = 2.4 Hz, 1H, CHO); 7.65 (m, 4H, Ar-H); 7.42 (m, 
6H, Ar-H); 3.88 (m, 1H, CHOH); 3.76 (dd, 1H, J = 10.0, 3.7 Hz, CH2CHOH); 3.65 (dd, 
1H, J = 10.0, 6.0 Hz, CH2CHOH); 2.69 (d, 1H, J = 4.8 Hz, OH); 2.58 (m, 1H, CHCH3); 
1.06 (m, 12H, Si(CH3)3, CHCH3); 13C NMR (75 MHz, CDCl3) δ 204.5, 135.7, 132.9, 
130.2, 128.0, 73.2, 49.0, 27.2, 19.6; HRMS (CI) exact mass calcd for [M + H]+ 
(C21H29O3Si) requires m/z 357.1886, found m/z 357.1870; [α]D = + 8.78 (c = 1.0, CHCl3).  
The product ratios were determined by HPLC analysis of the corresponding alcohol 
(obtained by NaBH4 reduction) using a Chiracel OD-H and OD-H guard column (2% 
ethanol/hexanes, 1 mL/min) column; (2R, 3S) anti isomer tr = 26.2 min, (2S, 3R) anti 
isomer tr = 31.5 min, (2R, 3R) and (2S, 3S) syn isomers tr = 35.4, 41.5 min. 
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(2S, 3R)-4-Triisopropylsilanoxy-3-hydroxy-2-isopropylbutanal (table 2, entry 3).  A 
solution of freshly distilled isovaleraldehyde (354 µL, 3.3 mmol) in 0.66 mL DMF pre-
cooled to 4 ºC was added slowly over the course of 12 h to a stirring suspension of 
triisopropylsilanoxy-acetaldehyde (143 mg, 0.66 mmol), L-proline (7.5 mg, 0.066 mmol) 
and 0.66 mL DMF at 4 ºC.  After 18 hours, the resulting solution was diluted with diethyl 
ether and washed successively with water and brine.  The combined aqueous layers were 
back extracted with 3 portions dichloromethane.  The organic layers were combined, 
dried over anhydrous Na2SO4, and concentrated in vacuo.  Flash chromatography (9:1 
pentane:diethyl ether) afforded the title compound as a clear, colorless oil in 54% yield 
(107 mg, 0.36 mmol), 99% ee and 4:1 anti:syn.  IR (film) 3480, 2960, 2868, 1722, 1464, 
1388, 1115, 1013, 996.4, 882.5, 795.1, 682.6 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.80 
(d, 1H, J = 3.9 Hz, CHO); 4.03 (m, 1H, CHOH); 3.73 (dd, 1H, J = 10.2, 4.2 Hz, 
CH2OSi); 3.62 (dd, 1H, J = 10.2, 6.9 Hz, CH2OSi); 2.71 (d, 1H, J = 5.1 Hz, CHOH); 
2.24 (m, 1H, CH(CH3)2); 2.05 (ddd (apparent dt), 1H, J = 7.8, 3.9, 3.9 Hz, CHCHO); 
1.17-0.95 (m, 27H, CH(CH3)2, SiCH(CH3)2); 13C NMR (75 MHz, CDCl3) δ 206.2, 71.0, 
66.2, 60.0, 26.6, 20.9, 20.4, 18.1, 12.0; HRMS (CI) exact mass calcd for [M + H]+ 
(C16H35O3Si) requires m/z 303.2356, found m/z 303.2348.  [α]D = –4.11 (c = 1.0, CHCl3). 
The product ratios were determined by HPLC analysis following reduction to the 
corresponding alcohol (obtained by NaBH4 reduction) and bis-acetylation with p-
nitrobenzoyl chloride, using a Chiracel OD-H and OD-H guard column (2% 
isopropanol/hexanes, 1 mL/min) column; (2S, 3R) anti isomer tr = 24.8 min, (2R, 3S) anti 
isomer tr = 33.7 min, (2R, 3R) and (2S, 3S) syn isomers tr = 27.9, 30.7 min. 
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(2S, 3R)-4-Benzyloxy-3-hydroxy-2-isopropylbutanal (table 2, entry 4).  A solution of 
freshly distilled benzyloxyacetaldehyde (141 µL, 1.0 mmol) in 1.0 mL 
dimethylformamide pre-cooled to 4 ºC was added slowly over the course of 18 h to a 
stirring suspension of isovaleraldehyde (214 µL, 2.0 mmol), L-proline (11.5 mg, 0.10 
mmol) and 1.0 mL dimethylformamide at 4 ºC.  After 19 hours, the resulting solution was 
diluted with diethyl ether and washed successively with water and brine.  The combined 
aqueous layers were back extracted with 3 portions dichloromethane.  The organic layers 
were combined, dried over anhydrous Na2SO4, and concentrated in vacuo.  Flash 
chromatography (4:1 pentane:diethyl ether) afforded the title compound as a clear, 
colorless oil in 64% yield (151 mg, 0.64 mmol), 95% ee and 4:1 anti:syn.  IR (film) 3456, 
2961, 2929, 2871, 1721, 1468, 1453, 1390, 1370, 1101, 1028, 990.3, 946.0, 914.4, 738.2, 
698.6 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.81 (d, 1H, J = 3.6 Hz, CHO); 7.33 (m, 5H, 
Ar-H); 4.54 (s, 2H, CH2Ph); 4.18 (m, 1H, CHOH); 3.57 (dd, 1H, J = 6.6, 3.0 Hz, 
CH2OBn); 3.45 (dd, 1H, J = 9.3, 6.6 Hz, CH2OBn); 2.63 (d, 1H, J = 5.1 Hz, CHOH); 
2.23 (m, 1H, CH(CH3)2); 2.07 (ddd (apparent dt), 1H, J = 7.8, 3.9, 3.9 Hz, CHCHO); 
1.06 (d, 3H, J = 6.9 Hz, CH3); 0.95 (d, 3H, J = 6.9 Hz, CH3); 13C NMR (75 MHz, CDCl3) 
δ 206.2, 137.7, 128.7, 128.0, 73.8, 73.1, 69.7, 60.4, 26.6, 21.1, 20.6; HRMS (CI) exact 
mass calcd for [M + H]+ (C14H21O3) requires m/z 237.1491, found m/z 237.1492.  [α]D = 
–14.4 (c = 1.0, CHCl3). The product ratios were determined by HPLC analysis of the 
corresponding alcohol (obtained by NaBH4 reduction) using a Chiracel AD and AD 
guard column (4% isopropanol/hexanes, 1 mL/min) column; (2R, 3S) anti isomer tr = 
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22.4 min, (2S, 3R) anti isomer tr = 24.5 min, (2R, 3R) and (2S, 3S) syn isomers tr = 29.3, 
31.8 min. 
 
(2S, 3S)-3-Hydroxy-4-methyl-2-triisopropylsilanyloxy-pentanal (table 2, Entry 5). A 
solution of freshly distilled triisopropylsilanyloxyacetaldehyde (216 mg, 1.0 mmol) in 1.0 
mL dimethylformamide pre-cooled to 4 ºC was added slowly over the course of 36 h to a 
stirring suspension of isobutyraldehyde (272 µL, 3.0 mmol), L-proline (22.6 mg, 0.2 
mmol) and 1.0 mL dimethylformamide at 4 ºC.  After 37 h, the resulting solution was 
diluted with diethyl ether and washed successively with water and brine.  The combined 
aqueous layers were back extracted with 3 portions of dichloromethane.  The organic 
layers were combined, dried over anhydrous Na2SO4, and concentrated in vacuo.  Flash 
chromatography (39:1 hexanes:ethyl acetate) afforded the title compound as a clear, 
colorless oil in 43% yield (124 mg, 0.43 mmol), 99% ee and 8:1 anti:syn. IR (film) 3464, 
2947, 2864, 1735, 1464, 1379, 1316, 1254, 1109, 1064, 1016, 958.5, 917.0 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 9.70 (d, 1H, J = 2.1 Hz, CHO); 4.14 (dd (apparent t), 1H, J = 
3.3 Hz, CHCHO); 3.48 (m, 1H, CHOH); 2.67 (d, 1H, J = 2.1 Hz, CHOH); 1.78 (m, 1H, 
CH(CH3)2); 1.16-1.01 (m, 24H, SiCH(CH3)2, CHCH3); 0.94 (d, 3H, J = 9.0 Hz, 
CHCH3); 13C NMR (75 MHz, CDCl3) δ 203.6, 80.7, 78.9, 29.7, 19.6, 19.2, 18.3, 12.5; 
HRMS (CI) exact mass calcd for [M + H]+ (C15H34O3Si) requires m/z 289.2198, found 
m/z 289.2201. [α]D = –2.47 (c = 1.0, CHCl3).  The product ratios were determined by 
GLC analysis of the acetonide derived from the corresponding alcohol (obtained by 
NaBH4 reduction) and 2-methoxypropene (obtained by the method of Lipshutz13) using a 
                                                
13 Lipshutz, B. H.; Barton, J. C., J. Org. Chem.  1988, 53, 4495. 
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Bodman Chiraldex β-DM (30 m x 0.25 mm) column (110 ºC isotherm, 23 psi); (2S, 3S) 
anti isomer tr = 88.4 min, (2R, 3R) anti isomer tr = 90.5 min, (2R, 3S) and (2S, 3R) syn 
isomers tr = 100.4, 102.2 min. 
 
Determination of the absolute stereochemistry of (2S, 3S)-3-Hydroxy-4-methyl-2-
triisopropylsilanyloxy-pentanal by correlation to (2S, 3R)-3-[(4-
Methoxyphenyl)methoxy]-4-methyl-1,2-pentanediol.  A stirring solution of (2S, 3S)-3-
Hydroxy-4-methyl-2-triisopropylsilanyloxy-pentanal (70 mg, 0.24 mmol) in 10.0 mL of 
4:1 dichloromethane:ethanol was treated with NaBH4.  After stirring for 5 minutes, the 
reaction was quenched with a saturated aqueous solution of NaHCO3, and extracted with 
3 portions of dichloromethane. The combined organic extracts were dried over anhydrous 
Na2SO4, filtered, and concentrated in vacuo.  The residue was then dissolved in 250 µL 
dimethylformamide, and treated with triisopropylsilyl chloride (55 µL, 0.26 mmol) and 
imidazole (35 mg, 0.52 mmol) according to the method of Cunico.14  After stirring for 12 
hours, the mixture was diluted in ether, and washed with saturated aqueous solutions of 
NH4Cl and NaHCO3, and water.  The residue was then dissolved in 2.0 mL 
tetrahydrofuran, and treated sequentially with NaH (6.7 mg, 0.28 mmol), 4-methoxy-
benzyl chloride (38 µL, 0.28 mmol) and tetrabutylammonium iodide (9 mg, 0.024 mmol).  
After stirring for 14 hours, the mixture was diluted in ether, and washed with saturated 
aqueous solutions of NH4Cl and NaHCO3, and water.  The combined organic extracts 
were dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. Flash 
chromatography (0%–2.5% ethyl acetate in hexanes, linear gradient) afforded a 51% 
                                                
14 Cunico, R.F.; Bedell, L., J. Org. Chem.  1980, 45, 4797. 
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yield (63 mg, 0.12 mmol) of (2S, 3R)-3-[(4-Methoxyphenyl)methoxy]-4-methyl-1,2-
triisopropylsilanyloxy-pentane. To this compound was added tetrabutylammonium 
fluoride (174 µL, 1 M in tetrahydrofuran).  After refluxing for 12 hours, the mixture was 
diluted in ether and washed with saturated aqueous solutions of NH4Cl and NaHCO3, and 
water. Flash chromatography (5:1 ethyl hexanes:ethyl acetate) afforded a 33% yield (10 
mg, 0.04 mmol) of (2S, 3R)-3-[(4-Methoxyphenyl)methoxy]-4-methyl-1,2-pentanediol; 
[α]D = -11.2 (c = 1.0, CHCl3) (lit.15 [α]D = – 14.0 (c = 1.19, CHCl3) for (2S, 3R)-3-[(4-
methoxyphenyl)methoxy]-4-methyl-1,2-pentanediol). 
 
(2S, 3S)-2-(Benzylyloxy)-3-hydroxy-4-methyl-pentanal (table 2, entry 6).  A solution 
of benzyloxyacetaldehyde (150.2 mg, 1.0 mmol) in dimethylformamide (1.0 mL) was 
added slowly over the course of 24 hours to a suspension of isobutryldehyde (914 µL, 
10.0 mmol) and L-proline (23.0 mg, 0.20 mmol) in dimethylformamide (1.0 mL) at room 
temperature.  The resulting solution was diluted with water, extracted with ethyl acetate 
and washed with brine, dried over anhydrous Na2SO4.  Flash chromatography (1:3 ethyl 
acetate: hexanes) afforded the title compound as a clear, colorless oil in 33% yield (74 
mg, 0.33 mmol), 96% ee (anti), and 7:1 anti:syn. IR (film) 3460, 3032, 2963, 2932, 2874, 
1732, 1497, 1455, 1101, 1027, 738.5, 698.5 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.78 (d, 
1H, J = 2.7 Hz, CHO); 7.36 (m, 5H, Ar-H); 4.72 (d, 1H, J = 12.0 Hz, CH2Ar); 4.56 (d, 
1H, J = 12.0 Hz, CH2Ar); 3.81 (dd, 1H, J = 4.8, 2.4 Hz, CHCHO); 3.69 (m, 1H, CHOH); 
2.28 (d, 1H, J = 4.5 Hz, OH); 1.92 (m, 1H, CH(CH3)2); 0.95 (d, 3H, J = 6.9 Hz, CH3); 
0.95 (d, 3H, J = 6.9 Hz, CH3);  13C NMR (75 MHz, CDCl3): δ 203.6, 137.1, 128.9, 128.6, 
                                                
15Oikawa, M.; Ueno, T.; Oikawa, H.; Ichihara, A., J. Org. Chem.  1995, 60, 5048. 
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128.4, 84.3, 73.2, 29.8, 19.4, 17.7; [α]D = –53.1  (c = 0.47, CHCl3);  HRMS (CI) exact 
mass calcd for [M + H]+ (C19H21O4) requires m/z 222.1256, found m/z 222.1259.  The 
enantiomeric purity was determined after reduction (NaBH4) by HPLC analysis using a 
Chiracel AD and AD guard column (5% ethanol/hexanes, 1 mL/min): (2S, 3S)-
enantiomer: tr = 14.7 min, (2R, 3R)-enantiomer: tr = 17.3 min, syn isomers tr = 24.7, 27.4 
min.  The diastereomer ratio was determined by 1H NMR analysis of the crude title 
compound and verified by HPLC analysis after NaBH4 reduction. 
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C h a p t e r  3  
Total Synthesis of Brasoside and Littoralisone* 
Isolation and Biological Activity  
 Brasoside and littoralisone are members of a class of natural products commonly 
referred to as iridoids.1  These compounds are generally characterized by a bicyclic 
cyclopentanoid-monoterpene core, around which a variety of oxidation states and 
substitution patterns have been observed (figure 1).  Several hundred iridoids have 
already been isolated,2 and they have been found to be ubiquitous in the vegetable 
kingdom, particularly amongst angiosperms of the superorder of Sympetalae.3  Iridoids 
have found use as medicinal agents for a variety of folk medicines, and are now known 
for use as sedatives, analgesics, diuretics and antimicrobials.4 Leaf extracts of Verbena  
Figure 1: Some Representative Iridoids
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* For a communication of this work, see: Mangion, I. K.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 3696. 
1 For reviews on the iridoid class of natural product, see: (a) Isoe, S.  Studies in Natural Products Chemistry, vol. 16; 
Atta-ur-Rahman, ed., Elsevier Science, New York, 1995; (b) Bianco, A.  Studies in Natural Products Chemistry, 
Vol. 7; Atta-ur-Rahman, ed., Elsevier Science, New York, 1990; (c) Franzyk, H.  Fortschritte der Chemie Org. 
Naturstoffe  2000, 79, 1. 
2 For compilations of iridoid structures see: (a) El-Naggar, L. J.; Beal, J. L.  J. Nat. Prod. 1980, 43, 649; (b) Boros, C. 
A.; Stermitz, F. R.  J. Nat. Prod. 1991, 53, 1055; (c) Boros, C. A.; Stermitz, F. R.  J. Nat. Prod. 1991, 54, 1173. 
3 Jensen, S. R.; Nielsen, B. J.; Dahlgren, R.  Botaniska Notisier  1975, 128, 148. 
4 For reviews on biological activities of irioid natural products, see: (a) Buzogany, K.; Cucu, V. Farmacia, 1983,  
   31, 129.; (b) Tietze, L.-F. Angew. Chem. Int. Ed. 1983, 22, 828. 
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littoralis, a plant used widely in traditional folk remedies for typhoid fever and tonsillitis, 
possess intriguing activity as enhancers for the neurotrophic properties of nerve growth 
factor (NGF).5 Littoralisone (1, Figure 2), isolated by Ohizumi in 2001, was 
demonstrated to be the active agent for increased NGF-induced neurite outgrowth in 
PC12D cells.6  As such, it is a prominent member of a small but growing class of natural 
non-peptidic neurotrophic agents with potential implications for the treatment of 
Alzheimer’s disease.7   
Figure 2: Structures of Littoralisone and Brasoside
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 Littoralisone is also a uniquely complex member of the iridoid class of natural 
products.  Synthetic challenges include the presence of four- and nine-membered rings as 
well as fourteen stereocenters, all within the context of a dense heptacyclic framework.  
Littoralisone shares several key structural features with brasoside8 (2) and indeed may be 
biosynthetically derived from 2, though no intermediates on such a pathway have been 
isolated.  We sought to design a rapid organocatalytic approach to 1 that would also allow 
access to 2 from a common intermediate.  This analysis began with a consideration of the 
biosynthesis of 1 and other iridoids.   
                                                
5 Umana, E.; Castro, O. Int. J. Crude Drug Res. 1990, 28, 175. 
6 Li, Y.-S.; Matsunaga, K.; Ishibashi, M.; Ohizumi, Y. J. Org. Chem. 2001, 66, 2165.  
7 Hefti, F.  Annu. Rev. Pharmacol. Toxicol.  1997, 37, 239. 
8 (a) Schafer, B.; Rimpler, H.  Z. Naturforsch, 1979, 34, 311; (b) Franke, A.; Rimpler, H. Phytochemistry, 1987, 26, 3015; 
(c) Jensen, S. R.; Kirk, O.; Nielsen, B. J.; Norrestam, R.  Phytochemistry  1987, 26, 1725. 
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Biosynthesis of Iridoid Natural Products 
 The first known isolation of an iridoid is credited to Geiger as early as 1835,9 with 
subsequent reisolation from Verbena officinalis in 1908 by Boudier,10 who named it 
verbenalin (3).  However, the name “iridoid” arose in 1956 from Cavill et al.,11 who 
isolated a 1,5-dialdehydic compound they named iridodial (4) after the Australian ant 
from which it was derived (Iridomyrmex detectus).  Iridodial represents the basic skeleton  
Figure 3: Verbenalin and Iridodial
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of the vast majority of iridoids, and it is noteworthy that it exists as an equilibrium 
mixture of lactol and dialdehyde forms.  This observation led to the supposition that 
iridoids are only stable when the lactol is locked in a glycosidic or ether bond, a notion 
that has been borne out by total synthetic efforts.12 
 Several biosynthetic pathways have been proposed to explain the molecular 
origins of iridoids, though now the most commonly accepted is the mevalonic acid 
(MVA) pathway13 (Scheme 1).  On the basis of 14C labeling, it was determined that 
mevalonic acid is incorporated into presumed iridodial precursor 5.  This labeling was 
                                                
9 Geiger, P. L.  Ann. 1835, 14, 206. 
10 Boudier, L.  Compt. Rend. Soc. Biol. 1908, 63, 367. 
11 Cavill, G. W. K.; Ford, D. L.; Locksley, H. D.  Aust. J. Chem. 1956, 9, 288. 
12 For related iridoid syntheses see: (a) Büchi, G.; Carlson, J. A.; Powell, J. E.; Tietze, L.-F. J. Am. Chem. Soc. 1970, 
92, 2165; (b) Callant, P.; Ongena, R.; Vandewalle, M.  Tetrahedron 1981, 37, 2085; (c) Callant, P.; Storme, P.; Van 
der Eycken, E.; Vandewalle, M. Tetrahedron Lett. 1983, 24, 5797; (d) Trost, B. M.; Balkovec, J. M.; Mao, M. K.-T. 
J. Am. Chem. Soc. 1986, 108, 4974; (e) Laabassi, M.; Gree, R.  Tet. Lett. 1988, 29, 611; (f) Piccinini, P.; Vidari, G.; 
Zanoni, G. J. Am. Chem. Soc. 2004, 126, 5088, and references therein. 
13 Inouye, H.; Uesato, S.  Prog. Chem. Org. Nat. Prod. 1986, 50, 169. 
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also observed in iridodial itself, lending credence to the conclusion that 4 arises directly 
from 5, perhaps by way of an enzyme-mediated Michael addition.14  Iridodial may then 
serve as the synthetic precursor for a range of more complex iridoids through subsequent 
oxidations. 
Scheme 1: The Mevalonic Acid Pathway to Iridoids
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 Further studies have suggested modified pathways, including a direct hydride 
reduction/Michael cyclization leading directly from 10-oxoneral (6) to 4,15 or oxidation to 
9,10-dioxoneral with subsequent Michael addition.16  Recent work from Pagnoni suggests 
that more than one pathway may be operative depending on the iridoid in question, and 
also on the plant source from which it is derived.17 
 Iridoids have also been identified through isotopic labeling studies as biosynthetic 
precursors to the non-tryptophan portions of  indole alkaloids, such as catharanthine and 
aspidospermidine.13 Heathcock and Ruggeri postulated the intermediacy of an iridoid, 
produced by an intramolecular enamine/enal cyclization mediated by a pyridoxal 
                                                
14 (a) Coscia, C. J.; Guarnaccia, R.  J. Am. Chem. Soc. 1967, 89, 1280; (b) Coscia, C. J.; Guarnaccia, R.  Biochemistry 
1969, 8, 5036. 
15 Escher, S.; Loew, P.; Arigoni, D.  Chem. Comm. 1970, 823. 
16 Inouye, H.; Ueda, S.; Uesato, S.  Tet. Lett. 1977, 18, 709. 
17 Bellesia, F.; Pagnoni, U. M.; Pinetti, A.; Trave, R.  Phytocehmistry 1983, 22, 2197. 
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cofactor, in the biosynthesis of the Daphniphyllum alkaloids18 (Scheme 2)–a strategy that 
was mimicked in Heathcock’s total synthesis of (±)-proto-daphniphylline.19 
Scheme 2: Heathcock's Proposed Biosynthesis of Daphniphyllum Alkaloids
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 Taking inspiration from the wealth of knowledge concerning iridoid natural 
products, we sought to design a rapid synthesis of littoralisone taking advantage of 
organocatalytic methodologies recently developed in the MacMillan lab.  Our efforts 
toward this goal are described below. 
 
Retrosynthetic Analysis 
 It was envisioned that littoralisone could be accessed from 7 by way of an 
intramolecular [2+2] photocycloaddition, in accord with the proposed biosynthetic 
pathway to 1 (Scheme 3).  This transformation provides tremendous simplification, as it 
                                                
18 Ruggeri, R. B.; Heathcock, C. H.  Pure Appl. Chem. 1989, 61, 289. 
19 Piettre, S.; Heathcock, C. H.  Science 1990, 248, 1532. 
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would implement several challenging synthetic features: an elaborate fully substituted 
cyclobutane, a nine-membered lactone, and a quaternary carbon stereocenter.  However,    
Scheme 3: Initial Retrosynthetic Disconnections
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it was not immediately obvious that such a cycloaddition was necessarily accessible.  In 
particular, we wondered as to whether the two reacting olefins could truly adopt a low 
energy conformation in which they could achieve overlap.  Computational modeling,20 on 
the other hand, provided some evidence that such a conformation was indeed accessible, 
and that cycloaddition might well proceed with high stereochemical control (figure 4).   
Figure 4: Computational Model of [2 + 2] Transition State
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This information fits well with the biosynthetic proposal, but is also bolstered by the 
prevalence of iridoid natural products bearing a coumaroyl ester functionality as in 7.2  
Such iridoids are diverse in their acylation pattern (figure 5), but one can imagine that the 
                                                
20 Gaussian 03™ calculation, B3LYP/3-21G(d,p). 
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2-substitution21 of 7 might be vital for achieving an intramolecular reaction with the core 
pyran.  The strong resemblance of 7 to brasoside (2) is suggestive of a role for 2 in the 
biosynthesis of 1 and implies that both are accessible from a common precursor (8).   
Figure 5: Representative Coumaroyl-Substituted Iridoids
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 Selectively substituted glucose 9 should be accessible by way of the iterative aldol 
technology developed and discussed in Chapter 2 (Scheme 4).  This analysis leaves 
iridolactone 8 as the remaining target.  We envisioned a late-stage introduction of the 
lactone, revealing bicyclic pyran 10 as the simplified intermediate.  This compound we 
hoped to access by way of a linear precursor (11), perhaps through an amine-catalyzed 
cyclization reaction as has been implicated in the biosynthesis of iridoid natural products.  
Scheme 4: Approach to the Key Sugar and Iridolactone
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21 Glucose numbering. 
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Dial 11 might then simply be produced from elaboration of commercially available 
material (i.e., (–)-citronellol).   
 
Synthesis of Iridolactone 8 
 Having recognized the utility of the carbon skeleton of (–)-citronellol in previous 
synthetic efforts toward iridoids,12 we sought to elaborate this material toward dial 11.  
Key to this approach was the recognition that proline-catalyzed enantioselective 
oxyamination technology recently developed in the MacMillan lab22 might be used to 
introduce the chiral secondary alcohol of 11 in a diastereocontrolled fashion (figure 6).23   
Figure 6: Organocatalytic Nitrosobenzene Oxidation is Catalyst-Controlled and Highly Selective
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Synthesis of 11 was initiated by protection of commercially available (–)-citronellol as its 
mesitoate ester, followed by treatment with O3 to furnish aldehyde 12 (figure 7).  It was 
found that 12 could be treated with nitrosobenzene and D-proline to furnish the 
corresponding α-oxyamino aldehyde with full catalyst control, in accord with reported 
stereochemical models.24 Fortuitously, we realized that Horner-Wadsworth-Emmons 
olefination of this resultant aldehyde and cleavage of the aminoxy bond on standing in 
MeOH could furnish γ-chiral α, β-unsaturated ester 13 in a single synthetic operation 
without purification.  While this transformation could also be performed in a stepwise 
fashion, the yields were variable due to the instability of the aminoxy N-O bond, and a  
                                                
22 Brown, S. P.; Brochu, M. P.; Sinz, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2003, 125, 10808. 
23 For other reports on proline-catalyzed oxidation of aldehydes, see: (a) Zhong, G. Angew. Chem., Int. Ed. 2003, 
42, 4247; (b) Hayashi, Y.; Yamaguchi, J.; Hibino, K.; Shoji, M. Tetrahedron Lett. 2003, 44, 8293. 
24 Cheong, P. H.-Y.; Houk, K. N.  J. Am. Chem. Soc. 2004, 126, 13912. 
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Figure 7: Three Step Synthesis of Ester 13
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mild in situ cleavage seems the best approach.25  This procedure allowed us remarkably 
rapid access to the carbon framework of the target iridolactone intermediate.26,27 
 At this point, we sought to access 11 to test the feasibility of the proposed amine-
catalyzed cyclization.  This was achieved by protection of the secondary alcohol as its 
TBDPS ether, treatment with DIBAL to reduce the esters to the corresponding alcohols, 
and Dess-Martin oxidation to the desired dialdehyde 11 (figure 8).  There is good 
literature precedent for amine-mediated cyclization of aldehyde-enals such as 11.28  Work 
Figure 8: Completion of Dialdehyde 11
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performed in the Schreiber group demonstrated the ability of N-methyl aniline to effect 
cyclization to bicyclic aminopyrans with high diastereocontrol (figure 9).28a This 
                                                
25 Methanolysis proved higher yielding for this substrate than other reported procedures, such as: CuSO4/MeOH, 
Zn/AcOH, Na/EtOH, etc. 
26 For a related two-step approach, see: Zhong, G.; Yu, Y. Org. Lett. 2004, 6, 1637. 
27 To our surpise, conventional Wittig and Peterson olefinations provided no reactivity, while Takai olefination led 
to rapid, undesired side reactions. 
28 For a stoichiometric amine-mediated intramolecular Michael reaction see: (a) Schreiber, S. L.; Meyers, H. V.; 
Wiberg, K. B. J. Am. Chem. Soc. 1986, 108, 8274; For an imidazolidinone-catalyzed intramolecular Michael 
providing trans-cyclopentanes see: (b) Fonseca, M. T. H.; List, B. Angew. Chem. Int. Ed. 2004, 43, 395. 
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methodology facilitates precisely the type of cyclization we would like to perform in this 
synthesis, but suffers from the slight drawback that it requires a stoichiometric amount of 
the amine source.  This requirement is likely a consequence of an irreversible catalyst 
trapping event – indeed, the original publication provides a separate method for acidic 
hydrolysis to liberate the amine after purification of the initial adduct.28a  The mechanism 
shown in Figure 9 is speculative, but seems likely given the propensity of amines to 
condense with aldehydes and form enamines that can perform conjugate additions.28b 
While a hetero Diels-Alder reaction might provide the same product, for these purposes 
this is a formalism that will not be discussed here.29 
Figure 9: Schreiber's Anline-Mediated Cyclization
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 A key challenge we sought to address in this synthesis was the development of a 
catalytic, stereoselective variant of this Michael addition.  It was envisioned that variation 
of the amine source might allow for interception of the amine trapping event and allow 
for catalytic turnover.  In particular, proline might prove amenable to catalysis as its 
carboxylic acid might well trap forming iminiums, as was observed in the direct aldol 
                                                
29 For recent work on an amine-catalyzed hetero Diels-Alder reaction see: Juhl, K.; Jorgensen, K. A.  Angew. Chem. 
Int. Ed. 2003, 42, 1498. 
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work described in Chapter 2 (Scheme 5).  That is, carbon-carbon bond formation would 
lead to iminium 15, which might then be trapped as N,O-acetal 16 rather than undergoing 
Scheme 5: Possible Catalytic Cycle for Proline-Catalyzed Intramolecular Michael
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the catalyst trapping event depicted in Figure 9.  As described earlier, such an acetal has 
been observed to be part of a productive catalytic cycle, and appears to hydrolyze under 
ambient reaction conditions.  Hydrolysis would furnish dialdehyde 17, which is simply a 
tautomer of the desired bicyclic pyran.  However, the question was not only whether such 
a catalytic cycle would proceed, but also which of the possible diastereomers would be 
produced in the Michael addition and with what degree of stereocontrol.  The precedent 
offered in Figure 9 is somewhat discouraging as it implies that the two stereocenters that 
exist in 11 might work in opposition to produce a mixture of two diastereomers.  Here 
again proline might offer a solution – as a chiral catalyst, it might provide the steric 
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environment required to overcome the likely preference of 11 to produce an undesired 
diastereomer. 
 In the event, initial efforts with proline were met with some success (eq 1).  Not 
only was catalytic turnover observed, but also some of the desired bicyclic pyran (18) 
was produced, albeit in modest yield as a 3:1 mixture of diastereomers.  In an attempt to 
improve on this yield, the reaction time was extended (eq 2), with the surprising result 
that the only diastereomer observed (19) was the one in which all four substituents about 
the cyclopentane ring are oriented trans relative to each other.  To examine this result  
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further, the desired pyran was resubjected to identical reaction conditions (eq 3), and a 
complete inversion in stereochemistry to the undesired diastereomer was observed.  All 
these observations can perhaps be explained by a retro-Michael/Michael thermodynamic 
equilibration of the product, leading ultimately to the thermodynamically favored trans 
stereochemistry. 
 Since the problem could be reduced to favoring kinetic over thermodynamic 
selectivity, subsequent investigations focused on optimizing reaction conditions towards 
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a kinetic result (table 1).  Changing the reaction medium had the surprising effect of 
drastically altering the distribution of diastereomers produced in the intramolecular 
Michael reaction.  More polar solvents (MeOH and DMSO, entries 4-5) drove selectivity 
markedly toward 18 (7-10:1 selectivity).  In the case of DMSO, this also proved to be an 
efficient (91% yield) reaction.  To demonstrate that this phenomenon was not simply a 
dielectric effect, the enantiomer of the catalyst was varied under identical conditions, 
resulting in an inversion of selectivity (entries 5-7).  It was further shown that the ratios 
observed in DMSO were kinetic rather than thermodynamic, as exposure of isolated 18 to   
Table 1: Examination of the Organocatalytic Intramolecular Michael
L-proline
L-proline
L-proline
L-proline
L-proline
(±)-proline
D-proline
entry
1
2
3
4
5b
6b
7b
18:19
2:1
3:1
3:1
7:1
10:1
2:1
1:2
11
54
61
26
91
86
83
yieldacatalyst
 30 mol% proline
23 °C, 48 h
Et2O
CH2Cl2
CHCl3
MeOH
DMSO
DMSO
DMSO
Me
O
TBDPSO
O
O
Me
H
H
OH
TBDPSO
O
Me
H
H
TBDPSO
O
solvent
18 19
aRepresents combined yield of diastereomers.  b Run at 40 °C for 60 h  
D- or L-proline for three days under identical reaction conditions led to no change in 
stereochemistry.  1H NMR studies in d6-DMSO suggest that the rate-limiting step in that 
medium is catalyst turnover.  This idea seems validated by the observation that the 
addition of H2O to DMSO greatly accelerates the Michael addition, with complete 
conversion at room temperature.30  For the purposes of the synthesis, however, it was 
                                                
30 As little as 2% (v/v) H2O is sufficient to effect full conversion to 18 in 48 h at 23 °C in DMSO. 
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found to be more convenient to run the reaction in anhydrous DMSO, which allowed for 
in situ acetylation of the lactol once conversion was complete (eq 4, below). 
 Initial computational studies20 on the nature of catalyst stereocontrol in the 
Michael addition revealed a synergy between catalyst and subtrate (figure 10).  The 
lowest-energy transition state observed predicts production of 18 through a closed, 
hydrogen-bonded transition state, in accord with proline studies cited in Chapters 1 and 2.   
Figure 10: Computational Model of Intramolecular Michael
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The closed transition state favors a cis orientation of the hydrogens of the forming 
cyclopentane, translating into the observed cis selectivity in the product.  Another feature 
of this transition state is the pseudo-equatorial orientation of the chiral methyl substituent 
and the pseudo-axial alignment of the siloxy group.  There is a seemingly accessible 
transition state in which the enal attacks from the opposite face of the enamine, activated 
by a similar hydrogen bond, to produce 20.  However, the methyl group is now oriented 
axially, and engages in an unfavorable transannular and allylic interactions with axial 
hydrogens.  A calculated energetic penalty of 1.67 kcal/mol results, which may explain 
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why 20 has not been observed in the course of these studies.  Thus the stereocontrol 
observed is a combination of catalyst diastereocontrol and substrate facial control.31 
(4)
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 With a selective method for the production of 21 (after in situ acetylation), efforts 
could now be resumed toward iridolactone 8.  Attempts were made to acylate the enol 
ether of the pyran in order to introduce the desired lactone.  Initial experiments32 failed 
either for lack of reactivity or because of competing decomposition.  While the lack of 
reactivity was disappointing in light of the successful acylation applied by the Trost lab in  
(5)O
H
HO
O
Me
O
O
CCl3Cl
O
H
HO
O
Me
O
O CCl3
85% yield
CH2Cl2
DTBMP
 
their synthesis of plumericin12d (eq 5), the presence of an electron-withdrawing acetoxy 
acetal could certainly be expected to contribute to failure.  Similarly, decomposition can 
be expected in basic conditions because of this labile acetate, whereas acidic conditions 
have been well documented1 to lead to ring-opening degradation of iridoids.  However, 
the acetoxy acetal had been identified as a key activating functionality for the glycosyl 
couplings that would be needed in the future, so attempts were made to find a mild and 
effective acylation method. 
                                                
31 Use of achiral substrates with proline follows this prediction: high diasterecontrol (9-12:1 cis:trans), but poor 
enantiocontrol (<16% ee). 
32 Reagents attempted included, but are not restricted to: phosgene, trichloroacetyl chloride, chlorosulfonyl 
isocyanate, Br2, I2, NBS, and NIS. 
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 Success was achieved through a Vilsmeier-Häack formylation, which installed an 
aldehyde at the β–position of the enol ether (eq 6).33 However, this result was dependent  
(6)73% yield
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POCl3
DMF, 40 °C
21 22  
upon the nature of the protecting group on the secondary alcohol (table 2).  Trace acid 
generated in the course of the reaction promotes deprotection of smaller silyl groups 
(entries 1-2) and subsequent formylation of the secondary alcohol.  While this should be 
a workable result, yields were variable and problems were encountered trying to 
deprotect the formyl group in the presence of the labile acetate.  Use of PMB and benzyl 
Table 2: Optimization of the Vilsmeier-Haack Formylation
TBS
TBS
PMB
Bn
TBDPS
TBDPS
entry
1
2
3b
4b
5
6
23:24
0:1
0:1
--
--
3:1
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0
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H
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ether protecting groups failed as well, with decomposition of the starting material (entries 
3-4).34  The more acid-stable TBDPS protecting group proved optimal, with little in situ 
desilylation and improved overall efficiency when DMF was used as solvent (entry 6, 
73% yield). 
                                                
33 For a related example see: Jensen, S. R.; Kirk, O.; Nielsen, B. J.  Tetrahedron 1987, 43, 1949. 
34 This did not appear to be related to formylation of the protecting groups. 
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 Following formylation, elaboration to iridolactone 8 was a straightforward matter 
(figure 11).  Sodium hypochlorite oxidation converted the aldehyde to a carboxylic acid 
(25), at which point silyl deprotection was effected by HF•pyridine in THF.  Closure of 
this hydroxy acid to lactone 8 is effectively mediated by DCC, furnishing the target 
iridolactone from 22 in 56% yield.   
Figure 11: Completion of Iridolactone 8
O
H
H
Me H
O
H
OAc
O
H
H
Me H OAc
TBDPSO CO2H
NaH2PO4, tBuOH
i. HF•pyridine
ii. DCC, CH2Cl2
O
H
H
Me H OAc
TBDPSO
O
CHO
 NaClO2
23 25 8
(93%) (82%)
 
 
Total Synthesis of Brasoside 
 Completion of 1 and 2 would now require coupling of 8 with appropriately 
functionalized carbohydrates.  Brasoside requires introduction of glucose, which in this 
case could come from TMS-protected glucose tetraacetate (26) (derived in two steps from 
the commercially available pentaacetate).35  Exposure of 8 to TMSOTf in the presence of 
26 led to efficient union of these two fragments (86% yield, Eq. 7).  The product, 
brasoside tetraacetate (27), is a literature compound produced in the isolation of 
brasoside, and allows confirmation of the absolute stereochemistry of 8.8a  Careful 
deprotection of 27 completed the first total synthesis of brasoside, with synthetic material 
(7)
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35 Allevi, P.; Anastasia, M.; Ciuffreda, P.; Bigatti, E.; MacDonald, P.  J. Org. Chem.  1993, 58, 4175. 
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corresponding exactly to spectral data for the natural isolate (eq 8). 
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 The TMSOTf-mediated carbohydrate coupling was based on methodology 
developed by Tietze,36 who found existing coupling methods insufficient in his own 
iridoid syntheses.  A traditional approach might involve reaction of a nucleophilic lactol 
with an electrophilic carbohydrate source, as in the well-known Koenigs-Knorr method.37  
However, there are few examples of such a method being successfully applied in iridoid 
chemistry, perhaps because of two related limitations: a pyran lactol is poorly 
nucleophilic and requires more forcing coupling conditions, and under these conditions 
anomeric stereochemical control with respect to the carbohydrate is poor. 
 Thus Tietze envisioned inverting the roles of the coupling partners by forcing the 
iridoid into the role of the acceptor (figure 12).  The Lewis acid TMSOTf likely aids in 
Figure 12: Tietze's Iridoid-Carbohydrate Coupling Method
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ionizing the anomeric acetoxy group, which can then be attacked by the carbohydrate.  
Although the attacking alcohol is blocked by a silyl group, Tietze speculates that the 
ionized acetoxy group is associated with the pyran in a tight ion pair, and this anion 
attacks the TMS protecting group to liberate the nucleophilic alcohol and generate 
                                                
36 Tietze, L.-F.; Fischer, R.; Remberg, G. Liebigs Ann. Chem. 1987, 971. 
37 Davis, B. G.; Fairbanks, A. J.  Carbohydrate Chemistry; Oxford University Press, Oxford, UK, 2002. 
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TMSOAc.  The presence of TMSOAc was confirmed in Tietze’s work, and this 
mechanism also accounts for the necessity of the TMS protecting group – in its absence 
the anomeric stereochemistry in the carbohydrate is lost, and a mixture of diastereomers 
is produced.  In its presence the anomeric alcohol does not isomerize below –30 °C, and 
is revealed only in the course of nucleophilic attack.  Further, the oxocarbenium 
intermediate is empirically verified by the improvement in yield observed by introducing 
more electron-withdrawing substituents on the iridoid lactol noted in Figure 12. 
 With a productive method for coupling a carbohydrate to iridolactone 8, a key 
remaning task was the selective synthesis of a 2-coumarated glucose derivative.  
Coupling of such a carbohydrate with 8 would complete the carbon skeleton of 
littoralisone and permit investigation of the key intramolecular photocycloaddtion. 
 
Synthesis of Carbohydrate 9 and Completion of Littoralisone 
 Construction of a selectively substituted glucose such as 9 should certainly be 
possible using conventional sugar protecting group schemes.  However, we wondered 
whether such a carbohydrate could be more efficiently and perhaps more rapidly 
produced by taking advantage of the two-step carbohydrate synthesis developed in the 
MacMillan lab, as described in Chapter 2 (figure 13).38  In practice this approach proved  
Figure 13: Projected Two-Step Synthesis of Functionalized Glucose
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38 (a) Northrup, A. B.; Mangion, I. K.; Hettche, F.; MacMillan, D. W. C. Angew. Chem., Int. Ed. 2004, 43, 2152; (b) 
Northrup, A. B.; MacMillan, D. W. C. Science, 2004, 305, 1752. 
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feasible, as reaction between enol silane 2839 and aldol dimer 29 (see Chapter 2) yielded 
the differentially functionalized carbohydrate core of 9 (30, Figure 14).  From this stage, 
completion of 9 required a three step manipulation of protecting groups, providing the 
final product as a single anomer.  While the available precedent38b for this aldol approach 
to carbohydrates provided only for silicon-based protecting group schemes, it was 
anticipated that such protecting groups might cause problems in the TMSOTf-mediating 
coupling, with deprotection or silyl scrambling being major concerns.  Fortunately, this 
chemistry proved amenable to benzyl ether protecting groups with few modifications.40 
Figure 14: Completion of Coumarated Glucose 9
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 With an appropriately substituted carbohydrate now available, coupling of 9 with 
iridolactone 8 was now attempted (eq 9).  Under conditions essentially identical to those 
used in the completion of brasoside an efficient (74% yield) union was observed, 
providing the total carbon skeleton of littoralisone (31).  The key issue to be addressed 
was the proposed intramolecular photocycloaddition.  While modeling studies had been 
suggestive of an accessibile [2 + 2] transition state, there remained the energetic penalties 
                                                
39 Synthesized in three steps – see supporting information. 
40 See supporting information for details. 
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one might expect to have to overcome, including the formation of a fully substituted 
cyclobutane including a quaternary carbon stereocenter, as well as an adjacent nine-
membered lactone. 
 There is a wealth of literature concerning the photochemistry of enones, 
particularly for cycloadditions with other enones.41  While a literature search failed to 
reveal an analogous 4,9-bicyclization, there is certainly encouragaing precedent for the 
formation strained or hindered systems.  One of the most pressing challenges in these 
cycloadditions is stereochemical control, as E/Z geometric olefin isomerism generally 
occurs at a greater rate than carbon-carbon bond forming reactions for acylic enones.  
This was a concern in the projected completion of littoralisone, since olefin isomerization 
could lead to a mixture of cyclobutane diastereomers.  However, it was anticipated that 
the Z isomer of coumarate 31 would be unreactive in cycloaddition due to nonbonding 
interactions with the iridolactone core.   
 Another issue was the choice of UV wavelength with which to attempt 
cycloaddition.  Acrylates have a broad range of absorption in the ultraviolet spectrum 
(extending to at least the 360-70 nm wavelengths).41a  As such, it was expected that 
optimal irradiation might come from a photobox with lamps tuned to 350 nm, with the 
                                                
41 (a) Patai, S.; Rappoport, Z., ed.  The Chemistry of Enones, Wiley, New York, 1989; (b) Kagan, J.  Organic 
Photochemistry: Principles and Applications; Academic Press, London, 1993; (c) Griesbeck, A. G.; Mattay, J., ed. 
Synthetic Organic Photochemistry; Marcel Dekker, New York, 2005; (d) Crimmins, M. T.  Chem. Rev. 1988, 88, 1453. 
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reaction carried out in a Pyrex flask.42  The energy imparted to an organic molecule by 
absorption of a photon can be calculated as shown in Eq. 10.43  By choosing the longest 
wavelength at which a desired functionality absorbs photons, one can lower the energy of 
absorption and avoid higher-energy side reactions. 
(10)E (kcal/mol) =
2.86 x 104
! (nm)
for ! = 200 nm, E = 143 kcal
for ! = 254 nm, E = 113 kcal
for ! = 310 nm, E = 92 kcal
for ! = 350 nm, E = 82 kcal  
 Reaction medium can be critical for certain photochemical reactions, as the 
solvent can absorb photons depending on wavelength.  In this way the solvent can 
sometimes act as a sensitizer or can suppress the reaction by absorbing available photons.  
Further, dielectric effects can partition molecules toward various excitation states.  For 
enones, more polar solvents tend to stabilize n-π* transitions while less polar solvents 
favor π-π* transitions.  For this synthesis, benzene was chosen both for its high 
transmittance at 350 nm and its ability to completely dissolve 31.  As shown in Eq. 11, 
irradiation of 31 in these conditions led to a quantitative conversion to the desired 
cyclobutane as a single diastereomer.  In situ hydrogenolysis of the benzyl ethers 
completed the first total synthesis of littoralisone (1), a substance that was identical in all  
(11)
O
H
H
Me H
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O
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O
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OBn
OBn
O
BnO
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H
Me H
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O
H
H
OH
H
O
OO OH
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O
h! (350 nm), benzene;
H2, Pd/C, EtOH
84% yield
31 1  
                                                
42 Pyrex glass transmits above 310 nm, and increasingly absorbs at lower wavenumbers. 
43 From Evans, D. A.; Breit, B.  Chemistry 206, Lecture Number 34; Harvard University, 2000. 
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respects to the natural isolate.  This synthesis was completed in 13 linear steps and 13% 
overall yield. 
 The surprising facility of the key intramolecular photocycloaddition provides 
some circumstantial support for the notion that this pathway is operative in the 
biosynthesis of littoralisone.  Given that littoralisone was isolated from the leaf of 
Verbena littoralis (figure 15), one can easily imagine the exposure to natural UV light of 
littoralisone and its biosynthetic precursors.  In an effort to probe this idea further, I 
subjected 31 to standing in natural sunlight for three days under otherwise identical 
reaction conditions (Pyrex flask, benzene), and obtained 44% yield of 1 after 
hydrogenolysis.  This remarkable result supports the biosynthetic hypothesis even further, 
and raises the possibility that there may well be other cyclobutane-substituted iridoids 
that have yet to be identified. 
 
Figure 15: Verbena Littoralis  and a Biomimetic Cycloaddition
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Conclusions 
 The first total syntheses of the iridoid natural products brasoside and littoralisone 
have been completed from a common intermediate.  Each synthesis was achieved in 13 
steps and 13% overall yield.   This work highlights the use of organocatalysis in the 
stereoselective construction of complex natural product targets.  Proline was used to 
perform a diastereoselective oxidation, overcome the inherent stereoinduction of 
enamine-Michael reactions, and enable the two-step asymmetric construction of a polyol 
differentiated glucose coupling partner.  The synthetic route demonstrated here lends 
support to the proposed biochemical formation of littoralisone from brasoside. 
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Supporting Information 
 
 General Information.  Commercial reagents were purified prior to use following 
the guidelines of Perrin and Armarego.1 All solvents were purified according to the 
method of Grubbs.2 CH3CN was stored under argon over activated molecular sieves.  
TMSOTf was doubly distilled from CaH2 prior to use.  Non-aqueous reagents were 
transferred under argon via syringe or cannula.  Organic solutions were concentrated 
under reduced pressure on a Büchi rotary evaporator using a water bath.  
Chromatographic purification of products was accomplished using forced-flow 
chromatography on ICN 60 32-64 mesh silica gel or Iatrobeads® according to the method 
of Still.3 Thin-layer chromatography (TLC) was performed on EM Reagents 0.25 mm 
silica gel 60-F plates.  Visualization of the developed chromatogram was performed by 
fluorescence quenching or by anisaldehyde stain. 
1H and 13C NMR spectra were recorded on a Varian Mercury 300 (300 MHz and 
75 MHz) or 500 (500 MHz and 125 MHz) Spectrometer as noted, and are internally 
referenced to residual protio solvent signals.  Data for 1H NMR are reported as follows: 
chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet), integration, coupling constant (Hz) and assignment.  Where appropriate, the 
notations H1, H2, H3, H4, H5, and H6 have been used to refer to protons residing on the 
denoted carbons in a sugar.  Data for 13C NMR are reported in terms of chemical shift.  
IR spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported 
in terms of frequency of absorption (cm-1).  Mass spectra were obtained from the 
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California Institute of Technology Mass Spectral Facility.  Optical rotations were 
measured on a Jasco P-1010 polarimeter, and [α]D values are reported in 10-1 dg cm2 g-1. 
(S)-3,7-dimethyloct-6-enyl 2,4,6-trimethylbenzoate.  To a stirring solution of  
(–)-citronellol (8.8 mL, 48 mmol), pyridine (7.8 mL, 96 mmol), and DMAP (100 mg, 
0.82 mmol) in CH2Cl2 (250 mL) was added 2,4,6-trimethylbenzoyl chloride (9.0 mL, 53 
mmol).  After 10 h the solution was diluted in 500 mL Et2O and washed with 150 mL 
saturated solutions of NH4Cl, NaHCO3, and NaCl. The organic layer was dried over 
Na2SO4 and concentrated in vacuo.  Flash chromatography (95:5 pentane:Et2O) afforded 
the title compound as a clear, colorless oil in 99% yield (14.4 g, 47.5 mmol). IR (film) 
2956, 2921, 2852, 1778, 1726, 1613, 1453, 1436, 1376, 1264, 1214, 1170, 1083 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 6.85 (s, 2H, Ar-H); 5.09 (m, 1H, (CH3)2C=CH); 4.35 (m, 2H, 
CH2OMes); 2.29 (s, 9H, ArCH3); 1.96 (m, 2H, C=CHCH2); 1.82-1.26 (m, 11H, 
C=C(CH3)2, CH2CHCH3, CHCH3); 1.02 (d, 3H, J = 6.6 Hz, CHCH3); 13C NMR (75 
MHz, CDCl3) δ 170.5, 151.1, 139.3, 135.2, 131.6, 131.4, 128.9, 128.6, 124.9, 63.5, 40.6, 
37.2, 35.9, 29.7, 25.9, 25.7, 21.2, 20.0, 19.5, 17.8; HRMS (FAB+) exact mass calculated 
for [M + H]+ (C20H31O2) requires m/z 303.2324, found m/z 303.2333. 
! 
["]
D
25  = –1.84 (c = 
1.0, CHCl3).  
 
 (S)-5-formyl-3-methylpentyl 2,4,6-trimethylbenzoate (12).  A solution of (S)-
3,7-dimethyloct-6-enyl 2,4,6-trimethylbenzoate (9.0 g, 30 mmol) and pyridine (2.6 mL, 
45 mmol) in CH2Cl2/MeOH (140 mL/15 mL) was cooled to –78 °C.  Ozone was bubbled 
through the solution until a dark blue color developed.  At this time triphenylphosphine 
(8.6 g, 33 mmol) was added and the resulting mixture was stirred for 3 h allowing it to 
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reach 0 °C.  After concentration, flash chromatography (19:1-10:1 pentane:Et2O) 
afforded the title compound as a clear, colorless oil in 96% yield (7.96 g, 28.8 mmol). IR 
(film) 2959, 2926, 2873, 1724, 1612, 1458, 1435, 1380, 1266, 1170, 1085, 958.7, 853.1 
cm-1; 1H NMR (300 MHz, CDCl3) δ 9.77 (t, 1H, J = 1.8 Hz, CHO); δ 6.85 (s, 2H, Ar-H); 
4.36 (m, 2H, CH2OMes); 2.46 (m, 2H, CH2CHO); 2.28 (s, 9H, ArCH3); 1.83-1.46 (m, 
5H, CH2CHCH3, CHCH3); 0.96 (d, 3H, J = 6.3 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) 
δ 202.4, 170.3, 151.1, 139.4, 135.1, 131.4, 128.6, 128.5, 63.1, 41.6, 35.6, 29.6, 28.9, 21.3, 
20.0, 19.2, 19.1; HRMS (EI+) exact mass calculated for [M]+ (C17H24O3) requires m/z 
276.1728, found m/z 276.1726. 
! 
["]
D
25  = –0.33 (c = 1.0, CHCl3).  
 
(E,3R,5S)-7-(methoxycarbonyl)-5-hydroxy-3-methylhept-6-enyl 2,4,6-
trimethyl-benzoate (13). D-Proline (530 mg, 4.6 mmol) was added to a stirring solution 
of 12 (3.12 g, 11.3 mmol) and nitrosobenzene (1.21 g, 11.3 mmol) in DMSO (45 mL).  
After 0.5 h the solution became a bright orange, at which time it was cooled to –15 °C.  A 
premixed solution of methyl diethyl phosphonoacetate (6.0 mL, 34 mmol), 1,8-
diazabicyclo[5.4.0]undec-7-ene (5.1 mL, 34 mmol) and lithium chloride (1.44 g, 34 
mmol) in CH3CN (45 mL) was added over 5 min via cannula.  After 15 min the solution 
was diluted with MeOH (150 mL) and NH4Cl (1.8 g, 34 mmol) was added.  The resulting 
mixture was allowed to warm to room temperature and stand for 2 d.  At this time the 
solution was diluted with Et2O (700 mL), and washed successively with 200 mL 
saturated solutions of NH4Cl, NaHCO3, and NaCl. The aqueous layers were extracted 
with 3 x 100 mL CH2Cl2, and the combined organic layers were dried over Na2SO4 and 
concentrated in vacuo.  Flash chromatography (5:1-3:2 pentane:Et2O) afforded the title 
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compound as a clear, colorless oil in 56% yield (2.2 g, 6.33 mmol).  IR (film) 3479, 2958, 
2925, 1723, 1612, 1455, 1436, 1267, 1170, 1085, 1036, 983.8, 853.0 cm-1; 1H NMR (300 
MHz, CDCl3) δ 6.95 (dd, 1H, J = 15.6, 4.8 Hz, C=CHCHOH); 6.85 (s, 2H, Ar-H); 6.05 
(dd, 1H, J = 15.6, 1.6 Hz, C=CHCO2Me); 4.45-4.27 (m, 3H, CH2OMes, CHOH); 3.74 (s, 
3H, OCH3); 2.28 (s, 9H, ArCH3); 1.98-1.24 (m, 5H, CH2CHCH3, CHCH3); 1.01 (d, 3H, J 
= 6.6 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 170.6, 167.3, 151.8, 139.4, 135.2, 
135.0, 131.4, 128.6, 128.5, 119.4, 68.6, 63.2, 51.7, 43.8, 36.3, 26.6, 21.3, 20.0, 19.9 19.1; 
HRMS (EI+) exact mass calculated for [M + H]+ (C20H29O5) requires m/z 349.2015, found 
m/z 349.2023. 
! 
["]
D
25  = –5.78 (c = 1.0, CHCl3).  
 
(E,3R,5S)-7-(methoxycarbonyl)-5-(tert-butyl-diphenyl-silanyloxy)-3-
methylhept-6-enyl 2,4,6-trimethylbenzoate.  tert-Butylchlorodiphenylsilane (4.6 mL, 
17.8 mmol) was added to a stirring solution of 13 (3.1 g, 8.9 mmol), imidazole (1.5 g, 
22.2 mmol), and DMAP (100 mg, 0.82 mmol) in DMF (20 mL).  After 12 h the solution 
was diluted in 250 mL Et2O and washed with 50 mL saturated solutions of NH4Cl, 
NaHCO3, and NaCl. The organic layer was dried over Na2SO4 and concentrated in vacuo.  
Flash chromatography (85:15 pentane:Et2O) afforded the title compound as a clear, 
colorless oil in 97% yield (5.1 g, 8.63 mmol). IR (film) 3072, 3049, 2957, 2931, 2858, 
1726, 1612, 1472, 1428, 1362, 1267, 1170, 1112, 1085, 1036, 852.6, 821.8, 740.9, 702.0, 
607.9, 504.3 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.81-7.34 (m, 10H, SiPhH); 6.90 (dd, 
1H, J = 15.6, 5.4 Hz, C=CHCHOSi); 6.87 (s, 2H, Ar-H); 5.86 (d, 1H, J = 15.6 Hz, 
C=CHCO2Me); 4.39 (m, 1H, CHOSi); 4.20 (m, 2H, CH2OMes); 3.72 (s, 3H, OCH3); 
2.29 (s, 9H, ArCH3); 1.76-1.28 (m, 5H, CH2CHCH3, CHCH3); 1.10 (s, 9H, SiC(CH3)3); 
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0.90 (d, 3H, J = 6.6 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 170.5, 167.1, 150.6, 
139.4, 136.2, 136.1, 136.0, 135.6, 135.5, 135.3, 135.1, 134.0, 130.5, 130.3, 130.1, 129.9, 
128.6, 128.1, 128.0, 127.9, 127.8, 120.1, 71.3, 63.2, 51.8, 45.1, 35.8, 27.3, 26.8, 26.7, 
26.4, 21.4, 20.0, 19.9, 19.6; HRMS (FAB+) exact mass calculated for [M + H]+ 
(C36H47O5Si) requires m/z 587.3193, found m/z 587.3192. 
! 
["]
D
25  = –12.13 (c = 1.0, 
CHCl3).  
 
(E,4S,6R)-6-methyl-4-(tert-butyl-diphenyl-silanyloxy)-oct-2-ene-1,8-diol (14).  
A 1M solution of diisobutylaluminum hydride in hexanes (75 mL, 75 mmol) was slowly 
added to a stirred –78 °C solution of (E,3R,5S)-7-(methoxycarbonyl)-5-(tert-butyl-
diphenyl-silanyloxy)-3-methylhept-6-enyl 2,4,6-trimethylbenzoate (7.4 g, 12.6 mmol) in 
Et2O (250 mL).  After 30 min MeOH (3 mL) was slowly added, followed by dilution 
with 250 mL Et2O and warming to room temperature. Saturated Rochelle’s salt (300 mL) 
was then added, followed by vigorous stirring overnight.  The aqueous layer was then 
separated and extracted with 2 x 100 mL CH2Cl2 and Et2O. The combined organic layers 
were dried over Na2SO4 and concentrated in vacuo.  Flash chromatography (1:3 
pentane:Et2O) afforded the title compound as a clear, colorless oil in 96% yield (5.0 g, 
12.1 mmol). IR (film) 3338, 3072, 3049, 2956, 2930, 2858, 1472, 1462, 1428, 1362, 
1112, 1057, 972.6, 822.2, 739.1, 702.2, 612.4, 504.8 cm-1; 1H NMR (300 MHz, CDCl3) δ 
7.70-7.32 (m, 10H, SiPhH); 5.56 (ddt, 1H, J = 16.2, 7.5, 1.2 Hz, C=CHCH2OH); 5.38 
(ddt, 1H, J = 16.2, 5.5, 0.6 Hz, C=CHCHOSi); 4.24 (m, 1H, CHOSi); 3.87 (d, 2H, J = 5.5 
Hz, CHCH2OH); 3.56 (m, 2H, CH2CH2OH); 1.76-1.18 (m, 5H, CH2CHCH3, CHCH3); 
1.06 (s, 9H, SiC(CH3)3); 0.78 (d, 3H, J = 6.9 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 
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136.4, 136.2, 135.0, 134.8, 129.9, 129.8, 129.6, 129.5, 128.0, 127.9, 127.8, 127.6, 72.5, 
63.2, 61.0, 45.6, 39.9, 27.4, 27.3, 27.2, 25.7, 20.3, 19.6; HRMS (FAB+) exact mass 
calculated for [M + H]+ (C25H37O3Si) requires m/z 413.2512, found m/z 413.2513. 
! 
["]
D
25  = 
–19.57 (c = 1.0, CHCl3).  
 
(1S,4aR,5S,7S,7aR)-1,4a,5,6,7,7a-hexahydro-5-(tert-butyl-diphenyl-
silanyloxy)-7-methylcyclopenta[c]pyran-1-yl acetate (21).  Dess-Martin periodinane 
(2.54 g, 6.1 mmol) was added to a stirred solution of (E,4S,6R)-6-methyl-4-(tert-butyl-
diphenyl-silanyloxy)-oct-2-ene-1,8-diol (1.07 g, 2.60 mmol) in CH2Cl2 (26 mL).  After 
40 minutes the reaction was concentrated and extracted with 3 x 50 mL pentane.  The 
combined organics were concentrated in vacuo, providing 1.0 g (94% yield, 2.44 mmol) 
of the corresponding dialdehyde, which was immediately redissolved in DMSO (61 mL).  
L-Proline (93 mg, 0.80 mmol) was added to this stirred solution in one portion. After 5 h, 
the reaction was warmed to 40 °C and stirred at this temperature for 60 h at which point 
TLC analysis showed completion.  The reaction was then cooled to 0 °C, and acetic 
anhydride (2.3 mL, 24 mmol) was added, followed by pyridine (1.0 mL, 12 mmol) and 
DMAP (25 mg, 0.23 mmol).  After 15 min the reaction was diluted with 200 mL Et2O 
and washed with 50 mL saturated solutions of NH4Cl, NaHCO3, and NaCl.  The aqueous 
layers were then extracted with 2x50 mL CH2Cl2 and 2x50 mL  Et2O. The combined 
organic layers were dried over Na2SO4 and concentrated in vacuo.  Flash chromatography 
(19:1 pentane:Et2O) afforded the title compound as a clear, colorless oil in 83% yield 
(910 mg, 2.02 mmol). IR (film) 3072, 2956, 2931, 2858, 1761, 1652, 1472, 1428, 1362, 
1211, 1112, 1026, 953.8, 702.3 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.70-7.35 (m, 10H, 
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SiPhH); 6.35 (dd, 1H, J = 6.3, 2.4 Hz, OCH=CH); 6.08 (d, 1H, J = 6.6, CHOAc); 5.05 
(dd, 1H, J = 6.3, 2.7 Hz, OCH=CH); 4.32 (dd, 1H, J = 12.0, 6.6 Hz, CHOSi); 2.59 (m, 
1H, C=CHCH); 2.10 (s, 3H, OC(O)CH3); 2.08-1.84 (m, 3H, CH2CHCH3, CHCH3, 
CHCHOAc); 1.24 (m, 1H, CH2CHCH3); 1.08 (s, 9H, SiC(CH3)3); 0.94 (d, 3H, J = 6.9 Hz, 
CHCH3); 13C NMR (75 MHz, CDCl3) δ 170.0, 141.0, 136.1, 136.0, 135.9, 135.8, 130.0, 
129.9, 129.8, 127.9, 127.8, 127.7, 101.3, 91.6, 75.3, 46.0, 40.9, 38.8, 31.6, 27.2, 21.5, 
21.4, 19.5; HRMS (FAB+) exact mass calculated for [M + H]+ (C27H35O4Si) requires m/z 
451.2305, found m/z 451.2305. 
! 
["]
D
25  = –104.1 (c = 1.0, CHCl3).  
 
(1S,4aS,5S,7S,7aR)-4-formyl-1,4a,5,6,7,7a-hexahydro-5-(tert-butyl-diphenyl-
silanyloxy)-7-methylcyclopenta[c]pyran-1-yl acetate (23).  DMF (6 mL) that had been 
stored over activated molecular sieves for at least 24 h was added to a flame-dried 
schlenk flask and cooled to –20 °C.  Freshly distilled phosphorous oxychloride (0.84 mL, 
9.0 mmol) was added dropwise with stirring.  The mixture was allowed to slowly warm 
to room temperature over the course of 1 h, and then stirred at that temperature for an 
additional 1 h.  A solution of 21 (580 mg, 1.3 mmol) in DMF (3 mL) was then added 
dropwise, and the resulting mixture was warmed to 40 °C.  After 60 h the reaction was 
cooled to –20 °C, quenched by addition of 10 mL of a saturated solution of NaHCO3, and 
extracted with 3x50 mL Et2O.  The combined organics were dried over Na2SO4 and 
concentrated in vacuo.  Flash chromatography (5:1 pentane:Et2O) afforded the title 
compound as a clear, colorless oil in 73% yield (451 mg, 0.94 mmol) and 24 in 6% yield 
(see below). IR (film) 3072, 2957, 2931, 2858, 1766, 1677, 1633, 1472, 1428, 1367, 
1215, 1183, 1091, 1071, 821.6, 740.0, 704.5 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.18 (s, 
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1H, CHO); 7.67-7.29 (m, 11H, SiPhH, OCH=C); 6.45 (d, 1H, J = 9.3, CHOAc); 4.60 
(apparent t, 1H, J = 3.4 Hz, CHOSi); 2.83 (dd, 1H, J = 8.8, 3.4, Hz C=CCH); 2.22 (s, 3H, 
OC(O)CH3); 2.13 (m, 1H, CHCHOAc); 1.85-1.71 (m, 2H, CH2CHCH3, CHCH3); 1.20 
(m, 1H, CH2CHCH3); 1.02 (s, 12H, SiC(CH3)3, CHCH3); 13C NMR (75 MHz, CDCl3) δ 
190.0, 169.7, 162.7, 136.4, 136.3, 136.2, 136.1, 134.2, 133.2, 129.9, 129.8, 127.8, 127.7, 
127.6, 119.1, 96.3, 76.1, 44.7, 43.5, 40.2, 34.2, 27.3, 27.2, 21.7, 21.2, 19.6; HRMS 
(FAB+) exact mass calculated for [M + H]+ (C28H35O5Si) requires m/z 479.2254, found 
m/z 479.2266. 
! 
["]
D
25  = –13.82 (c = 1.0, CHCl3).  
 
(1S,4aS,5S,7S,7aR)-4-formyl-1,4a,5,6,7,7a-hexahydro-5-(formyl)-7-
methylcyclopenta[c]pyran-1-yl acetate (24).  DMF (6 mL) that had been stored over 
activated molecular sieves for at least 24 h was added to a flame-dried schlenk flask and 
cooled to –20 °C.  Freshly distilled phosphorous oxychloride (0.84 mL, 9.0 mmol) was 
added dropwise with stirring.  The mixture was allowed to slowly warm to room 
temperature over the course of 1 h, and then stirred at that temperature for an additional 1 
h.  A solution of 21 (580 mg, 1.3 mmol) in DMF (3 mL) was then added dropwise, and 
the resulting mixture was warmed to 40 °C.  After 60 h the reaction was cooled to –20 
°C, quenched by addition of 10 mL of a saturated solution of NaHCO3, and extracted 
with 3 x 50 mL Et2O.  The combined organics were dried over Na2SO4 and concentrated 
in vacuo.  Flash chromatography (5:1 pentane:Et2O) afforded the title compound as a 
clear, colorless oil in 6% yield (18 mg, 0.078 mmol) and 23 in 73% yield (see above). IR 
(film) 2958, 2924, 1763, 1724, 1673, 1633, 1368, 1216, 1180, 1092, 1066, 1018, 990.9, 
963.5 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.32 (s, 1H, C=CCHO); 7.93 (d, 1 H, OCHO, 
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J = 0.6 Hz); 7.36 (s, 1H, OCH=C); 5.98 (d, 1H, J = 9.0, CHOAc); 5.66 (apparent t, 1H, J 
= 4.2 Hz, CHOCHO); 3.11 (dd, 1H, J = 9.0, 4.2 Hz, C=CCH); 2.22 (s, 3H, OC(O)CH3); 
2.13 (m, 1H, CHCHOAc); 1.97-159 (m, 2H, CH2CHCH3, CHCH3); 1.20 (m, 1H, 
CH2CHCH3); 1.02 (d, 3H, J = 6.6 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 189.7, 
169.7, 162.4, 159.9, 117.9, 95.2, 76.1, 44.8, 40.7, 37.8, 34.4, 21.3, 21.1; HRMS (FAB+) 
exact mass calculated for [M + H]+ (C13H16O6) requires m/z 268.0947, found m/z 
268.0954. 
! 
["]
D
25  = –13.18 (c = 1.0, CHCl3).  
 
(1S,4aS,5S,7S,7aR)-1-acetoxy-1,4a,5,6,7,7a-hexahydro-5-(tert-butyl-diphenyl-
silanyloxy)-7-methylcyclopenta[c]pyran-4-carboxylic acid (25).  Sodium hypochlorite 
(1.06 g, 9.4 mmol) was added to a stirred solution of NaH2PO4 (864 mg, 6.3 mmol) in 
H2O (3.2 mL).  The resulting solution was added dropwise over 30 min to a stirred 
mixture of (1S,4aS,5S,7S,7aR)-4-formyl-1,4a,5,6,7,7a-hexahydro-5-(tert-butyl-diphenyl-
silanyloxy)-7-methylcyclopenta[c]pyran-1-yl acetate (300 mg, 0.63 mmol) in 2-methyl 
butene (4.2 mL) and tBuOH (6.3 mL).  The resulting solution was stirred for 24 h, at 
which time an additional portion of sodium hypochlorite (354 mg, 3.1 mmol) and 
NaH2PO4 (288 mg, 2.1 mmol) in H2O (1.0 mL) was added.  After a further 24 h of 
stirring, the reaction was diluted with 10 mL H2O, and extracted with 3x20 mL CH2Cl2 
and 3x20 mL Et2O.  The combined organics were dried over Na2SO4 and concentrated in 
vacuo.  Flash chromatography (5:1-1:6 pentane:Et2O) afforded the title compound as a 
clear, colorless oil in 93% yield (288 mg, 0.58 mmol). IR (film) 3073, 2958, 2932, 2859, 
1764, 1682, 1634, 1428, 1367, 1287, 1193, 1089, 960.2, 912.0, 737.0, 704.3 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 7.76 (s, 1H, OCH=C); 7.69-7.29 (m, 10H, SiPhH); 6.40 (d, 
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1H, J = 8.7 Hz, CHOAc); 4.52 (m, 1H, CHOSi); 2.77 (dd, 1H, J = 8.4, 3.0 Hz, C=CCH); 
2.22 (s, 3H, OCOCH3); 2.15 (m, 1H, CHCHOAc); 1.86-1.73 (m, 2H, CH2CHCH3, 
CHCH3); 1.24 (m, 1H, CH2CHCH3); 1.04 (s, 12H, SiC(CH3)3, CHCH3); 13C NMR (75 
MHz, CDCl3) δ 172.9, 169.9, 156.2, 136.4, 136.3, 136.2, 136.1, 134.5, 133.1, 129.9, 
129.8, 127.8, 127.7, 127.6, 105.7, 95.5, 76.4, 44.9, 43.1, 42.3, 34.2, 27.3, 27.2, 21.7, 21.2, 
19.4; HRMS (FAB+) exact mass calculated for [M + H]+ (C28H35O6Si) requires m/z 
495.2203, found m/z 495.2225. 
! 
["]
D
25  = –13.82 (c = 1.0, CHCl3).  
 
Iridolactone (8).  A solution of HF•pyridine (2 mL, 70% HF) was added to a 
stirred solution of (1S,4aS,5S,7S,7aR)-1-acetoxy-1,4a,5,6,7,7a-hexahydro-5-(tert-butyl-
diphenyl-silanyloxy)-7-methylcyclopenta[c]pyran-4-carboxylic acid (240 mg, 0.48 
mmol) in THF (4 mL). After 10 h the reaction was diluted with 50 mL Et2O, and washed 
with 20 mL of a saturated NaHCO3 solution (Caution: violent bubbling).  The aqueous 
layer was thoroughly extracted with 3x20 mL CH2Cl2 and Et2O.  The combined organics 
were dried over Na2SO4 and concentrated in vacuo.  The resultant residue was then 
immediately dissolved in CH2Cl2 (10 mL), at which time 1,3-dicyclohexyl carbodiimide 
(150 mg, 0.73 mmol) was added in one portion.  After 15 min, the reaction was 
concentrated in vacuo. Flash chromatography (5:1-1:4 pentane:Et2O) afforded the title 
compound as a clear, colorless oil in 82% yield (95 mg, 0.40 mmol). IR (film) 2954, 
2931, 2854, 1756, 1661, 1237, 1216, 1170, 1012, 972.2, 872.0 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 7.31 (d, 1H, 2.7 Hz, OCH=C); 6.35 (s, 1H, CHOAc); 5.06 (apparent t, 1H, J = 
4.6 Hz, CHOC(O)); 3.42 (m, 1H, C=CCH); 2.20-2.10 (m, 4H, OCOCH3, CHCHOAc); 
1.98 (m, 1H, CH2CHCH3); 1.66 (m, 1H, CHCH3); 1.24 (m, 1H, CH2CHCH3); 1.07 (d, 
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3H, J = 6.3 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 170.2, 169.2, 148.3, 103.6, 88.8, 
81.1, 45.0, 42.0, 38.1, 31.8, 20.9, 17.6; HRMS (EI+) exact mass calculated for [M]+ 
(C12H14O5) requires m/z 238.0841, found m/z 238.0838. 
! 
["]
D
25  = –229.2 (c = 1.0, CHCl3).  
 
Brasoside Tetraacetate.  1-O-(Trimethylsilyl)-2,3,4,6-tetra-O-acetyl-β-D-
glucopyranose (31.5 mg, 0.075 mmol, prepared according to the method of Allevi4) and 8 
(7.0 mg, 0.030 mmol) were added as benzene solutions to a schlenk flask under argon.  
The benzene was then frozen and sublimed.  The remaining solid was redissolved in 
CH3CN (0.15 mL) and cooled to –30 °C.  At this time TMSOTf (2.3 µL, 0.012 mmol) 
was added dropwise as a 5% solution in CH3CN.  After stirring at –30 °C for 3 d, the 
reaction was quenched with 1 mL pH 7 buffer and extracted with 3x10 mL Et2O.  The 
combined organics were dried over Na2SO4 and concentrated in vacuo. Flash 
chromatography (1:1-1:3 pentane:Et2O) afforded the title compound as a clear, colorless 
oil in 86% yield (13.6 mg, 0.026 mmol). The spectral data (1H and 13C) were in full 
accord with those reported for the natural isolate,5,6 except for the IR and HRMS which 
have not been described: IR (film) 2955, 2920, 2858, 1756, 1660, 1367, 1219, 1216, 
1038, 1013, 972.8, 862.2cm-1; HRMS (EI+) exact mass calculated for [M + H]+ 
(C24H31O13) requires m/z 527.1765, found m/z 527.1764. 
! 
["]
D
25  = –270.9 (c = 1.0, CHCl3); 
lit: [α]D = –229 (c = 0.9, CHCl3).5 
 
Brasoside (2).  A solution of MeOH:Et3N:H2O (0.08 mL, 8:1:1) was added 
slowly to a –15 °C solution of Brasoside tetraacetate (5.0 mg, 0.007 mmol) in CH2Cl2 
(0.04 mL).  After 3 h the reaction was quenched with 0.5 mL pH 7 buffer, and extracted 
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with 3x5 mL EtOAc.  The combined organics were dried over Na2SO4 and concentrated 
in vacuo. Flash chromatography (9:1 EtOAc:MeOH) afforded the title compound as a 
white powder in 90% yield (2.3 mg, 0.0063 mmol). The spectral data (1H and 13C) were 
in full accord with those already reported (table 2),5-7 except for the IR and HRMS which 
have not been described: IR (film) 2960, 2917, 2849, 1749, 1654, 1261, 1090, 1019, 
799.0 cm-1; HRMS (FAB+) exact mass calculated for [M + H]+ (C16H23O9) requires m/z 
359.1342, found m/z 359.1332. 
! 
["]
D
25  = –181.0 (c = 0.41, EtOH); lit: [α]D = –170 (c = 
0.97, EtOH)5; [α]D = –283 (c = 1.4, EtOH)6. 
 
(E)-2-hydroxyethyl 3-(4-(benzyloxy)phenyl)acrylate.  Oxalyl chloride (8 mL, 
2M solution in CH2Cl2) was added to a stirred solution of p-benzyloxycinammic acid 
(2.89 g, 11.3 mmol, prepared according to the method of Doherty8) in CH2Cl2 (45 mL) at 
0 °C.  A few drops of DMF were then added, and the resulting solution was stirred at 0˚C 
for 1 h and at 23 °C for a further 1 h.  At this stage the solution was added dropwise via 
cannula to a stirred mixture of ethylene glycol (12.6 mL, 226 mmol), triethylamine (4 
mL, 28 mmol), and DMAP (100 mg, 0.82 mmol) in CH2Cl2 (110 mL) cooled to 0 °C.  
The resulting solution was stirred for 12 h, at which time the reaction was quenched with 
a saturated solution of NaHCO3 (200 mL), and after extraction the organic layer was 
washed with brine, dried over Na2SO4 and concentrated in vacuo.  Flash chromatography 
(4:1 Et2O:pentane) afforded the title compound as a white solid in 93% yield (3.14 g, 
10.5 mmol). IR (film) 3420, 2956, 2932, 2859, 1707, 1636, 1602, 1511, 1254, 1172, 
984.1, 825.5 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.68 (d, 1H, J = 16.2 Hz, ArCH=CH); 
7.50-7.35 (m, 7H, ArH); 6.98 (d, 2H, J = 9.0 Hz, ArH); 6.34 (d, 1H, J = 16.2 Hz, 
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ArCH=CH); 5.10 (s, 2H, CH2Ph); 4.35 (m, 2H, CO2CH2CH2); 3.90 (dd, 2H, J = 9.0, 5.1 
Hz, CO2CH2CH2); 13C NMR (75 MHz, CDCl3) δ 167.9, 160.9, 145.3, 136.7, 130.2, 128.9, 
128.4, 127.7, 127.4, 115.5, 115.4, 70.3, 66.4, 61.5; HRMS (FAB+) exact mass calculated 
for [M + H]+ (C18H19O4) requires m/z 299.1283, found m/z 299.1276. 
 
Enolsilane (28).  Dess-Martin periodinane (2.15 g, 5.1 mmol) was added to a 
stirred solution of (E)-2-hydroxyethyl 3-(4-(benzyloxy)phenyl)acrylate (1.21 g, 4.06 
mmol) in CH2Cl2 (20 mL).  After 10 h the reaction was concentrated and extracted with 
3x50 mL Et2O.  The combined organics were concentrated in vacuo, providing 1.15 g 
(95% yield, 5.8 mmol) of the corresponding aldehyde, which was immediately 
redissolved in CH3CN (5 mL).  The resulting solution was added dropwise to a premixed 
solution of triethylamine (3.75 mL, 27 mmol) and chlorotrimethylsilane (2.44 mL, 19.2 
mmol) in CH3CN (5 mL).  This mixture was stirred for 2 h, at which time the reaction 
was concentrated in vacuo.  Flash chromatography (3:1 pentane:Et2O) on Iatrobeads 
afforded the title compound as a white solid in 82% yield (1.75 g, 4.8 mmol). IR (film) 
3117, 3065, 3035, 2958, 2931, 2898, 2860, 1732, 1682, 1634, 1601, 1511, 1270, 1158, 
1122, 985.2, 843.5 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.74 (d, 1H, J = 16.2 Hz, 
ArCH=CH); 7.51-7.36 (m, 7H, ArH); 6.98 (d, 2H, J = 8.7 Hz, ArH); 6.74 (d, 1H, J = 3.6 
Hz, CH=CHOTMS); 6.39 (d, 1H, J = 16.2 Hz, ArCH=CH); 5.84 (d, 1H, J = 3.6 Hz, 
CH=CHOTMS); 5.10 (s, 2H, CH2Ph); 0.25 (s, 9H, Si(CH3)3); 13C NMR (75 MHz, 
CDCl3) δ 164.3, 161.0, 146.1, 136.6, 130.2, 130.0, 128.9, 128.4, 127.7, 127.4, 121.2, 
115.5, 114.7, 70.3, -0.2; HRMS (FAB+) exact mass calculated for [M + H]+ (C21H25O4Si) 
requires m/z 369.1522, found m/z 369.1517. 
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 2-O-Benzylcoumaroyl-4,6-bis-O-benzyloxy-α-D-glucopyranose (30).  (2R,3R)-
3-Hydroxy-2,3-bis-(benzylyloxy)-propionaldehyde (29) (125 mg, 0.42 mmol, prepared 
according to the method of MacMillan9 using D-proline) was added as a solution in 2.0 
mL of toluene to a flame-dried schlenk flask charged with finely divided magnesium 
bromide diethyl etherate (322 mg, 1.25 mmol, freshly prepared from magnesium turnings 
and dibromoethane in Et2O) and 2.0 mL of toluene cooled to –20 °C.  After stirring for 30 
minutes at –20 °C, 13 (230 mg, 0.63 mmol) was added as a solution in 0.5 mL toluene.  
The suspension was stirred at –20 °C for 2 hours, then allowed to warm to 4 °C over the 
course of 4 hours.  After stirring for an additional 24 hours at 4 °C, the reaction was 
acidified by the addition of 50 mL saturated aqueous NH4Cl and extracted with Et2O 
(3x50 mL).  The combined organics were washed with 50 mL brine, dried over 
anhydrous Na2SO4 and concentrated in vacuo.  The residue was taken up in 5 mL of 7:2:1 
THF:water:trifluoroacetic acid at 0 °C and stirred for 30 minutes before being quenched 
with 50 mL 10% NaHCO3, extracted with 2x100 mL Et2O, dried over anhydrous Na2SO4, 
filtered and concentrated in vacuo.  Crude 1H NMR analysis indicated an 10:1 mixture of 
glucose:mannose-derived diastereomers.  Flash chromatography (1:1-4:1 Et2O:pentane) 
afforded the title compound as a white solid (163 mg, 0.27 mmol) in 65% yield, 8:1 α:β.  
IR (film) 3425, 3064, 3032, 2924, 2869, 1710, 1633, 1603, 1511, 1454, 1251, 1171, 
1058, 910.58, 828.2, 743.8, 697.6 cm-1; 1H NMR (300 MHz, CDCl3) α-isomer: δ 7.72 (d, 
1H, J = 15.9 Hz, ArCH=CH); 7.47-7.20 (m, 17H, ArH); 6.94 (d, 2H, J = 8.7 Hz, ArH); 
6.37 (d, 1H, J = 15.9 Hz, ArCH=CH); 5.48 (m, 1H, H1); 5.06 (m, 2H, CH2Ph); 4.87 (dd, 
1H, J = 10.2, 3.9 Hz, H2); 4.85 (d, 1H, J = 11.4 Hz, CH2Ph); 4.64-4.50 (m, 3H, CH2Ph); 
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4.24 (m, 1H, H6); 4.09 (m, 1H, H6); 3.72-3.53 (m, 3H, H3, H4, H5); 13C NMR (75 MHz, 
CDCl3) α-isomer: δ 167.4, 161.0, 146.0, 138.4, 138.0, 136.6, 130.2, 128.9, 128.8, 128.7, 
128.4, 128.3, 128.2, 128.0, 127.7, 127.4, 115.4, 114.9, 90.7, 78.5, 75.0, 74.0, 73.7, 72.0, 
70.3, 70.0, 68.9; HRMS (FAB+) exact mass calcd for [M+H]+ (C36H37O8) requires m/z 
597.2488, found m/z 597.2512; 
! 
["]
D
25  = 30.59  (c = 1.0, CHCl3, 8:1 α:β mixture). 
 
2-O-Benzylcoumaroyl-3,4,6-tris-O-benzyloxy-α-D-glucopyranose.  Benzyl 
bromide (0.132 mL, 1.1 mmol) was added to a solution of freshly prepared Ag2O (255 
mg, 1.1 mmol) and 9 (131 mg, 0.22 mmol) in 2.3 mL of CH2Cl2 stirred in the dark.  After 
stirring for 18 h, the reaction was filtered through a pad of celite and concentrated in 
vacuo.  The resulting residue was redissolved in MeOH (3 mL), at which time 
ammonium formate (208 mg, 3.3 mmol) and 10% Pd on alumina (220 mg) were added.  
The suspension was stirred for 10 hours, then filtered and concentrated in vacuo.  Flash 
chromatography (1:1-3:1 Et2O:pentane) afforded the title compound as a white solid (103 
mg, 0.15 mmol) in 68% yield, 12:1 α:β.  IR (film) 3424, 3063, 3030, 2892, 2868, 1713, 
1631, 1602, 1510, 1453, 1249, 1172, 1060, 827.6, 736.4, 697.1 cm-1; 1H NMR (300 MHz, 
CDCl3) α-isomer: δ 7.70 (d, 1H, J = 15.9 Hz, ArCH=CH); 7.48-7.18 (m, 22H, ArH); 
6.98 (d, 2H, J = 8.7 Hz, ArH); 6.33 (d, 1H, J = 15.9 Hz, ArCH=CH); 5.50 (t, 1H, J = 3.6 
Hz, H1); 5.08 (m, 2H, CH2Ph); 4.88-4.83 (m, 3H, H2, CH2Ph); 4.64-4.51 (m, 4H, 
CH2Ph); 4.21-4.14 (m, 2H, H6); 3.86 (m, 1H, H3); 3.72-3.67 (m, 2H, H4, H5); 13C NMR 
(75 MHz, CDCl3) α-isomer: δ 166.8, 161.0, 145.7, 138.7, 138.3, 138.0, 136.7, 130.2, 
128.9, 128.8, 128.7, 128.6, 128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.5, 
115.5, 115.2, 90.9, 80.2, 78.4, 77.8, 77.4, 76.9, 75.8, 75.4, 73.9, 73.7, 70.5, 70.3, 69.0; 
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HRMS (EI+) exact mass calcd for [M]+ (C43H42O8) requires m/z 686.2880, found m/z 
686.2891; 
! 
["]
D
25  = 38.62  (c = 1.0, CHCl3, 12:1 α:β mixture). 
 
1-O-(Trimethylsilyl)-2-O-Benzylcoumaroyl-3,4,6-tris-O-benzyloxy-β-D-
glucopyranose (9).  Chlorotrimethylsilane (27.8 µL, 0.22 mmol) was added dropwise 
over 20 min as a benzene (1 mL) solution to a refluxing mixture of triethylamine (0.202 
mL, 1.46 mmol) and 2-O-benzylcoumaroyl-3,4,6-tris-O-benzyloxy-α-D-glucopyranose 
(100 mg, 0.146 mmol) in benzene (2.9 mL).  After refluxing for 2 h, the reaction was 
filtered through a pad of celite and concentrated in vacuo.  Flash chromatography (3:1 
pentane: Et2O) on Iatrobeads afforded the title compound as a clear oil that solidifies to a 
white solid on standing in vacuo (101 mg, 0.133 mmol) in 91% yield.  IR (film) 3064, 
3032, 2958, 2868, 1716, 1634, 1603, 1511, 1454, 1251, 1150, 1068, 846.6, 736.6, 697.3 
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.73 (d, 1H, J = 15.9 Hz, ArCH=CH); 7.55-7.25 (m, 
22H, ArH); 7.03 (d, 2H, J = 8.7 Hz, ArH); 6.33 (d, 1H, J = 15.9 Hz, ArCH=CH); 5.20-
5.15 (m, 3H, H1, CH2Ph); 4.92-4.61 (m, 7H, H2, CH2Ph); 3.85-3.76 (m, 4H, H3, H5, 
H6); 3.62 (m, 1H, H4); 0.24 (s, 9H, Si(CH3)3); 13C NMR (75 MHz, CDCl3): δ 166.1, 
160.9, 145.1, 138.6, 138.6, 138.4, 138.3, 136.8, 130.1, 129.0, 128.7, 128.6, 128.5, 128.4, 
128.3, 128.2, 128.0, 127.9, 127.8, 127.7, 127.6, 115.8, 115.6, 96.3, 83.0, 78.4, 75.7, 75.4, 
75.3, 75.2, 73.8, 70.4, 69.3, 0.48; HRMS (FAB+) exact mass calcd for [M – H]+ 
(C46H49O8Si) requires m/z 757.3197, found m/z 757.3174; 
! 
["]
D
25  = 44.67  (c = 1.0, CHCl3). 
 
2-O-Benzylcoumaroyl-3,4,6-tris-O-benzyloxy-brasoside (31). 9 (71 mg, 0.094 
mmol) and 8 (15 mg, 0.063 mmol) were added as benzene solutions to a schlenk flask 
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under argon.  The benzene was then frozen and evaporated.  The remaining solid was 
redissolved in CH3CN (0.25 mL) and cooled to –30 °C.  At this time TMSOTf (6.1 µL, 
0.031 mmol) was added dropwise as a 10% solution in CH3CN.  After 5 d stirring at –30 
°C the reaction was quenched with 2 mL pH 7 buffer, and extracted with 3x15 mL Et2O.  
The combined organics were dried over Na2SO4 and concentrated in vacuo. Flash 
chromatography (50:1-25:1 CH2Cl2:Et2O) afforded the title compound as a clear, 
colorless oil in 74% yield (40 mg, 0.047 mmol).  IR (film) 3069, 3032, 2962, 2873, 1756, 
1716, 1660, 1603, 1511, 1455, 1258, 1081, 800.0, 737.4, 698.4 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.56 (d, 1H, J = 15.9 Hz, ArCH=CH); 7.49-7.15 (m, 23H, ArH, OCH=C); 
6.98 (d, 2H, J = 8.7 Hz, ArH); 6.14 (d, 1H, J = 15.9 Hz, ArCH=CH); 5.52 (d, 1H, J = 0.9 
Hz, OCHO-Glucose); 5.12-4.53 (m, 11H, H1, H2, CH2Ph, CHOC(O)); 3.81-3.72 (m, 4H, 
H3, H5, H6); 3.58 (m, 1H, H4), 3.42 (dt, 1H, J = 6.9, 2.7 Hz, OC=CCH); 2.05 (m, 2H, 
CH2CHCH3, CHCHO-Glucose); 1.86 (m, 1H, CHCH3); 1.54 (m, 1H, CH2CHCH3); 1.00 
(d, 3H, J = 6.3 Hz, CHCH3); 13C NMR (75 MHz, CDCl3): δ 170.4, 165.9, 160.8, 147.7, 
145.5, 137.8, 136.5, 133.8, 130.0, 128.7, 128.6, 128.5, 128.4, 128.2, 128.1, 128.0, 127.9, 
127.8, 127.7, 127.6, 127.5, 127.1, 115.3, 114.8, 106.7, 104.0, 96.3, 92.9, 82.5, 81.0, 77.7, 
77.2, 75.4, 75.2, 75.1, 73.5, 72.7, 70.1, 68.4, 45.1, 42.1, 38.1, 31.4, 17.8; HRMS (FAB+) 
exact mass calcd for [M + H]+ (C53H53O11) requires m/z 865.3588, found m/z 865.3563; 
! 
["]
D
25  = –37.42  (c = 1.0, CHCl3). 
 
Littoralisone (1).  16 (10 mg, 0.012 mmol) was dissolved in degassed benzene 
(3.8 mL) in a Pyrex flask under argon.  This solution was exposed to 350 nm UV light 
(Hitachi UVA lamps, Luzchem 10 lamp photoreactor) with stirring for 2 h.  At this time 
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the reaction was concentrated in vacuo, then redissolved in EtOAc/MeOH (2:1), and 10% 
Pd/C (5 mg) was added with stirring.  This suspension was degassed and backfilled with 
H2 three times, at which point it was kept under a slight positive pressure of H2.  After 30 
min, the reaction was filtered, and concentrated in vacuo.  Flash chromatography (50:1-
25:1 CH2Cl2:MeOH) afforded the title compound as a white powder in 84% yield (5.1 
mg, 0.010 mmol).  1H and 13C NMR, IR and HRMS spectra confirm that synthetic and 
natural 1 are identical in all respects (table 1).  IR (film) 3391, 1745, 1635, 1518, 1448, 
1187, 1076, 972.4 cm-1.  Synthetic 1 
! 
["]
D
25= –46.1 (c = 0.4, MeOH), natural 1 
! 
["]
D
25
 =       
–49.5 (c = 0.4, MeOH)10.  HRMS (FAB+) exact mass calcd for [M + H]+ (C25H29O11) 
requires m/z 505.1710, found m/z 505.1699. 
1 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed., Pergamon Press, Oxford, 1988. 
2 Pangborn, A. B.; Giardello, M. A,; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J.  Organometallics 1996, 15, 1518. 
3 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
4 Allevi, P.; Anastasia, M.; Ciuffreda, P.; Bigatti, E.; MacDonald, P.  J. Org. Chem.  1993, 58, 4175.  
5 Jensen, S. R.; Kirk, O.; Nielsen, B. J.; Norrestam, R.  Phytochemistry  1987, 26, 1725.  
6 Schafer, B.; Rimpler, H.  Z. Naturforsch  1979, 34, 311. 
7 Franke, A.; Rimpler, H.  Phytochemistry  1987, 26, 3015. 
8 Doherty, D. G.  J. Am. Chem. Soc. 1955, 77, 4887. 
9 Northrup, A. B.; Mangion, I. K.; Hettche, F.; MacMillan, D. W. C. Angew. Chem., Int. Ed. 2004, 43, 2152. 
10 Li, Y.-S.; Matsunaga, K.; Ishibashi, M.; Ohizumi, Y. J. Org. Chem. 2001, 66, 2165. 
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Table 1.  1H and 13C NMR Data for Natural10 and Synthetic 1a 
 
  Natural Littoralisoneb  Synthetic Littoralisonec 
position   13C (δ) 1H (δ), m, J  (Hz)  13C (δ) 1H (δ), m, J  (Hz) 
        
 1  96.45 5.23, s  96.46 5.23, s 
 3  66.84 5.06, d, 11.1  66.87 5.04, d, 10.8 
 4  48.13   48.15  
 4a  43.87 3.35, dd, 9.2, 4.6  43.90 3.33, dd, 9.0, 4.5 
 5  83.47 5.16, dd, 5.0, 4.6  83.48 5.15, dd, 6.8, 4.4 
 6  43.23 2.03 (H-6α), dd, 12.6, 3.8 
1.42 (H-6β), dd, 12.6, 5.0 
 43.26 2.02 (H-6α), dd, 12.6, 3.9 
1.41 (H-6β), dd, 12.6, 5.3 
 7  33.21 1.49, m  33.24 1.47, m 
 7a  46.98 1.70, dd, 11.8, 9.2  47.01 1.70, dd, 12.2, 9.0 
 8  16.58 1.03, d, 5.7  16.61 1.03, d, 5.7 
 9  176.94   176.96  
 1’  100.37 4.83, d, 8.4  100.39 4.81, d, 8.3 
 2’  80.49 4.73, dd, 9.9, 8.4  80.51 4.72, dd, 9.8, 8.4 
 3’  74.59 3.72, dd, 9.9, 8.4  74.62 3.70, dd, 9.8, 8.4 
 4’  71.93 3.37, dd, 9.9, 8.4  71.94 3.36, dd, 9.8, 8.4 
 5’  79.54 3.41, ddd, 9.9, 5.3, 2.3  79.57 3.40, ddd, 9.8, 5.3, 2.0 
 6’  62.63 3.68 (H-6’a), dd, 11.8, 5.3 
3.90 (H-6’b), dd, 11.8, 2.3 
 62.66 3.67 (H-6’a), dd, 12.2, 5.3 
3.89 (H-6’b), dd, 12.2, 2.0 
 1”  175.13   175.14 0.97, d, 6.6 
 2”  50.14 3.94, dd, 11.1, 4.6  50.17 3.93, dd, 11.0, 4.6 
 3”  49.65 4.15, d, 4.6  49.66 4.14, d, 4.4 
 1’’’  128.37   128.39  
 2’’’  130.32 7.06, dd, 6.5, 1.9  130.35 7.05, dd, 6.8, 1.9 
 3’’’  116.19 6.72, dd, 6.5, 1.9  116.20 6.71, dd, 6.8, 1.9 
 4’’’  157.79   157.84  
 5’’’  116.19 6.72, dd, 6.5, 1.9  116.20 6.71, dd, 6.8, 1.9 
 6’’’  130.32 7.06, dd, 6.5, 1.9  130.35 7.05, dd, 6.8, 1.9 
aSpectra were measured in CD3OD.  b1H NMR (500 MHz); 13C (125 MHz).  c1H NMR (500 
MHz);  
13C (125 MHz).   
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1H NMR of synthetic 1  
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13C NMR of synthetic 1     
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Table 2.  1H and 13C NMR Data for Natural5 and Synthetic 2a 
 
  Natural Brasosideb  Synthetic Brasosidec 
position   13C 
(δ) 
1H (δ), m, J  (Hz)  13C (δ) 1H (δ), m, J  (Hz) 
        
 1  95.3 5.75, s  95.5 5.75, s 
 3  150.7 7.45, d, 2.6  150.8 7.44, d, 2.5 
 4  104.1   104.2  
 4a  38.6 3.50, dt, 7.2, 2.5  38.7 3.49, m 
 5  84.4 5.20, t, 7.7  84.6 5.20, t, 7.5 
 6  41.8 2.08 (H-6α), dd, 15.2, 7.6 
1.73 (H-6β), ddd, 15.1,  
                    11.4, 8.0 
 41.8 2.07 (H-6α), dd, 15.0, 8.0 
1.71 (H-6β), ddd, 15.0,             
                     11.5, 8.0 
 7  32.3 1.94, m  32.3 1.93, m 
 7a  45.5 2.18, ddd, 11.0, 6.8, 0.8  45.6 2.16, ddd, 11.0, 6.5, 0.7 
 8  17.5 1.03, d, 7.0  17.5 1.02, d, 6.5 
 9  175.0   175.2  
 1’  99.4 4.91, d, 8.0  99.5 4.90, d, 8.0 
 2’  73.4 --  73.4 3.30, dd, 9.3, 8.2 
 3’  76.3 --  76.3 3.55-3.47, m 
 4’  70.4 --  70.4 3.41, dd, 10.0, 9.3 
 5’  77.1 --  77.2 3.55-3.47, m 
 6’  61.5 --  61.5 3.74 (H-6’a), dd, 12.4, 5.0 
3.94 (H-6’b), dd, 12.4, 2.2 
aSpectra were measured in D2O.  b1H NMR (500 MHz); 13C (125 MHz).  c1H NMR (500 MHz);  
13C (125 MHz).   
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1H NMR of synthetic 2 
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13C NMR of synthetic 2 
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C h a p t e r  4  
Progress Toward the Total Synthesis of Diazonamide A* 
Isolation, Biological Activity, and Structural Revision 
 The diazonamides were isolated by Fenical and Clardy in 19911 from the 
methanol extracts of the marine ascidian Diazona angluata, originally misidentified as 
Diazona chinensis2 (figure 1).  From these extracts were obtained considerable quantities 
of each isolate: 54 mg of diazonamide A (1) and 132 mg of diazonamide B (2).  
However, the paucity of protons and abundance of heteroatoms in these structures made 
unambiguous structural assignment strictly through 1H-13C NMR correlation methods 
difficult.  Instead, a single crystal X-ray structure of a p-bromobenzoyl derivative of 2 led   
Figure 1: Original and Revised Structures for the Diazonamides
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* A communication of this work is in preparation. 
1 Lindquist, N.; Fenical, W.; Van Duyne, G. D.; Clardy, J.  J. Am. Chem. Soc. 1991, 113, 2303. 
2 Vervoort, H. C.; PhD thesis, University of California at San Diego, 1999. 
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to the erroneous assignment of diazonamide B as 4, with diazonamide A assigned as 3 
based on 1H NMR and analogy to the crystal structure.  Significantly, diazonamide A was 
found to be tremendously cytotoxic (IC50 <15 nM) against HCT-116 and B-16 human 
cancer cell lines.1  Subsequent studies at the National Cancer Institute showed even 
greater potency (4.9 nM) against CA46, MCF7, PC-3, and A549 cell lines.3  Detailed 
biochemical studies have also indicated that 1 arrests cells at the G2/M phase of the cell 
cycle through distortion of the microtubules constituting the mitotic spindle.  
Diazonamide A may also have a binding site on microtubules distinct from other tubulin-
binding natural products (e.g., vinca alkaloids, dolastatins, epothilones).4  
 The excitement in the synthetic community for this novel, elaborate class of 
natural product was immediate.  Numerous synthetic groups have reported progress 
toward the originally proposed structure 3, but since this work has been thoroughly and 
precisely reviewed5 I will focus strictly on the recent successful syntheses of 1 that can 
put our own efforts in proper context.  In 2001, the Harran lab at the UT Southwestern 
Medical Center reported the first and only total synthesis of 3.  This feat was remarkable 
Figure 2: Accepted Carbon Numbering and Ring Labeling Terminology for 1
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3 Li, J.; Jeong, S.; Esser, L.; Harran, P. G.  Angew. Chem. Int. Ed. 2001, 40, 4765. 
4 Cruz-Monserrate, Z.; Vervoort, H. C.; Bai, R.; Newman, D. J.; Howell, S. B.; Los, G.; Mullaney, J. T.; Williams, 
M. D.; Pettit, G. R.; Fenical, W.; Hamel, E.  Mol. Pharmacology 2003, 63, 1273. 
5 (a) Fuerst, D, E.; PhD thesis, Yale University, 2004; (b) Ritter, T.; Carreira, E. M.  Angew. Chem. Int. Ed. 2002, 41, 
2489. 
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in many respects, including highly creative chemistry.  Most noteworthy was their 
revelation that synthetic 3 did not match natural diazonamide A in terms of spectral data, 
TLC mobility, biological activity and stability.  Indeed, 3 turned out to be substantially 
less stable than the natural sample, and led the Harran lab to perform a detailed structural 
reassignment based on the available data.  In back-to-back communications, Harran 
reported his synthesis of 3 and revised structures of the diazonamides (now 1 and 2), and 
proposed a biosynthetic origin for 1 that is more concise than those envisioned for 3 
(figure 3).3,6  Armed with these new insights, synthetic chemists could finally hope to 
complete the synthesis of diazonamide A. 
 
Figure 3: Harran's Proposed Biosynthesis of 1
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Total Syntheses of Diazonamide A 
 Although the Harran synthesis of 3 provided only the incorrect structure, this 
work provided at least two critical contributions to chemists confronted by diazonamide 
A’s daunting features (scheme 1).  First was a demonstration that the 14-membered right-
hand macrocycle could be closed along its biaryl bond via a novel Witkop-type 
photocyclization.  First reported in 1966,7 the Witkop photocyclization has been 
documented to facilitate the closure of medium (7-9) rings at the 4-position of tryptophan  
                                                
6 Li, J.; Burgett, A. W. G.; Esser, L.; Amezcua, C.; Harran, P. G.  Angew. Chem. Int. Ed. 2001, 40, 4770. 
7 Yonemitsu, O.; Cerutti, P.; Witkop, B.  J. Am. Chem. Soc. 1966, 88, 3941. 
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Scheme 1: Key Steps From Harran's Synthesis of 3
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derivatives (figure 4).8  This method has found several applications in total synthesis,9 but 
until Harran’s work had been restricted to relatively simple indolic compounds and had 
not been demonstrated in the formation of either twelve-membered rings or biaryl bonds.  
Though the yields reported in this case were moderate (32%-40%), the ability to forge 
such a difficult ring closure in the presence of a wide array of sensitive functionalities 
identified this photocyclization as a viable technique for future work.  Mechanistic 
studies are sparse, but Harran proposed a photoinduced electron transfer between the D 
and E rings to create a biradical intermediate (5) that collapses to form the key bond. 
                                                
8 (a) Mascal, M.; Moody, C. J.  J. Chem. Soc. Chem. Comm. 1988, 589; (b) Griesbeck, A. G.; Henz, A.; Hirt, J.  Synthesis 
1996, 1261; (c) Ruchkina, E. L.; Blake, A. J.; Mascal, M.  Tet. Lett. 1999, 40, 8443. 
9 For a recent example see: Feldman, K. S.; Ngernmeesri, P.  Org. Lett. 2005, 7, 5449. 
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Figure 4: Typical Application of the Witkop Photocyclization
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 Secondly, Harran demonstrated that the sensitive chlorine substituents could be 
introduced onto an essentially fully elaborated core of 3 without an indolic protecting 
group (6 to 7, Scheme 1).  This impressive late-stage transformation has enabled all 
subsequent approaches, allowing installation of these chlorines to be a relatively 
straightforward matter. 
 
• Nicolaou’s Total Syntheses of 1 
 Having already made substantial progress toward the originally reported structure 
for diazonamide A, the Nicolaou group was forced to alter its approach to account for the 
new structural features.10  Two distinct synthetic plans arose from this work, the first of 
which was completed and published in 2002.11 Some key elements of this strategy are 
shown in Scheme 2.  Central to this effort was a rapid synthesis of oxindole 8 from 
simple precursors, allowing construction of the oxazole-substituted quaternary carbon 
stereocenter of 9 by way of an acid-mediated dehydration/Friedel-Crafts arylation.  The 
yield (47%) was fairly impressive given the complexity of the product produced, but this 
reaction proceeded without stereocontrol and thus gave a 1:1 mix of diastereomers of the 
key stereocenter. 
                                                
10 For a complete review of this work see: Snyder, S. A.; PhD thesis, The Scripps Research Institute, 2004. 
11 (a) Nicolaou, K. C.; Bella, M.; Chen, D. Y. K.; Huang, X. H.; Ling, T. T.; Snyder, S. A.  Angew. Chem. Int. Ed. 
2002, 41, 3495; (b) Nicolaou, K. C.; Chen, D. Y. K.; Huang, X. H.; Ling, T. T.; Bella, M.; Snyder, S. A.  J. Am. 
Chem. Soc. 2004, 126, 12888. 
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11
Scheme 2: Highlights of Nicolaou's First Synthesis of 1
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 Elaboration to 10 allowed closure of the left-hand macrocycle using a standard 
uronium peptide coupling reagent, though the reaction suffered from competing 
dimerization or oligomerization processes, requiring high dilution and ultimately 
providing a modest 36% yield of a mixture of 11 and 12.  At this point, completion of 1 
was greatly facilitated by the precedent from Harran, as closure of the right-hand biaryl 
macrocycle was accomplished under conditions closely resembling those reported in his 
synthesis of 3.  However, as in Harran’s work, the yield for photocyclization of 13 was 
modest (33%), reflecting both the difficulty of this reaction and the instability of the 
product to the conditions.  
Nicolaou’s second synthesis of diazonamide A, first reported in 2003,12 was based 
                                                
12 (a) Nicolaou, K. C.; Rao, P. B.; Hao, J. L.; Reddy, M. V.; Rassias, G.; Huang, X. H.; Chen, D. Y. K.; Snyder, S. 
A.  Angew. Chem. Int. Ed, 2003, 42, 1753; (b) Nicolaou, K. C.; Hao, J. L.; Reddy, M. V.; Rao, P. B.; Rassias, G.; 
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on an alkylation strategy to produce the C-10 quaternary carbon stereocenter, again 
without stereocontrol.  This strategy differed markedly from the first in the construction 
of the biaryl macrocycle (scheme 3).  A Suzuki coupling introduced the biaryl bond as a 
mixture of atropisomers (15 to 16).  Elaboration of 16 to oxime 17 set the stage for an 
unusual hetero pinacol coupling to close the twelve-membered ring.  Without isolation, 
this macrocycle was coupled to valine to furnish advanced intermediate 18 in fairly 
impressive overall yield (45%-50%).  Shortly thereafter, the A-ring oxazole 19 was 
completed via a modified Robinson-Gabriel dehydration developed in the Nicolaou lab.12 
Scheme 3: Highlights of Nicolaou's Second Approach
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Snyder, S. A.; Huang, X. H.; Chen, D. Y. K.; Brenzovich, W. E.; Giuseppone, N.; Giannakakou, P.; O’Brate, A.  
J. Am. Chem. Soc. 2004, 126, 12897. 
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One significant drawback to this route not shown here is the macrolactamization used to 
produce the left-hand macrocycle, which ultimately proceeded in no better than 10%-
15% yield.13 
 
• Harran’s Total Synthesis of 1 
In 2003, Harran reported completion of his own synthesis of diazonamide A.14  
Central to his success was the execution of an oxidative macrocyclization/furanoindoline 
formation analogous to that mentioned in his biosynthetic proposal (20 to 21, Scheme 4).  
In this one reaction was introduced the F- and H-rings, the C-10 quaternary carbon 
stereocenter (in 3:1 dr, 27-33% yield), and the left-hand macrocycle.  While mechanistic 
studies have yet to be disclosed, it is proposed that this reaction proceeds via oxidation of 
the phenol, facilitating Friedel-Crafts attack by the indole leading to cyclization.  This 
Scheme 4: Highlights of Harran's Synthesis of 1
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13 Some loss in yield can be accounted for by the resolution of the 1:1 mix of C-10 diastereomers that took place 
in this step. 
14 Burgett, A. W. G.; Li, Q.; Wei, Q.; Harran, P. G.  Angew. Chem. Int. Ed. 2003, 42, 4961. 
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powerful transform enables rapid assembly of the natural product, taking advantage of 
the photocyclization chemistry developed earlier in the Harran lab (22 to 23).  In this 
case, the yield was greatly improved (72%) by the inclusion of an electron-donating 
phenoxide at the 7-position of the indole that was revealed in situ by basic cleavage of the 
corresponding acetate.  That this functionality improves reactivity is in full accord with 
Harran’s photoinduced electron transfer hypothesis. 
 
Retrosynthetic Analysis 
 The MacMillan lab commenced its own efforts toward the synthesis of 
diazonamide A in late 2002 after Nicolaou’s first synthesis drew our attention to this 
target.  We recognized in the C-10 quaternary stereocenter both a key challenge and a 
tremendous opportunity.  Formation of this hindered center in a stereoselective, catalytic 
fashion became our primary goal, and all three syntheses published so far have served to 
verify our motivation since they have not addressed this problem in a comprehensive 
way.  We were informed in our approach by recent work in our lab performed by Joel 
Austin and co-workers, who developed a method for the enantio- and diastereoselective 
synthesis of pyrroloindolines using our imidazolidinone organocatalyst (figure 5, see 
Chapter 1).15  Most significant for our approach to 1 was the revelation that this reaction 
could be successfully applied to the synthesis of furanoindolines as well, with little loss 
in enantiocontrol (24, 82% ee, Figure 5).  As 24 represents the E-H ring system of 
diazonamide A, we sought to expand on this methodology to forge the core of 1 in a 
stereoselective fashion. 
                                                
15 Austin, J. F.; Kim, S. G.; Sinz, C. J.; Xiao, W. J.; MacMillan, D. W. C.  Proc. Nat. Acad. Sci. U.S.A. 2004, 101, 
5482. 
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Figure 5: Organocatalytic Pyrroloindoline Formation
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 Based on analogy to other enantioselective iminium-catalyzed reactions 
developed in our lab, the mechanism proposed for these reactions is a conjugate 
addition/cyclization cascade (scheme 5).  Iminium formation leads to intermediate 25, 
which is then activated towards Friedel-Crafts attack by the π-nucleophilic tryptamine.  
This creates an indolenium ion (27) that can be rapidly trapped by the pendant nitrogen,  
Scheme 5: Proposed Catalytic Cycle of Organocatalytic Pyrroloindoline Synthesis
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quenching the charge and furnishing the pyrroloindoline core (28).  Hydrolysis of the 
bound imidazolidinone provides the product and reintroduces the catalyst to the cycle. 
 Taking our lead from the work of Harran and Nicolaou, we began our 
retrosynthesis of 1 with excision of the chlorines and disconnection of the two 
macrocycles to arrive at 29.  Removal of the tryptamine and A-ring oxazole 
functionalities reveals 30, a compound we hoped to access via an organocatalytic 
addition/cyclization cascade.  Aldehyde 30 should be the product from such a reaction 
starting from phenol 31, an intermediate we first targeted for initiation of our studies. 
Scheme 6: An Organocatalysis-Based Approach to 1
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The following represents our combined efforts toward the synthesis of 
diazonamide A.  This work was performed in conjunction with several co-workers, 
including Robert Knowles, Dr. Simon Blakey, Dr. Akio Kayano, and Dr. Christopher 
Sinz.  The work produced in this project has been greater than the sum of individual 
efforts, and little presented here would have been accomplished without the involvement 
of all who contributed. 
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Synthesis of Organocatalysis Product 30  
Our construction of 30 began with the synthesis of two fragments representing the 
G- and E-F rings of diazonamide A (eqs. 1-2).  Commercially available iodo-tyrosine 
methyl ester (32) was acylated with silylated hydroxy valeric acid 3316 to produce the 
first fragment.  Commercial 7-benzyloxyindole was then functionalized via bromination 
and in situ protection as its para-methoxy benzyl amine (35).  Lithiation of this indole 
was followed by trapping as the corresponding boronate ester (36).   
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 Fragments 34 and 36 could then be brought together in a convergent manner 
under typical Suzuki coupling conditions (78% yield, Eq. 3).  This completed the 
synthesis of the key organocatalysis substrate (31) in three linear steps. 
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(78%)
8
10
TIPSO TIPSO
10 mol %
34 36 31  
                                                
16 See supporting information for the one-step synthesis of 33. 
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 Attempts to use 31 in the proposed addition/cyclization cascade with acrolein 
were met with success (88% yield, 5:1 dr), although for reproducibly high conversions on 
scale this reaction required the use of 50 mol% catalyst (figure 6).  It was also found to be 
important to maintain temperature control, as the reverse reaction to produce 31 from 30 
proves to be facile at higher temperatures in the presence of the imidazolidinone catalyst.  
Indeed, this retro-cyclization event proves to be a threat to 30 and related analogs, under 
a range of conditions involving base or nucleophile.17  However, since our basic strategy 
of organocatalytic asymmetric construction of the C-10 quaternary carbon stereocenter 
had proven successful, we next sought to overcome the apparent fragility of the 
furanoindoline system to install the A-ring oxazole. 
Figure 6: Organocatalytic Construction of C-10 Quaternary Carbon Stereocenter
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Completion of the A-Ring Oxazole 
                                                
17 A similar observation has been made previously: see reference 12b. 
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 Considerable effort was devoted toward finding a method for advancing 30, 
which contains some of the carbon skeleton necessary for the A-ring oxazole, toward that 
heterocycle.  However, due to the instability of 30 noted earlier, a more roundabout way 
was ultimately devised that allows access to a more stable intermediate from which to 
build on the carbon skeleton of diazonamide A (figure 7).  Selenation of aldehyde 30 was 
followed by a sodium periodate oxidation/elimination, producing unsaturated aldehyde 
37.  We next wished to perform ozonolytic cleavage of this newly formed double bond, 
but this required exchange of the PMB protecting group for a trifluoroacetamide (38) that 
can better shield the indoline nitrogen from oxidation.  Ozonolysis then provides 
aldehyde 39, which proves to be considerably more stable than 30.   
Figure 7: Elaboration to a More Stable Aldehyde
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 While the above sequence has apparently accomplished little more than the 
removal of two carbons that map well onto the skeleton of the natural product, access to 
39 let us perform chemistry that had been previously inaccessible.  A considerable 
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remainder of the natural product structure can be directly introduced to 39 by way of an 
aldol reaction with thioester 40 (eq. 4).  This soft-enolization aldol functions surprisingly 
(4)
N
OBn
O
CO2Me
NH
O
Me
Me
TIPSO
O
O
CF3
N
OBn
O
NH
O
CF3
O C(O)SEt
O
Me
Me
BocHN
Me
Me N
H
O
SEt
OBocHN
TiCl4, Et3N, MeCN
CH2Cl2, –20 °C
i.
ii. Dess-Martin periodinane
78% yield,  two steps
NH
MeO2C
O
Me
Me
TIPSO
H
39 41
40
 
without competition from retro-cyclization, and the product appears stable to handling 
without retro-aldol degradation.  While the reaction is relatively non-selective (3:3:1:1 
mixture of diastereomers), this proves irrelevant since subsequent transformations 
eliminate the newly formed stereocenters.  Interestingly, the addition of acetonitrile to the 
titanium enolate is necessary for reactivity, perhaps to break up titanium aggregates.  
Following this, Dess-Martin oxidation furnishes ketone 41 in an efficient manner.  To our 
surprise, the Dess-Martin periodinane proved unique amongst oxidizing agents we used 
in its ability to perform this transformation, with others failing to react or resulting in 
degradation.18   
 In 41 we now had a β-keto amide that we thought would serve as a viable 
precursor for the A-ring oxazole.  In the event, however, dehydration of 41 proved to be a 
difficult task.  Methods derived from the literature, such as Wipf’s PPh3/I2 
cyclodehydration19 or Nicolaou’s modified Robinson-Gabriel procedure12 suffered from 
decomposition problems or poor reactivity.  Searching for alternative procedures, we 
                                                
18 Other methods attempted include: Swern oxidation, TPAP, Pfitzner-Moffatt oxidation, PCC, Corey-Kim 
oxidation. 
19 Wipf, P.; Miller, C. P.  J. Org. Chem. 1993, 58, 3604. 
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were intrigued by a recent report from the Wipf group on the synthesis of oxazolines 
from β-hydroxy amides using the relatively benign dehydrating agent diethylamino sulfur 
trifluoride (DAST, Scheme 7).20  Although this manuscript might initially appear to have 
Scheme 7: Wipf's DAST-Mediated Oxazoline Synthesis
DAST, K2CO3
Et3N, CH2Cl2
MeMe
AllocHN
O
H
N
O
OMe
OH
MeMe
AllocHN
O
N
CO2Me
(90%)  
only passing relevance to our attempted cyclodehydration of a β-keto amide, we noted 
two important features of DAST: the broad functional group tolerance demonstrated by 
Wipf, and its ability to react with ketones to produce difluorides noted in earlier  
reports.21  Combining these observations, we postulated DAST might prove reactive 
toward the C-30 ketone and induce cyclization without causing decomposition.  
Attempting this transformation for the first time, we found to our delight that DAST 
mediates the cyclodehydration of 41 to produce oxazole 42 in 55% yield (figure 8).  This 
method has no direct precedent in direct oxazole synthesis, 22 but there is some analogy in 
a recent report of microwave-assisted cyclodehydration of β-keto amides using the 
Burgess reagent.23  We have performed no mechanistic studies to date, but one can 
envision a mechanism involving the known ketone fluorination followed by cyclization 
and elimination, as shown in Figure 8.  We now sought to exploit oxazole 42 to complete 
the remaining heterocyclic ring structures of diazonamide A. 
 
                                                
20 Phillips, A. J.; Uto, Y.; Wipf, P.; Reno, M. J.; Williams, D. R.  Org. Lett. 2000, 2, 1165. 
21 (a) Middleton, W. J.  J. Org. Chem. 1975, 40, 574; (b) El-Laghdach, A.; Echarri, R.; Matheu, M. I.; Barrena, M. I.; 
Castillon, S.  J. Org. Chem. 1991, 56, 4556. 
22 For a recent review on oxazoles in natural product synthesis, see: Yeh, V. S. C.  Tetrahedron 2004, 60, 11995. 
23 Brain, C. T.; Paul, J. M.  Synthesis 1999, 1642. 
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Figure 8: DAST-Mediated Cyclodehydration and Mechanistic Hypothesis
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Completion of the B-D Rings and Photochemical Macrocyclization 
 Introduction of the B-D ring oxazole and indole would be greatly simplified if 
tryptamine could be used to directly displace ethane thiol from thioester 42.  Fortunately 
Aggarwal has developed a method for precisely this kind of amine displacement, 
mediated by silver salts.24  Treatment of 42 with AgTFA and tryptamine produced indole 
43 in good (87%) yield (eq. 5).  Remarkably, this reaction proceeds without displacement  
(5)
Tryptamine, AgTFA
87% yield
N
OBn
O
O
CF3
NH
MeO2C
O
Me
Me
TIPSO N
O
O
BocHN
Me
Me
CH3CN, 40 °C
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O
O
CF3
NH
MeO2C
O
Me
Me
TIPSO N
O
O
BocHN
Me
Me
HN
NH
42 43  
                                                
24 Aggarwal, V. K.; Esquivel-Zamora, B. B.  J. Org., Chem. 2002, 67, 8618. 
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of the labile TFA protecting group,25 despite the fact that such deprotection occurs 
rapidly in the absence of silver.  Closure of the B-ring oxazole could now follow 
established procedures in the diazonamide literature, with DDQ oxidation of 43 to the 
corresponding α-keto indole (44) followed by Wipf cyclodehydration to produce 
bisoxazole 45 (eq. 6). 
(6)
i. DDQ, THF/H2O
ii. PPh3, Cl3CCCl3,
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O
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O
N
Et3N, CH2Cl2
(79%)
43 45  
 Attention was now turned toward the two key macrocyclizations.  In each case, a 
twelve-membered ring requires closure, an endeavor that we thought could prove 
challenging but perhaps the closure of a second macrocycle might be entropically aided 
by completion of the other.  Given this logic, the wealth of literature concerning cyclic 
peptide synthesis gave us hope that the left-handed macrolactam might prove easier to 
manage first.26  To this end, 45 was converted into amino acid 46 in a high-yielding 
(88%) two-step process (eq. 7).  Investigations into lactamization of 46 revealed some of 
(7)i. LiOH, THF/H2O
ii. TFA, Me2S
N
OBn
O
O
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NH
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O
Me
Me
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Me
Me
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NH
HO2C
O
Me
Me
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O
H2N
Me
Me
NH
O
N
TFA•
45
46  
                                                
25 Deprotection of the TFA protecting group can be induced through an excess of tryptamine relative to AgTFA. 
26 For lead reviews on reagents for peptide synthesis, see: (a) Chamberlin, R. A.; Humphey, J. M.  Chem. Rev. 1997, 
97, 2243; (b) Li, P.; Roller, P. P.; Xu, J.  Curr. Org. Chem. 2002, 6, 411; (c) Han, S-Y.; Kim, Y.-H.  Tetrahedron 
2004, 60, 2447. 
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the challenges encountered in similar attempts in the Nicolaou lab.11,12  The popular 
uronium-based coupling reagents (HATU, TBTU) provided only slow guanidation of the 
primary amine.  More reactive coupling reagents (PyBroP, PyClU, BOPCl) resulted in 
formation of an unstable epimeric oxazolone (eq. 8), indicating a potential liability in the  
(8)
e.g. PyClU
NH
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O
NH
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O
Me
Me
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Me
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Me
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O
N
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O
O
H2O
 
inclusion of the hydroxy valeric acid side chain from the beginning of our synthesis 
rather than a protecting group that might not undergo this side reaction.  It was thought 
that pre-activation of the carboxyl group as a pentafluorophenyl ester would circumvent 
oxazolone formation and facilitate closure.  However, this resulted only in the formation 
of a macrolactam dimer, a problem that also plagued the Nicolaou syntheses.   
 We considered the possibility that formation of the biaryl macrocycle might prove 
easier to accomplish, in contrast to our earlier analysis.  We sought to activate 45 toward 
biaryl bond formation, a task that was completed in a two-step procedure of 
hydrogenation of the benzyl ether and triflation of the resultant phenol (45 to 49, Eq. 9).    
(9)i. H2, Pd(OH)2, 50 °C
ii. PhNTf2, Et3N
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Me
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Me
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O
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Me
Me
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O
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49  
It was thought that 49 provided at least two pathways for closure of the right-hand 
macrocycle: the Witkop-type photocyclization pioneered by Harran, or the aryl Heck 
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methodology recently pioneered by Fagnou (figure 9).27  While the photochemistry has 
the benefit of precedent in the diazonamide literature, it was unclear to us whether or not 
49 could truly function as a substrate for electron transfer as triflates and other sulfonates  
Figure 9: Selected Examples of Intramolecular Aryl Heck Cyclization27b,d
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are known to be photolabile.28  However, our efforts to perform the aryl Heck 
macrocyclization with 49 were met with failure, ranging from lack of reactivity to 
decomposition of starting material under more forcing conditions.  Perhaps the generally 
high temperatures required in the Fagnou procedures are incompatible with 49, despite 
the use of stoichiometric amounts of palladium. 
 We were encouraged, on the other hand, by work from the Albini lab which 
demonstrated that aryl sulfonates (as well as halides) can serve as sources for triplet 
cations when exposed to UV light (figure 10).29  These cations react selectively with π-
                                                
27 Campeau, L.-C.; Parisien, M.; Leblanc, M.; Fagnou, K.  J. Am. Chem. Soc. 2004, 126, 9186; (b) Leblanc, M.; 
Fagnou, K.  Org. Lett. 2005, 7, 2849; (c) Campeau, L.-C.; Parisien, M.; Jean, A.; Fagnou, K.  J. Am. Chem. Soc. 
2006, 128, 581; see also: (d) Miki, Y.; Shirokoshi, H.; Asai, M.; Aoki, Y.; Matsukida, H.  Heterocycles 2003, 60, 
2095. 
28 (a) Tsuchiya, T.; Nakamura, F.; Umezawa, S.  Tet. Lett. 1979, 30, 2805; (b) Liu, X.; Binkley, R. W.  J. Carbohydrate 
Chem. 1992, 11, 183; (c) Liu, X.; Binkley, R. W.; Yeh, P.  J. Carbohydrate Chem. 1992, 11, 1053. 
29 (a) Freccero, M.; Fagnoni, M.; Albini, A.  J. Am. Chem. Soc. 2003, 125, 13182; (b) De Carolis, M.; Protti, S.; 
Fagnoni, M.; Albini, M.  Angew. Chem. Int. Ed. 2005, 44, 1232; (c) Fagnoni, M.; Albini, A.  Acc. Chem. Res. 2005, 
38, 713. 
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nucleophiles, a situation that should be amenable to biaryl bond formation in 49 between 
the aryl triflate and the π-nucleophilic indole.  This mechanism is distinct from that 
proposed in Harran’s Witkop-type cyclization (see Scheme 1, above), although we had 
little basis to suggest the likelihood of one mechanism over the other (or either) for our 
substrate.  Rather, we found inspiration from this encouraging precedent. 
Figure 10: Photochemical Cross-Coupling Methodology28b
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 To our delight, subjecting 49 to UV light in degassed solvent produced biaryl 
macrocycle 50 in modest (38%) yield as a single atropdiastereomer, in accord with 
Harran’s work (eq. 10).  The mass balance was typically a small amount of recovered 49, 
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and substantial decomposition by undefined pathways.  Further experimentation 
demonstrated that 50 is not stable to the reaction conditions, so the best results came from 
running the reaction to moderate conversion and recycling starting material.  Optimal 
yield came with 350 nm irradiation, in contrast to Harran’s conditions (300 nm)3 or those 
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reported by Nicolaou (200 nm).12  Examination of the UV-Vis spectrum of 49 showed a 
broad absorbance ranging as high as 370 nm,30 so it is perhaps unsurprising that 
photocyclization can occur at a range of wavelengths.  What is surprising is that three 
separate optimization efforts would arrive at such drastically different energies of 
irradiation to produce the best yield.  We expected that a major side reaction for 49 would 
be solvent-assisted lysis of the triflate.  However, this seemed to be a minor problem at 
best, and also appeared to be independent of the reaction medium. 
 Despite the material throughput problems our photocyclization posed, we were 
optimistic at this point to be conceivably so close to the end of our synthesis.  However, 
we were continually frustrated in our efforts to convert 50 to the bismacrocyclic core of 
diazonamide A.  Attempts to close the macrolactam suffered from either lack of reactivity 
or competing dimerization as seen with 46.  The seemingly simple problem of amide 
bond formation had once again halted our efforts, and led us to reconsider our synthetic 
approach based on the thought that finding a new method to form the left-handed 
macrocycle would solve the last significant hurdle in our work. 
 
A Second Generation Retrosynthesis: Aldol-Based Macrocyclization 
 We devised a new strategy for the synthesis of diazonamide A that would allow 
us to take advantage of most of the chemistry we had already developed while addressing 
formation of the left-hand macrocycle at an earlier stage (scheme 8).  Centered on the 
organocatalytic addition/cyclization we had developed in our previous approach, this plan 
posed the question as to whether the soft-enolization aldol that functioned so well in an 
                                                
30 In accord with this observation, no reaction occurred upon irradiation at 420 nm. 
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Scheme 8: A Second Generation Approach to 1
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intermolecular sense might now work in an intramolecular fashion, closing the left-hand 
macrocycle in the process (53 to 52, Scheme 8).  While examples of aldol 
macrocyclizations are rare,31 we thought that our previous inability to macrolactamize 
might well have been due to the ring strain of the desired twelve-membered ring, and that 
some of the energetic penalty in our new approach would be delayed until formation of 
the A-ring oxazole (52 to 51).  This cyclodehydration could be driven irreversibly by the 
loss of water, leaving us with only the task of completing the biaryl macrocycle.  Given 
our previous success in formation of this bond, we thought this to be a feasible task.  If 
so, our new strategy would place us remarkably close to our target. 
 
Soft Enolization Aldol Macrocyclization and Synthesis of 51 
                                                
31 For examples see: (a) Meng, D.; Bertinato, P.; Balog, A.; Su, D.; Kamenecka, T.; Sorensen, E.; Danishefsky, S. J.  
J. Am. Chem. Soc. 1997, 119, 10073; (b) Hayward, C. M.; Yohannes, D.; Danishefsky, S. J.  J. Am. Chem. Soc. 1993, 
115, 9345. 
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We sought to take advantage of most of the chemistry we had previously 
developed in our synthetic efforts to produce 53.  Starting from phenol 31 described 
earlier, elaboration to thioester 56 was a simple matter of methyl ester hydrolysis and 
amide bond formation (figure 11).    Following this, organocatalytic addition/cyclization 
produced aldehyde 57 in excellent (93%) yield, in accord with our first-generation 
approach.  Conversion of 57 into aldol macrocyclization precursor 53 followed without 
difficulty using the unsaturation/ozonolysis strategy we had applied earlier.  Remarkably, 
the thioester functionality present in our system proved robust to NaIO4 and DDQ 
oxidations as well as treatment with ozone (57 to 53, Figure 8).  
Figure 11: Synthesis of Macrocyclization Precursor 53
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 We now sought to test the key element of our new strategy – the aldol 
macrocyclization.  Our first efforts examined the conditions developed in our first 
generation synthesis, which involved TiCl4 as a Lewis acid and a tertiary amine base for 
soft enolization (table 1).  To our disappointment, these conditions furnished no 
discernible amount of the desired product.  Increasing the amount of Lewis acid or other 
components of the reaction did not change this outcome, with degradation of starting 
material acting as a limiting process.  We next chose to examine magnesium salts as 
promoters for this reaction since they generally display broader functional group 
tolerance.32  To our delight, we obtained macrocycle 52 in our initial efforts using MgBr2 
(entry 2), a result that improved substantially on addition of TMSCl to prevent retro-
aldolization (entry 3).33  The reaction did not appear to proceed catalytically, and efforts   
Table 1: Optimization of the Intramoelcular Aldol Macrocyclization
TiCl4
TiCl4
MgBr2
MgBr2
MgBr2
MgI2
Mg(ClO4)2
Mg(OTf)2
entry
1
2
3
4
5
6
7
8
yield
0
0
24
67
2
54
57
0
CH2Cl2
CH2Cl2
EtOAc
THF
THF
THF
THF
THF
solventLewis acid
Lewis acid
Et3N, solvent
23 °C
3
10
3
3
0.3
3
3
3
equivalents
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additive
 
                                                
32 For recent examples of magnesium-catalyzed aldol reactions see: (a) Evans, D. A.; Tedrow, J. S.; Shaw, J. T.; 
Downey, W. C.  J. Am. Chem. Soc. 2002, 124, 392; (b) Evans, D. A.; Downey, W. C.; Shaw, J. T.; Tedrow, J. S.  
Org. Lett. 2002, 4, 1127. 
33 Evans, D. A.; Shaw, J. T.  Unpublished review. 
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to improve the yield using other magnesium salts were met with little success.  
Interestingly, we found that 52 was produced as a single diastereomer (stereochemistry 
undetermined).  While the stereocenters formed are destroyed in subsequent reactions, it 
is nonetheless an unexpected outcome.  It is also noteworthy that this macrocyclization 
proceeds in good (67%) yield, a result that is substantially improved over those reported 
in the Harran and Nicolaou syntheses. 
 Having access to macrocycle 52, we hoped to make use of the DAST-mediated 
cyclodehydration developed in our first generation approach to produce the A-ring 
oxazole.  As this reaction has little substrate generality in our hands, we did not know 
what to expect from our second generation system in which the strain of cyclization 
might well be greater.  However, as seen in equation 11, 52 proved even more amenable 
to cyclodehydration (following Dess-Martin oxidation to the corresponding ketone) than 
our original system.  This completed our synthesis of 51 and left us to consider the task of 
introducing the remaining oxazole and indole ring systems.  
(11)
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Introduction of the B-D Rings and Attempts at Photocyclization 
 To maximize the efficiency of the necessary steps to complete the oxazole and 
indole ring systems (B-D), we slightly revised our first generation approach that involved 
thioester displacement followed by DDQ oxidation to create a β-keto amide B-ring 
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precursor.  We felt that the DDQ oxidation produced variable yields, and avoiding it 
could enhance our overall efficiency.  To this end, 51 was subjected to aqueous base in 
order to hydrolyze the thioester and trifluoroacetamide functionalities (eq. 12), producing 
carboxylic acid 60.  This could be coupled efficiently with known oxo-tryptamine 61,11 
directly accessing β-keto amide 62 without an intervening oxidation step (eq. 13).   
(12)
THF, MeOH, H2O
(99%)
60
CO2H
N
O
NH
HN
O
Me Me
H
N
O
TIPSO
Me Me
O
OBn
51
C(O)SEt
N
O
NTFA
HN
O
Me Me
H
N
O
TIPSO
Me Me
O
OBn
(13)
EDC, HOBt,
NaHCO3, DMF
(68%)
62
N
O
NH
HN
O
Me Me
H
N
O
TIPSO
Me Me
O
OBn
60
CO2H
N
O
NH
HN
O
Me Me
H
N
O
TIPSO
Me Me
O
OBn
O
HN
O
NH
LiOH
N
H
O
NH2•TFA
61
 
 Completion of the B-ring oxazole was now a straightforward matter.  Taking 
advantage of the cyclodehydration conditions that had worked successfully in our first 
generation approach, we converted 62 into 63 without difficulty (eq. 14).  Subsequent 
elaboration of 63 into triflate 64 for investigations into a Witkop-type photocyclization 
also followed nicely with the precedent from our earlier work (eq. 15). 
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 To our great disappointment, however, 64 proved a poor substrate for a 
photochemical biaryl bond formation, in contrast to what we had observed in our first 
approach.  Considering the lower entropic barrier this new macrocyclization should face, 
and the precedent from the Harran and Nicolaou syntheses that seem to differ almost 
exclusively by the presence of an aryl bromide rather than an aryl triflate, we thought this 
reaction would prove even more successful than that which we had developed for our 
first-generation system.  In a variety of solvents and wavelengths, we observed cleavage 
of the triflate to the phenol (as had been seen before), along with formation of unstable 
products that have not been identified.  While the desired bismacrocyclic product had 
been seemingly observed by mass spectrometry, no authentic sample was ever isolated.  
These results led us to consider a modified endgame approach in which we would pursue 
a more conventional, metal-mediated biaryl bond formation. 
 
Suzuki Macrocyclization: Completion of the Second Macrocycle 
 We thought that a 4-functionalized tryptamine derivative, applied in an otherwise 
similar sequence to that described above, could provide an advanced intermediate (66) in 
which there was appropriate functionalization for a Suzuki biaryl macrocyclization 
(figure 12).34  It seemed plausible that a subsequent palladium-catalyzed biaryl bond- 
                                                
34 Molander, G. A.; Dehmel, F.  J. Am. Chem. Soc. 2004, 126, 10313. 
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forming reaction would be more easily controlled and optimized than the photochemistry 
used in our earlier efforts.  Boronate 66 was accessed in a straightforward way from acid 
60 in three steps, including the previously developed conversion of the benzyl ether to the 
corresponding triflate.  Use of TBTU as the amide coupling reagent provided superior 
yields over those observed with DCC or other more conventional reagents. 
Figure 12: Synthesis of a Suzuki Macrocyclization Precursor
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 To our great delight, 66 proved amenable to a Suzuki coupling reaction to provide 
medium ring biaryl macrocycle 67 (eq. 16).  Although the yield is perhaps modest (41%), 
it is an intriguing result all the same.  Palladium couplings have not been utilized often in 
the late stages of complex syntheses and certainly less so in the context of challenging 
macrocyclizations.  Furthermore, this reaction should be amenable to optimization 
through tuning of the phosphine ligands on the palladium source, including variations of 
steric bulk, electron-donating capacity, and phosphine to palladium ratios.   
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 From bismacrocycle 67 the path toward diazonamide A appears feasible.  The 
remaining challenges include an oxidation/cyclodehydration sequence to introduce the B-
ring oxazole, removal of the silyl protecting group, and regioselective introduction of the 
chlorine substituents (figure 13).  A plausible set of reagents to complete this sequence is 
detailed below.  In particular, the bischlorination of the fully elaborated core of 
diazonamide A has some exceptional precedent in the form of Harran’s synthesis of 1.14   
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Figure 13: Projected Sequence for the Completion of Diazonamide A
 
As shown in equation 17, treatment of 68 with hexachloroquinone 69 provides a 
satisfactory (32-40%) yield of the selectively chlorinated product (70), essentially 
without need for protecting groups.  This technique should translate onto our own system 
once more fully elaborated, but that will be a story for another chemist to tell. 
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DMF, 23 °C
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Summary and Future Work 
 Two approaches toward the total synthesis of the marine natural product 
diazonamide A have been described.  In each case, an iminium-mediated addition-
cyclization cascade reaction has been applied to provide stereoselective, catalytic access 
to the crucial C-10 quaternary carbon stereocenter for the first time.  In our first-
generation approach, the Witkop-type photocyclization pioneered by Harran was 
exteneded in the context of an aryl triflate to forge the biaryl macrocycle.  In our second- 
generation approach, a novel intramolecular soft enolization aldol macrocyclization 
formed a precursor to the A-ring oxazole, which was subsequently completed in a newly 
discovered DAST-mediated cyclodehydration.  Closure of the fourteen-membered biaryl 
macrocycle has been accessed through an unusual Suzuki macrocyclization, and 
completion of diazonamide A should be accessible in four further steps.  Efforts to this 
end are ongoing, and should be reported in due course. 
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Supporting Information 
 
General Information: Commercial reagents were purified prior to use following the 
guidelines of Perrin and Armarego.35 All solvents were purified according to the method 
of Grubbs.36 Non-aqueous reagents were transferred under argon via syringe or cannula. 
Organic solutions were concentrated under reduced pressure on a Büchi rotary evaporator 
using a heated water bath. Chromatographic purification of products was accomplished 
using forced-flow chromatography on Silicycle 230-400 mesh silica gel 60 according to 
the method of Still.37 Thin-layer chromatography (TLC) was performed on Silicycle 0.25 
mm silica gel 60-F plates. Visualization of the developed chromatogram was performed 
by fluorescence quenching or by CAM stain. 
 1H and 13C NMR spectra were recorded on a Varian Mercury 300 (300 MHz and 
75 MHz) as noted, and are internally referenced to residual solvent signals. Data for 1H 
NMR are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant (Hz) and 
assignment. Data for 13C NMR are reported in terms of chemical shift. IR spectra were 
recorded on a Perkin Elmer 1000 spectrometer and are reported in terms of frequency of 
absorption (cm-1). Mass spectra were obtained from the Caltech Mass Spectral Facility. 
Optical rotations were measured on a Jasco P-1010 polarimeter, and [α]D values are 
reported in 10-1 dg cm2 g-1. 
 
                                                
35 Perrin, D. D.; Armarego, W. L. F.  Purification of Laboratory Chemicals; 3rd ed., Pergamon Press, Oxford, 1988. 
36 Pangborn, A. B.; Giardello, M. A,; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J.  Organometallics 1996, 15, 1518. 
37 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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OBn
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H N
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Bromoindole 35: To a room temperature solution of 7-benzyloxyindole (5.0 g, 22.4 
mmol) in 90 mL of DMF was added bromine (1.18 mL, 22.84 mmol) dropwise over the 
course of ten minutes. After 20 minutes the solution was cooled to 0 °C and KOtBu (5.78 
g, 51.5 mmol) was added in a single portion. 30 minutes later PMBCl (3.65 mL, 26.88 
mmol) was added dropwise over several minutes by syringe after which the reaction 
mixture was allowed to warm to room temperature. After 6 hours the reaction was judged 
complete by TLC and the reaction mixture was diluted with 300 mL of diethyl ether and 
washed with 100 mL of 1% Na2S2O3. The organic portions were washed three times with 
water and then once with brine before being dried over sodium sulfate. The organic 
portion was then concentrated in vacuo to yield a viscous yellow oil. These crude extracts 
could then be recrystallized from a hot mixture of 10% ethyl acetate in hexanes to afford 
7.27 g (77%) of the title compound as a white crystalline solid. IR (Film): 2931, 1611, 
1574, 1512, 1497, 1453, 1422, 1383, 1322, 1248, 1209, 1175, 1080, 1056, 1033, 988, 
875, 818, 774, 727, 695, 625 cm-1; 1H NMR: (300 MHz, CDCl3) δ 7.38-7.25 (m, 5H, 
ArH’s), 7.19 (dd, 1H, J = 0.9, 7.8 Hz, ArH), 7.07 (t, 1H, J = 7.8 Hz, ArH), 7.04 (s, 1H, 
C(2)-H), 6.95-6.88 (m, 2H, ArH), 6.80-6.72 (m, 3H, ArH), 5.51 (s, 2H, PhCH2), 5.12 (s, 
2H, PMBCH2),  3.77 (s, 3H, MeO-Ar) 13C NMR: (300 MHz, CDCl3) δ 158.9, 146.6, 
136.7, 130.9, 129.9, 128.6, 128.1, 127.8, 125.7, 120.8, 114.0, 112.3, 104,6, 90.4, 70.5, 
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55.3, 52.2 HRMS (EI+) exact mass calculated for [M+•] (C23H20NO2Br) requires m/z 
421.0677, found m/z  421.0672. 
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-78 °C
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Indole Boronic Ester 36: To a solution of n-butyllithium (7.34 mL, 10.65 mmol, 1.2 eq, 
1.45M in hexanes) in 80 mL of THF at –78 °C was added bromoindole 35 (3.75 g, 8.88 
mmol, 1.0 eq) in 10 mL of THF dropwise via syringe over 10 minutes. After 15 minutes, 
2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (3.62 mL, 17.76 mmol, 2.0 eq) 
was added via syringe. This reaction mixture was allowed to warm to ambient 
temperature over 3 hours. At this point, 100 mL of a saturated aqueous solution of NH4Cl 
was added to the reaction mixture and the layers were separated. The aqueous layer was 
washed 3 x 100 mL with EtOAc. The combined organic layer was washed with 100 mL 
of brine, dried over sodium sulfate, and concentrated in vacuo. The residual oil was then 
recrystallized from a hot solution of 10% EtOAc in hexanes to give the title compound as 
an off-white crystalline solid (3.40 g, 82% yield). The remaining mass was recovered as 
the debrominated starting material. IR (Film): 2976, 1613, 1573, 1539, 1513, 1495, 1454, 
1379, 1290, 1267, 1247, 1206, 1144, 1107, 1059, 1009, 783, 735, 696, 681 cm-1; 1H 
NMR: (300 MHz, CDCl3) δ 7.66 (dd, 1H, J = 0.6, 8.1 Hz, ArH), 7.48 (s, 1H, C(2)-H), 
7.35- 7.22 (m, 5H, ArH), 7.03 (t, 1H, J = 8.1Hz, ArH), 6.91-6.87 (m, 2H, ArH), 6.78-
6.65 (m, 3H, ArH), 5.52 (s, 2H, PhCH2), 5.09 (s, 2H, PMBCH2), 3.75 (s, 3H, MeO-Ar),  
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1.35 (s, 12H, 4xMe) 13C NMR: (300 MHz, CDCl3) δ 158.7, 146.6, 138.8, 137.0, 135.3, 
131.3, 128.5, 128.4, 128.1, 127.9, 127.8, 126.9, 120.8, 115.7, 113.8, 104.1, 82.8, 70.3, 
55.3, 52.2, 25.0 HRMS (EI+) exact mass calculated for [M+•] (C29H32BNO4) requires m/z 
469.2424, found m/z  469.2416. 
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Iodophenol 34: Amine 32 (15.4 g, 47.95 mmol), acid 33 (11.96 g, 43.59 mmol), EDC 
(9.19 g, 47.95 mmol) and HOBT (6.47 g, 47.95 mmol) are combined in a 500 mL round 
bottom flask and 190 mL of DMF is added. After 12 hours the reaction mixture is diluted 
with 500 mL of ether and washed with 3 x 500 mL of water. The combined organic 
fractions are washed with brine and concentrated. The resulting oil is purified on silica 
gel (30% ethyl acetate in hexanes) to yield the title compound as a colorless oil (21.2 g, 
84% yield). IR (Film): 3402, 2944, 2867, 1746, 1654, 1603, 1505, 1462, 1415, 1347, 
1292, 1215, 1099, 1058, 882, 822, 684 cm-1; 1H NMR: (300 MHz, CDCl3) δ 7.44 (d, 1H, 
J = 2.1 Hz, ArH ortho to iodide), 7.05 (br s, 1H, NH), 6.99 (dd, 1H, J = 2.1, 8.55 Hz, 
ArH para to iodide), 6.87 (d, 1H, J = 8.5 Hz, ArH meta to iodide), 5.82 (s, 1H, OH),  
4.87 (m, 1H, NHCH), 4.15 (d, 1H, J = 3.3 Hz, CHOTIPS), 3.69 (s, 3H, CO2Me), 2.91 
(m, 2H, ArCH2), 1.99 (m, 1H, CH(CH3)2), 1.1-1.0 (m, 21H, TIPS), 0.93 (d, 3H, J = 7.2 
Hz, CH(CH3)2), 0.861 (d, 3H, J = 7.2 Hz, CH(CH3)2), 13C NMR: (75 MHz, CDCl3) δ 
172.88, 171.6, 154.5, 139.2, 131.0, 130.0, 115.3, 85.6, 78.3, 52.6, 52.4, 37.4, 34.2, 18.2, 
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18.1, 17.9, 17.5, 12.6 HRMS (FAB+) exact mass calculated for [M+H] (C24H41NO5SiI) 
requires m/z 578.1799, found m/z  578.1791; 
! 
["]
D
25  = -5.75 (c = 1.0 CHCl3). 
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TIPS hydroxy valeric acid 33: To (S)–2-hydroxy valeric acid (5.0 g, 42.3 mmol) in a 
stirred solution of DMF (22 mL) was added triisopropylsilyl chloride (22 mL, 102 mmol) 
and imidazole (1.38 g, 204 mmol). After 24 hours, MeOH (210 mL) and 1M aqueous 
K2CO3 (64 mL) were added to this slurry, and after 4 h the resultant solution was diluted 
with 400 mL H2O, acidified to pH = 4, and extracted 3x300 mL with EtOAc.  The 
combined organic fractions are washed with brine and concentrated. The resulting oil is 
purified of remaining TIPSOH by vacuum distillation of this impurity (85 °C, min. 10 
mTorr) to yield the title compound as a colorless oil (9.7 g, 82% yield). IR (Film): 2963, 
2945, 2869, 1723, 1465, 1388, 1234, 1152, 1068, 997, 882, 825, 681 cm-1; 1H NMR: (300 
MHz, CDCl3) δ 4.26 (d, 1H, J = 3.6 Hz, CHOTIPS), 2.06 (m, 1H, CH(CH3)2), 1.10-0.97 
(m, 27H, TIPS, CH(CH3)2), 13C NMR: (75 MHz, CDCl3) δ 173.2, 65.9, 33.7, 17.9, 17.8, 
17.7, 17.0, 15.3, 12.2; HRMS (FAB+) exact mass calculated for [M+H] (C14H31O3Si) 
requires m/z 275.2043, found m/z  275.2041; 
! 
["]
D
25  = -16.81 (c = 1.0 CHCl3). 
 
 
 
139 
OH
CO2Me
NH
O
Me
Me
I
N
OBn
B
O
O
PMB
Me
Me
Me
Me
Pd(dppf)Cl2, K3PO4
dioxane/H2O
40 °C
TIPSO
OH
CO2Me
NH
O
Me
Me
N
PMB
OBn
TIPSO
36
34
31  
Phenol 31: A 100 mL round bottom flask with stirbar is charged with Pd(dppf)Cl2 (0.633 
g, 0.7755 mmol), K3PO4 (8.78 g, 41.36 mmol) and indole boronic ester 36 (8.74 g, 18.62 
mmol) in a glove box. This flask was capped with a rubber septa and brought out of the 
box where in it was placed under a balloon of argon. To the flask is add aryl iodide 34 
(5.976 g, 10.34 mmol) in a 60 mL of degassed 1,4 dioxane. To this solution is then added 
6 mL of degassed water and the resulting solution is stirred at 40 °C for 2 hours. After the 
reaction was judged complete by TLC analysis, the reaction mixture was diluted with 200 
mL of diethyl ether and washed sequentially with 100 mL portions of water, saturated 
NH4Cl solution and brine. The organic portion is dried over sodium sulfate and 
concentrated in vacuo. These crude extracts were purified by column chromatography 
(4% Et2O/DCM) to yield the title compound (6.38 g, 78%) as a white amorphous solid. 
IR (Film): 3409, 2945, 2867, 2360, 1747, 1654, 1612, 1570, 1512, 1456, 1385, 1248, 
1209, 1175, 1063, 882, 821 cm-1; 1H NMR: (300 MHz, CDCl3) δ 7.34-6.68 (m, 17H, ArH 
and NH); 5.59 (s, 2H, OCH2Ph), 5.34 (s, 1H, ArOH), 5.15 (s, 2H, OCH2-pMeOPh), 4.90 
(ddd, 1H, J = 6.0, 6.3 and 8.4 Hz, CHCO2Me), 4.14 (d, 1H, J = 3.3 Hz, CHOTIPS); 3.77 
(s, 3H, ArOMe); 3.66 (s, 3H, CO2Me); 3.05 (m, 2H, CH2Ar); 1.93 (ddq, 1H, J = 3.6, 7.2, 
and 7.9 Hz, CHMe2); 1.10-0.98 (m, 21H, TIPS); 0.88 (d, 3H, J = 6.9 Hz, CH(Me)Me); 
0.79 (d, 3H, J = 6.9 Hz, CH(Me)Me) 13C NMR: (300 MHz, CDCl3) δ 172.4, 171.8, 158.8, 
152.5, 146.9, 136.7, 131.0, 129.2, 129.1, 128.6, 128.1, 128.0, 127.8, 127.5, 126.5, 121.1, 
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120.9, 115.4, 113.9, 112.7, 110.9, 104.6, 78.1, 76.6, 70.4, 55.2, 52.5, 52.2, 52.1, 37.7, 
33.9, 18.0, 17.9, 17.7, 17.2, 12.3; HRMS (FAB+) exact mass calculated for [M+•] 
(C47H60N2O7Si) requires m/z 792.4170, found m/z 792.4175; 
! 
["]
D
25 : -9.39 (c = 1.03, 
CHCl3). 
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Aldehyde 30: (2R,5R)-2-tert-butyl-5-benzyl-3-methylimidazolidin-4-one•TFA (0.313 g, 
0.87 mmol) and phenol 31 (2.30 g, 2.90 mmol) are dissolved in 13.75 mL of 
dichloromethane and 0.75 mL of MeOH. This mixture is cooled to -78 °C. To this cold 
solution is added freshly distilled acrolein (1.94 mL, 29.0 mmol) at –78 °C. The reaction 
is left at –78 °C for 48 hours before being diluted with 25 mL of pH 7 buffer. The layers 
were separated and the organic portions were washed with brine and dried over sodium 
sulfate. Following concentration in vacuo, the crude reaction extracts were purified by 
flash chromatography in 12:3:1 ratio of dichloromethane, hexanes, and diethyl ether to 
afford the title compound as an amorphous white solid (1.92 g, 85%) in a 3.5:1.0 mixture 
of diastereomers at the C(10) stereocenter. IR(Film): 3415, 2944, 2866, 1743, 1677, 
1611, 1511, 1494, 1464, 1365, 1247, 1174, 1098, 882, 821, 734, 684 cm-1; 1H NMR: (300 
MHz, CDCl3) 9.49 (s, 1H, CHO), 7.33-6.68 (m, 12H, ArH and NH); 5.82 (s, 1H, 
OCHN), 5.29 (d, 1H, J = 15.3 Hz, NCH(H)Ar), 5.02 (d, 2H, J = 5.7 Hz, OCH2Ph), 4.88 
(m, 1H, NHCH),  4.49 (d, 1H, J = 15.3 Hz, NCH(H)Ar), 4.12 (d, 1H, J = 3.6 Hz, 
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CHOTIPS); 3.78 (s, 3H, ArOMe); 3.61 (s, 3H, CO2Me); 3.01 (m, 2H, CH2Ar); 2.15-1.80 
(m, 5H, CHOCH2CH2 and CH(CH3)2), 1.10-0.95 (m, 21H, TIPS); 0.88 (d, 3H, J = 7.2 
Hz, CH(Me)Me); 0.79 (d, 3H, J = 7.2 Hz, CH(Me)Me) 13C NMR: (75 MHz, CDCl3) δ 
200.6, 172.3, 171.7, 158.8, 157.8, 144.4, 137.1, 136.8, 133.5, 131.9, 130.9, 129.5, 129.4, 
128.5, 128.4, 127.9, 127.5, 123.7, 120.2, 115.7, 113.9, 113.4, 109.8, 105.8, 78.1, 70.9, 
68.0, 57.9, 55.2, 52.6, 52.1, 50.4, 39.0, 38.1, 33.9, 29.2, 25.6, 18.0, 17.91, 17.87, 17.7, 
17.3, 12.3 HRMS: (FAB+) exact mass calculated for [M+H] (C50H65N2O8Si) requires m/z 
849.4354, found m/z 849.4386. 
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Aldehyde 37: To a solution of aldehyde 30 (6.1 g, 7.184 mmol) in 36 mL of 
dichloromethane at room temperature was added PhSeNEt2 (1.80 mL, 9.34 mmol). After 
stirring for one hour the reaction was judged complete by TLC. The reaction mixture was 
concentrated in vacuo and the crude extracts were purified by flash chromatography 
(33% ethyl acetate in hexanes). The product was thus obtained as a yellow oil in a 3:3:1:1 
mixture of diastereomers as judged by H-NMR. This product was then taken up in 60 mL 
of THF, 30 mL of methanol, and 30 mL of water and cooled to 0 °C. To this cold 
solution was added sodium periodate (7.21 g, 7.184 mmol) in a single portion. After 24 
hours the reaction mixture was concentrated in vacuo to remove the methanol and THF, 
diluted with ethyl acetate and washed with water. After separation of the layers the 
organic portions were washed with brine and dried over sodium sulfate. Concentration of 
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the resulting solution gave a yellow oil which could be purified by column 
chromatography (20% – 35% ethyl acetate in hexanes) to give the title compound as an 
amorphous off-white solid (5.63 g, 88%). IR(Film): 3414, 2945, 2867, 2360, 1743, 1690, 
1611, 1511, 1494, 1464, 1365, 1248, 1176, 1100, 882, 822, 749, 684 cm-1; 1H NMR: (300 
MHz, CDCl3) 9.45 (d, 1H, J = 7.5 Hz, CHO), 7.40-6.68 (m, 17H, ArH, CHOCH=CH and 
NH); 5.97 (s, 1H, OCHN), 5.88 (dd, 1H, J = 7.8 and 15.6 Hz, CHOCH=CH) 5.23 (d, 1H, 
J = 15 Hz, NCH(H)Ar), 5.02 (d, 2H, J = 1.5 Hz, OCH2Ph), 4.89 (m, 1H, NHCH),  4.49 
(d, 1H, J = 15 Hz, NCH(H)Ar), 4.12 (d, 1H, J = 3.3 Hz, CHOTIPS); 3.76 (s, 3H, 
ArOMe); 3.61 (s, 3H, CO2Me); 3.02 (m, 2H, CH2Ar); 2.0-1.80 (m, 1H, CH(CH3)2), 1.10-
0.95 (m, 21H, TIPS); 0.88 (d, 3H, J = 7.2 Hz, CH(Me)Me); 0.78 (d, 3H, J = 7.2 Hz, 
CH(Me)Me) 13C NMR: (75 MHz, CDCl3) δ 192.7, 172.3, 171.6, 158.9, 158.1, 154.9, 
145.4, 137.4, 136.6, 133.1, 131.7, 130.3, 130.2, 129.7, 129.6, 129.2, 128.8, 128.5, 128.0, 
127.5, 127.0, 124.8, 121.2, 117.0, 113.9, 113.7, 110.1, 106.8, 78.1, 77.2, 70.8, 61.6, 55.2, 
52.7, 52.4, 52.1, 51.2, 38.0, 33.9, 21.0, 18.0, 17.91, 17.87, 17.7, 17.2, 14.2, 12.3 HRMS: 
(FAB+) exact mass calculated for [M+H] (C50H63N2O8Si) requires m/z 847.4354, found 
m/z 847.4313; 
! 
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25= -37.11 (c = 1.0 CHCl3). 
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Amine 37a: To a vigorously stirred solution of aldehyde 37 (810 mg, 0.956 mmol) in a 
1:1 mixture of dichloromethane and pH 7 buffer (16 mL each) at 0 °C was added freshly 
recrystallized DDQ (477 mg, 2.10 mmol). The resulting dark green heterogeneous 
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reaction mixture is allowed to warm to ambient temperature over the course of two hours 
after which time it is diluted with 100 mL of ethyl acetate and washed with 100 mL of a 
saturated solution of sodium bicarbonate. The layers were separated and the aqueous 
layer wash washed with three times with 50 mL of ethyl acetate. The combined organic 
layer was washed with brine and dried over sodium sulfate. Purification by flash 
chromatography on iatrobeads (25% - 35% ethyl acetate in hexanes) gave the desired 
product as an amorphous off-white solid as a 3.5:1 mixture of diastereomers in 89% yield 
(620 mg). IR(Film): 3413, 2945, 2867, 1743, 1689, 1620, 1497, 1464, 1348, 1250, 1207, 
1098, 1057, 882, 822, 737, 684 cm-1; 1H NMR: (300 MHz, CDCl3) 9.62 (d, 1H, J = 7.8 
Hz, CHO), 7.40-6.68 (m, 12H, ArH, CHOCH=CH and CONH); 6.27 (s, 1H, OCHN), 
6.18 (dd, 1H, J = 7.8 and 16.2 Hz, CHOCH=CH), 5.13 (br s, 1H, OCHNH) 5.05 (s, 2H, 
OCH2Ph), 4.91 (m, 1H, CONHCH), 4.13 (d, 1H, J = 3.6 Hz, CHOTIPS); 3.62 (s, 3H, 
CO2Me); 3.04 (m, 2H, CH2Ar); 2.00-1.85 (m, 1H, CH(CH3)2), 1.10-0.95 (m, 21H, TIPS); 
0.89 (d, 3H, J = 6.9 Hz, CH(Me)Me); 0.79 (d, 3H, J = 6.9 Hz, CH(Me)Me) 13C NMR: (75 
MHz, CDCl3) δ 192.9, 172.3, 171.6, 158.3, 155.0, 152.5, 144.2, 137.2, 136.7, 133.2, 
131.3, 130.3, 129.4, 129.3, 129.1, 128.7, 128.6, 128.33, 128.29, 128.1, 127.9, 127.6, 
124.7, 120.9, 116.5, 112.3, 110.2, 78.1, 77.2, 70.5, 63.7, 52.5, 52.1, 38.1, 33.9, 18.0, 
17.91, 17.88, 17.7, 17.6, 17.3, 17.2, 12.3 HRMS: (FAB+) exact mass calculated for 
[M+H] (C42H55N2O7Si) requires m/z 727.3779, found m/z 727.3758; 
! 
["]
D
25= -60.33 (c = 
1.0 CHCl3). 
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Aldehyde 38: To a solution of amino aldehyde 37a (354 mg, 0.487 mmol), pyridine (0.1 
mL, 1.2175 mmol) and DMAP (29.7 mg, 0.2435 mmol) in 5 mL of dichloromethane at 0 
°C was added trifluoroacetic anhydride (0.172 mL, 1.22 mmol) dropwise by syringe 
under argon. After 30 minutes the reaction was diluted with 50 mL of ethyl acetate and 
washed with 30 mL of saturated sodium bicarbonate solution. The layers were separated 
and the organic fraction was washed with brine and dried over sodium sulfate. 
Purification by flask chromatography on silica gel (25% ethyl acetate in hexanes) gave 
the title compound product as an amorphous yellow solid in 89% yield (354 mg) in a 
3.5:1 mixture of diastereomers. IR(Film): 3415, 2945, 2867, 1731, 1663, 1610, 1494, 
1462, 1203, 1182, 1154, 948, 881, 822, 738 cm-1; 1H NMR: (300 MHz, CDCl3) 9.67 (d, 
1H, J = 7.2 Hz, CHO), 7.50-6.75 (m, 13H, ArH, CHOCH=CH and CONH); 6.57 (d, 1H, 
J = 1.2 Hz, OCHN), 6.21 (dd, 1H, J = 7.5 and 15.9 Hz, CHOCH=CH), 5.20 (app q, 2H, 
OCH2PH), 4.92 (m, 1H, CONHCH), 4.13 (d, 1H, J = 3.3 Hz, CHOTIPS), 3.65 (s, 3H, 
CO2Me), 3.06 (m, 2H, CH2Ar); 2.00-1.85 (m, 1H, CH(CH3)2), 1.10-0.95 (m, 21H, TIPS); 
0.89 (d, 3H, J = 7.2 Hz, CH(Me)Me), 0.79 (d, 3H, J = 7.2 Hz, CH(Me)Me) 13C NMR: (75 
MHz, CDCl3) δ 192.2, 172.5, 171.7, 157.5, 151.3, 149.9, 136.5, 135.4, 135.3, 135.1, 
131.4, 130.8, 130.7, 129.3, 128.8, 128.5, 128.3, 128.2, 127.3, 124.7, 118.1, 116.7, 114.7, 
114.3, 110.7, 100.6, 78.3, 71.0, 63.6, 60.6, 52.8, 52.5, 52.4, 38.3, 34.1, 21.2, 18.2, 18.1, 
18.0, 17.7, 17.5, 17.3, 14.4, 12.6, 12.5 HRMS: (FAB+) exact mass calculated for [M+H] 
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(C44H54N2O8F3Si) requires m/z 823.3601, found m/z 823.3560; 
! 
["]
D
25= -88.69 (c = 1.0 
CHCl3).  
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Aldehyde 39: A stream of ozone is passed through a solution of α,β-unsaturated 
aldehyde 38 (2.52 g, 3.06 mmol) in 40 mL of dichloromethane and 4 mL of methanol at  
–78 °C for 45 minutes. The solution was bubbled through with oxygen for ten minutes 
and then quenched by the addition of triphenylphospine (0.96 g, 3.67 mmol). After 
warming to room temperature overnight the reaction mixture was concentrated in vacuo 
and loaded directly onto a silica gel column. Elution with 35% ethyl acetate in hexanes 
gives 2.10 g of title product (87%) as an amorphous white solid in a 3.5:1 mixture of 
diastereomers. IR(Film): 3414, 2945, 2868, 1729, 1666, 1610, 1492, 1462, 1203, 1181, 
1158, 986, 881, 822, 738, 681 cm-1; 1H NMR: (300 MHz, CDCl3) 10.05 (s, 1H, CHO), 
7.50-6.80 (m, 13H, ArH, OCHNTFA and CONH), 5.19 (app q, 2H, OCH2PH), 4.94 (m, 
1H, CONHCH), 4.14 (d, 1H, J = 3.3 Hz, CHOTIPS), 3.65 (s, 3H, CO2Me), 3.07 (m, 2H, 
CH2Ar), 2.0-1.85 (m, 1H, CH(CH3)2), 1.10-0.95 (m, 21H, TIPS), 0.88 (d, 3H, J = 7.2 Hz, 
CH(Me)Me), 0.79 (d, 3H, J = 6.6 Hz, CH(Me)Me) 13C NMR: (75 MHz, CDCl3) δ 191.7, 
173.0, 172.7, 171.8, 171.7, 157.0, 149.8, 136.9, 136.5, 135.0, 132.4, 131.7, 131.0, 130.9, 
130.5, 129.6, 129.5, 129.2, 128.8, 128.7, 128.2, 128.0, 127.3, 125.2, 124.2, 118.0, 116.0, 
115.3, 114.2, 110.9, 109.8, 99.1, 96.1, 78.3, 71.1, 70.8, 60.7, 56.1, 52.7, 52.4, 38.7, 38.2, 
34.1, 33.9, 33.8, 21.3, 18.2, 18.1, 17.8, 17.7, 17.5, 17.4, 17.2, 14.4, 12.55, 12.51 HRMS: 
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(FAB+) exact mass calculated for [M+H] (C42H52N2O8F3Si) requires m/z 797.3445, found 
m/z 797.3420; 
! 
["]
D
25= -112.22 (c = 1.0 CHCl3).  
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Ketoamide 41: To a solution of thioester 40 (461 mg, 1.449 mmol) in 6.0 mL of DCM at 
–78 °C under an argon balloon was added TiCl4 (0.334 mL, 3.029 mmol) and the resulting 
solution turned bright yellow. After 30 minutes triethylamine (0.423 mL, 3.029 mmol) 
was added turning the reaction mixture dark purple. After 30 minutes more MeCN 
(0.1375 mL, 2.634 mmol) was added. Ten minutes after aldehyde 39 (1.05 g, 1.317 
mmol) was added dropwise as a solution in 1.5 mL of DCM. The dark purple reaction 
mixture was stirred at –78 °C for 1 hour then placed in a –30 °C refrigerator for 12 hours. 
At this time the reaction was diluted with DCM and quenched with a saturated solution of 
NaHCO3. The layers were separated and the organic layer was washed with 2 x 50 mL of 
water then 50 mL of brine. The organic fractions were concentrated and purified by 
column chromatography (20%-25% ethyl acetate in hexanes) to afford the title compound 
as an amorphous yellow solid. This solid was immediately dissolved in 17.5 mL of DCM 
and Dess-Martin periodinane (1.11 g, 2.62 mmol) was added. After two hours the 
solution was diluted with ethyl acetate and washed with a saturated solution of NaHCO3. 
The organic fractions were concentrated and the resulting oil purified by column 
chromatography to afford in 65% yield over the two steps the title compound (1.05 g) as 
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an off-yellow solid as a 3.5:3.5:1:1 mixture of inseparable diastereomers by 1H-NMR. 
This material was carried on without further purification. HRMS: (FAB+) exact mass 
calculated for [M+H] (C56H76N4O12F3SiS) requires m/z 113.490, found m/z 113.491;  
! 
["]
D
25= -31.69 (c = 1.0 CHCl3) (for ketoamide). 
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Oxazole 42: To a solution of 41 (900 mg, 0.8 mmol) in benzene (15 mL) was added 
DAST (1.5 mL) dropwise by syringe. The solution was stirred at room temperature for 
one hour before being diluted with a saturated solution of NaHCO3. The layers were 
separated and the organic was washed with ethyl acetate 3 x 50 mL. The combined 
organics were washed with brine and concentrated. The resulting oil was purified on 
silica gel (20%-25% ethyl acetate in hexanes) to yield the title compound (500 mg, 55%) 
as pale yellow solid. IR(Film): 3415, 2963, 2868, 2360, 2340, 1732, 1674, 1608, 1495, 
1464, 1367, 1290, 1253, 1203, 1159, 1125, 1001, 878, 822, 738, 685, 668 cm-1; 1H NMR: 
(300 MHz, CDCl3): 7.80-6.80 (m, 13H, Ar-H, OCHNTFA and CONH), 5.59 (br d, 1H, J 
= 9.3 Hz, NHBoc), 5.17 (app q, 2H, OCH2Ph), 4.94 (m, 1H, CONHCH), 4.90 (m, 1H, 
CHNHBOC), 4.08 (d, 1H, J = 3.6 Hz, CHOTIPS), 3.59 (S, 3H, CO2Me), 3.00 (M, 2H, 
CH2Ar), 2.76 (q, 2H, J = 7.5 Hz, CH2CH3), 2.19 (m, 1H, NHCHCH(CH3)2), 1.85 (m, 1H, 
OCHCH(CH3)2), 1.47 (br s, 9H, Boc), 1.20 (t, 3H, J = 7.5 Hz, CH2CH3), 0.99 (m, 27H, 
TIPS and NHCHCH(CH3)2), 0.79 (d, 3H, J = 7.2 Hz, OCHCH(Me)Me); 0.75 (d, 3H, J = 
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6.9 Hz, CH(Me)Me); 13C NMR: (75 MHz, CDCl3) δ 186.8, 183.4, 180.6, 174.2, 172.2, 
171.6, 163.5, 162.7, 161.8, 157.5, 155.6, 154.2, 153.7, 149.8, 149.4, 137.0, 136.4, 135.5, 
135.0, 134.0, 133.1, 132.4, 131.0, 129.7, 128.5, 127.9, 127.7, 127.1, 125.1, 116.2, 115.5, 
114.2, 110.1, 99.7, 94.6, 80.0, 78.1, 70.8, 60.1, 59.1, 54.4, 52.1, 47.9, 38.4, 33.7, 32.5, 
28.3, 28.0, 22.9, 18.8, 18.2, 17.9, 17.8, 17.4, 17.1, 16.7, 16.0, 14.2, 13.6, 12.3; 19F NMR: 
(75 MHz, CDCl3) δ –70.4 (s, 3F, CF3); HRMS: (FAB+) exact mass calculated for [M–H] 
(C56H72N4O11F3SiS) requires m/z 1093.464, found m/z 1093.464; 
! 
["]
D
25  = -44.62 (c = 1.0 
CHCl3).  
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Thioester 40: To a 0 °C solution of carboxylic acid (2.96 g, 10.79 mmol) in 50 mL of 
DCM under argon was added NEt3 (3.91 mL, 28.054 mmol) followed by isobutyl 
chloroformate (1.66 mL, 12.95 mL). After 1 hour at 0 °C was added ethanethiol (1.67 
mL, 2.0 mmol) and the reaction was warmed to room temperature and stirred for ten 
hours. The reaction mixture was then diluted with NaHCO3 and extracted 3 x 100 mL of 
DCM. The combined organic layer was washed with 200 mL of brine and concentrated. 
The resulting oil was recrystallized from a hot solution of 10% ethyl acetate in hexanes to 
give the title compound as a white crystalline solid in 85% yield (2.90 g). IR (Thin Film): 
3310, 3077, 2968, 2932, 1688, 1663, 1525, 1392, 1366, 1298, 1247, 1170, 1094, 1043, 
1016, 966 cm-1; 1H NMR: (300 MHz, CDCl3) δ 6.66 (br s, 1H, NH), 5.03 (br s, 1H, 
NHBoc), 4.19 (d, 2H, J = 5.4 Hz, NHCH2), 4.00 (dd, 1H, J = 6.0, 8.4 Hz, CHNHBoc), 
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2.91 (q, 2H, J = 7.5 Hz, SCH2), 2.21 (m, 1H, CHMe(Me)), 1.44 (s, 9H, OtBu), 1.25 (t, 
3H, J = 7.5 Hz, SCH2CH3), 0.98 (d, 3H, J = 6.9 Hz,  CHMe(Me)), 0.94 (d, 3H, J = 6.9 
Hz,  CHMe(Me)); 13C NMR: (75 MHz, CDCl3) δ 196.9, 172.2, 156.2, 80.3, 60.1, 49.2, 
30.9, 28.5, 23.4, 19.6, 17.9, 14.8; HRMS: (FAB+) exact mass calculated for [M+H] 
(C14H27N2O4S) requires m/z 319.1702, found m/z 319.1692; 
! 
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D
25  = -17.01 (c = 1.0 
CHCl3). 
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Amide 43: To 42 (100 mg, 0.091 mmol), tryptamine (51 mg, 0.318 mmol) and AgTFA 
(46 mg, 0.209 mmol) in a light-protected round-bottom flask was added degassed CH3CN 
(1.8 mL) with stirring. The solution was warmed to 40 °C and held for 45 min before 
being diluted with Et2O and passed through celite. After concentration, the resulting oil 
was purified on silica gel (40 -80 % Et2O in hexanes) to yield the title compound (87 mg, 
87%) as pale yellow solid. IR(Film): 3410, 2961, 2868, 1724, 1672, 1607, 1494, 1458, 
1367, 1288, 1204, 1159, 1011, 880, 821, 739, 684 cm-1; 1H NMR: (300 MHz, CDCl3): 
8.14 (s, 1H, C=CNH), 7.78 (d, 1H, Ar-H, 1.2 Hz), 7.58-6.76 (m, 17H, Ar-H, OCHNTFA 
and CONH), 5.49 (br d, 1H, J = 9.3 Hz, NHBoc), 5.16 (m, 2H, OCH2Ph), 4.95 (m, 1H, 
CONHCH), 4.75 (m, 1H, CHNHBOC), \ 4.09 (d, 1H, J = 3.6 Hz, CHOTIPS), 3.58 (m, 
5H, CO2Me, NHCH2CH2), 3.00 (m, 4H, CH2Ar, NHCH2CH2), 2.14 (m, 1H, 
NHCHCH(CH3)2), 1.88 (m, 1H, OCHCH(CH3)2), 1.44 (br s, 9H, Boc),  0.99 (m, 27H, 
TIPS and NHCHCH(CH3)2), 0.78 (d, 3H, J = 7.2 Hz, OCHCH(Me)Me); 0.72 (d, 3H, J = 
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7.2 Hz, CH(Me)Me); 13C NMR: (75 MHz, CDCl3) δ 172.3, 171.7, 162.0, 160.0, 157.5, 
155.5, 150.0, 149.4, 136.5, 136.3, 135.6, 130.8, 130.3, 129.4, 128.5, 128.4, 128.3, 127.8, 
127.4, 127.3, 127.0, 126.9, 124.8, 122.1, 122.0, 119.3, 118.6, 116.5, 114.0, 112.8, 111.2, 
110.0, 100.1, 80.1, 78.1, 70.7, 60.0, 54.4, 52.2, 52.1, 39.3, 38.4, 33.9, 33.7, 32.3, 28.4, 
25.2, 18.8, 18.2, 18.0, 17.9, 17.8, 17.4, 17.1, 12.3; 19F NMR: (75 MHz, CDCl3) δ –70.4 
(s, 3F, CF3); HRMS: (FAB+) exact mass calculated for [M+H] (C64H78N6O11F3Si) 
requires m/z 1192.551, found m/z 1192.547; 
! 
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25  = -45.64 (c = 1.0 CHCl3). 
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Ketoindole 44: To a solution of 43 (300 mg, 0.25 mmol) in THF/H2O (10:1, 5 mL) was 
added DDQ (122 mg, 0.75 mmol). The solution was stirred at room temperature for 15 
min before being diluted with a saturated solution of NaHCO3. The layers were separated 
and the aqueous was washed with ethyl acetate 3 x 50 mL. The combined organics were 
washed with brine and concentrated. The resulting oil was purified on silica gel (60%-
80% Et2O in hexanes) to yield the title compound (228 mg, 75%) as pale yellow solid. IR 
(Film): 3406, 2962, 2868, 1732, 1674, 1608, 1511, 1495, 1455, 1367, 1288, 1247, 1204, 
1159, 1126, 1009, 910, 881, 822, 736, 685, 648 cm-1; 1H NMR: (300 MHz, CDCl3): 9.63 
(d, 1H, C=CNH, 2.1 Hz), 8.21 (d, 1H, Ar-H, 6.9 Hz), 7.98 (t, 1H, Ar-H, 4.8 Hz), 7.61-
6.75 (m, 16H, Ar-H, OCHNTFA and CONH), 5.62 (br d, 1H, J = 9.0 Hz, NHBoc), 5.09 
(m, 2H, OCH2Ph), 4.95 (m, 1H, CONHCH), 4.80 (m, 1H, CHNHBOC), 4.45 (t, 2H, J = 
5.0 Hz, CH2CO), 4.09 (d, 1H, J = 3.6 Hz, CHOTIPS), 3.59 (s, 3H, CO2Me), 3.03 (m, 2H, 
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CH2Ar), 2.20 (m, 1H, NHCHCH(CH3)2), 1.87 (m, 1H, OCHCH(CH3)2), 1.47 (br s, 9H, 
Boc),  0.99 (m, 27H, TIPS and NHCHCH(CH3)2), 0.77 (d, 3H, J = 7.2 Hz, 
OCHCH(Me)Me); 0.71 (d, 3H, J = 7.2 Hz, CH(Me)Me); 13C NMR: (75 MHz, CDCl3) δ 
186.5, 172.3, 171.6, 162.4, 160.2, 157.5, 155.6, 155.5, 151.1, 149.3, 136.4, 136.3, 135.8, 
132.0, 130.8, 130.3, 129.5, 128.7, 128.5, 128.2, 127.8, 127.0, 125.5, 125.3, 125.2, 123.7, 
122.7, 121.8, 118.1, 116.2, 114.7, 114.3, 114.0, 111.9, 110.0, 100.3, 80.2, 78.2, 70.7, 
65.9, 60.1, 54.5, 52.5, 52.1, 45.7, 38.3, 34.2, 33.8, 33.7, 32.6, 30.3, 28.4, 18.8, 18.2, 18.0, 
17.9, 17.8, 17.4, 17.1, 15.3, 12.3; 19F NMR: (75 MHz, CDCl3) δ –70.2 (s, 3F, CF3); 
HRMS: (FAB+) exact mass calculated for [M–H] (C64H78N6O12F3Si) requires m/z 
1207.540, found m/z 1207.536; 
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25  = -40.21 (c = 1.0 CHCl3).   
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Bisoxazole 45: To a solution of PPh3 (186 mg, 0.71 mmol) in CH2Cl2 (6.6 mL) was 
added C2Cl6 (168 mg, 0.71 mmol). The solution was stirred at room temperature for 10 
min at which time Et3N (0.20 mL, 1.42 mmol) was added dropwise.  The resultant 
solution was stirred for 10 min at which time it was added dropwise via cannula to a 
stirred CH2Cl2 (2.8 mL) solution of 44 (171 mg, 0.142 mmol) held at -15 °C.  After 
addition was complete, the reaction was warmed to 0 °C and held at this temperature for 
10 min, at which point it was allowed to warm to room temperature and stirred for an 
additional 10 min.  The solution was then diluted with a saturated solution of NaHCO3. 
The layers were separated and the aqueous was washed with CH2Cl2 3 x 20 mL. The 
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combined organics were washed with brine and concentrated. The resulting oil was 
purified on silica gel (50%-70% Et2O in hexanes) to yield the title compound (157 mg, 
93%) as a pale off-white solid. IR(Film): 3406, 2962, 2868, 1733, 1674, 1610, 1495, 
1458, 1367, 1288, 1256, 1203, 1156, 1124, 1057, 997, 882, 741, 668 cm-1; 1H NMR: (300 
MHz, CDCl3): 8.58 (s, 1H, C=CNH), 7.74-6.76 (m, 19H, Ar-H, OCHNTFA and CONH), 
5.71 (br d, 1H, J = 9.0 Hz, NHBoc), 5.11 (app d, 2H, OCH2Ph, J = 3.6 Hz), 4.92 (m, 1H, 
CONHCH), 4.82 (m, 1H, CHNHBOC), 4.09 (d, 1H, J = 3.3 Hz, CHOTIPS), 3.57 (s, 3H, 
CO2Me), 2.98 (m, 2H, CH2Ar), 2.20 (m, 1H, NHCHCH(CH3)2), 1.86 (m, 1H, 
OCHCH(CH3)2), 1.46 (br s, 9H, Boc),  0.99 (m, 27H, TIPS and NHCHCH(CH3)2), 0.77 
(d, 3H, J = 6.9 Hz, OCHCH(Me)Me); 0.69 (d, 3H, J = 6.9 Hz, CH(Me)Me); 13C NMR: 
(75 MHz, CDCl3) δ 172.5, 171.8, 164.1, 163.3, 161.6, 161.5, 161.4, 161.3, 161.2, 157.6, 
156.0, 155.8, 155.6, 151.7, 150.8, 149.4, 148.7, 147.5, 136.7, 136.4, 131.2, 130.2, 128.9, 
128.8, 128.2, 128.1, 127.4, 125.8, 125.7, 124.0, 123.2, 123.1, 121.5, 121.1, 119.9, 118.3, 
116.2, 114.3, 111.9, 110.4, 104.9, 100.3, 80.2, 78.4, 70.9, 60.6, 54.8, 52.5, 52.3, 38.6, 
33.9, 33.1, 30.6, 28.6, 19.0, 18.5, 18.2, 18.1, 18.0, 17.7, 17.3, 12.5; 19F NMR: (75 MHz, 
CDCl3) δ –70.3 (s, 3F, CF3); HRMS: (FAB+) exact mass calculated for [M–H] 
(C64H76N6O11F3Si) requires m/z 1189.529, found m/z 1189.525; 
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25  = -21.03 (c = 1.0 
CHCl3).  
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Amino Acid 46: To a solution of 45 (157 mg, 0.132 mmol) in THF/MeOH/H2O (10:2:1, 
4.4 mL) was added LiOH•H2O (56 mg, 1.32 mmol). The solution was stirred at room 
temperature for 1 h at which time it was acidified with 1% aqueous HCl to pH 2.  The 
aqueous layer was extracted 3x with EtOAc, the organics combined and dried over 
Na2SO4.  Following concentration, the resultant carboxylic acid was redissolved in 
CH2Cl2 (2.4 mL).  To this solution was then added Me2S (0.6 mL) and trifluoroacetic acid 
(1.2 mL) with stirring.  After stirring for 25 min, the solvents were removed in vacuo, and 
the resulting solid redissolved in benzene and concentrated three successive times in 
order to remove residual trifluoroacetic acid.  The resulting solid was purified on silica 
gel (5%-10% MeOH in CH2Cl2) to yield the title compound (125 mg, 88%) as a yellow 
solid. IR(Film): 3397, 2958, 2929, 2862, 1676, 1622, 1497, 1458, 1387, 1204, 1138, 
1054, 996, 881, 801, 727 cm-1; 1H NMR: (300 MHz, CD3OD): 7.70-6.52 (m, 19H, Ar-H, 
OCHNH and CONH), 4.82 (app d, 2H, OCH2Ph, J = 11.7 Hz), 4.37 (d, 1H, CONHCH, J 
= 5.1 Hz), 4.29 (d, 1H, CHNH2, J = 7.5 Hz), 4.01 (d, 1H, J = 4.2 Hz, CHOTIPS),  2.93 
(m, 2H, CH2Ar), 2.30 (m, 1H, NHCHCH(CH3)2), 1.78 (m, 1H, OCHCH(CH3)2), 1.04 (m, 
27H, TIPS and NHCHCH(CH3)2), 0.74 (d, 3H, J = 6.9 Hz, OCHCH(Me)Me); 0.68 (d, 
3H, J = 6.9 Hz, CH(Me)Me); 13C NMR: (75 MHz, CD3OD) δ 173.2, 172.6, 158.8, 158.6, 
152.6, 151.5, 149.9, 143.9, 138.2, 137.7, 136.7, 132.4, 132.3, 131.7, 131.6, 130.0, 129.2, 
129.0, 128.8, 128.7, 128.5, 128.2, 128.0, 127.5, 127.4, 127.1, 127.0, 126.9, 126.2, 124.6, 
123.7, 122.1, 120.2, 120.1, 119.3, 118.9, 118.5, 114.6, 112.2, 11.6, 109.5, 103.6, 103.2, 
78.2, 69.6, 67.4, 60.3, 53.9, 53.7, 52.3, 37.0, 33.5, 31.2, 29.5, 25.1, 23.3, 18.9, 17.5, 17.1, 
17.0, 16.9, 16.6, 16.5, 16.3, 12.1; HRMS: (FAB+) exact mass calculated for [M+H] 
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(C56H67N6O8Si) requires m/z 979.4790, found m/z 979.4801; 
! 
["]
D
25  = -42.16 (c = 1.0 
MeOH).  
 
Macrolactam dimer 47: To a solution of 45 (50 mg, 0.042 mmol) in THF/MeOH/H2O 
(10:2:1, 1.4 mL) was added LiOH•H2O (18 mg, 0.420 mmol). The solution was stirred at 
room temperature for 1 h at which time it was acidified with 1% aqueous HCl to pH 2.  
The aqueous layer was extracted 3x with EtOAc, the organics combined and dried over 
Na2SO4.  Following concentration, the resultant carboxylic acid was redissolved in 
EtOAc (1.4 mL).  To this solution was then added DCC (21.7 mg, 0.105 mmol) and 
pentafluorophenol (19.3 mg, 0.105 mmol).  This solution was stirred at room temperature 
for 20 min, at which time it was passed through celite and concentrated.  The resulting 
pentafluorophenyl ester was dissolved in CH2Cl2 (1.2 mL).  To this solution was then 
added Me2S (0.3 mL) and trifluoroacetic acid (0.6 mL) with stirring.  After stirring for 25 
min, the solvents were removed in vacuo, and the resulting solid redissolved in benzene 
and concentrated three successive times in order to remove residual trifluoroacetic acid.  
The resulting solid was redissolved in EtOAc (14 mL), and DIPEA (29 µL, 0.168 mmol) 
was added.  After stirring at room temperature for 24 h, this solution was concentrated 
and the residue purified on silica gel (60% EtOAc in hexanes) to yield the title compound 
(28 mg, 71%) as a yellow oil. IR(Film): 3403, 2932, 2868, 1652, 1533, 1516, 1463, 1370, 
1253, 1208, 1058, 1014, 996, 919, 882, 824, 742, 683 cm-1; 1H NMR: (300 MHz, CDCl3): 
7.83-6.40 (m, 36H, Ar-H, OCHNH and CONH), 5.15 (dd, 2H, CONHCH, J = 5.4, 3.3 
Hz), 4.89 (app d, 4H, OCH2Ph, J = 12.0 Hz), 4.75 (m, 2H, CONHCH), 4.23 (d, 2H, J = 
3.3 Hz, CHOTIPS),  3.18 (m, 4H, CH2Ar), 2.64 (m, 2H, NHCHCH(CH3)2), 2.30 (m, 2H, 
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OCHCH(CH3)2), 1.04 (m, 66H, TIPS and NHCHCH(CH3)2, OCHCH(Me)Me, 
CH(Me)Me); 13C NMR: (75 MHz, CDCl3) δ 172.8, 169.5, 161.2, 157.3, 157.1, 152.5, 
150.3, 147.8, 143.3, 138.2, 137.1, 136.3, 136.1, 132.3, 129.5, 128.9, 128.6, 128.0, 127.4, 
127.2, 126.3, 125.5, 125.4, 124.0, 123.0, 122.6, 121.5, 120.0, 119.7, 114.7, 112.6, 111.6, 
105.3, 103.3, 78.1, 69.7, 60.0, 55.3, 52.0, 49.6, 39.7, 34.4, 34.2, 33.8, 33.7, 30.3, 29.7, 
25.4, 24.8, 19.0, 18.8, 18.1, 18.0, 17.7, 17.3, 17.2, 12.5; HRMS: (FAB+) exact mass 
calculated for [M+H] (C112H130N12O14Si2) requires m/z 1922.9968, found m/z 1922.9356; 
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25  = -8.49 (c = 1.0 CHCl3).  
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Phenol 48: To a solution of 45 (192 mg, 0.161 mmol) in THF (10 mL) was added 
Pd(OH)2/C (80 mg). The solution was sparged with H2 for 20 min and warmed to 50 °C 
under H2 with stirring.  After 18 h, the solution was then filtered through celite. After 
concentration, the resulting oil was purified on silica gel (70%-90% Et2O in hexanes) to 
yield the title compound (144 mg, 89%) as a pale off-white solid. IR(Film): 3327, 2962, 
2868, 1748, 1671, 1633, 1611, 1500, 1463, 1367, 1292, 1250, 1172, 1058, 1014, 917, 
881, 820, 736, 684 cm-1; 1H NMR: (300 MHz, CDCl3): 9.24 (s, 1H, C=CNH), 7.60-6.52 
(m, 14H, Ar-H, OCHNH and CONH), 5.74 (br d, 1H, J = 9.0 Hz, NHBoc), 4.85 (m, 2H, 
CONHCH, CHNHBOC), 4.09 (d, 1H, J = 3.3 Hz, CHOTIPS), 3.50 (s, 3H, CO2Me), 2.93 
(m, 2H, CH2Ar), 2.16 (m, 1H, NHCHCH(CH3)2), 1.83 (m, 1H, OCHCH(CH3)2), 1.39 (br 
s, 9H, Boc),  0.98 (m, 27H, TIPS and NHCHCH(CH3)2), 0.73 (d, 3H, J = 7.2 Hz, 
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OCHCH(Me)Me); 0.67 (d, 3H, J = 7.2 Hz, CH(Me)Me); 13C NMR: (75 MHz, CDCl3) δ 
172.7, 171.6, 163.2, 158.1, 156.0, 152.0, 148.8, 141.7, 136.5, 136.2, 130.4, 130.0, 129.4, 
129.2, 128.9, 125.8, 125.2, 123.8, 123.7, 123.5, 122.6, 121.2, 120.6, 119.3, 116.0, 115.7, 
111.8, 110.0, 104.3, 104.2, 103.3, 80.2, 78.2, 60.6, 54.6, 52.6, 52.1, 52.0, 38.4, 33.8, 32.6, 
31.6, 29.7, 28.3, 18.9, 18.3, 18.1, 17.9, 17.5, 17.4, 12.3; HRMS: (FAB+) exact mass 
calculated for [M+H] (C55H71N6O10Si) requires m/z 1003.500, found m/z 1003.503; 
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25  
= -12.89 (c = 0.073 CHCl3).  
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Triflate 49: To a solution of 48 (45 mg, 0.045 mmol) in CH2Cl2 (0.9 mL) was added 
PhNTf2 (20 mg, 0.056 mmol) and Et3N (19 µL, 0.134 mmol). The solution was stirred 
under argon for 30 min and then diluted with saturated NaHCO3.  The aqueous layer was 
washed with EtOAc, and the combined organics were washed with H2O and dried over 
Na2SO4. After concentration of the solvents in vacuo, the resulting oil was purified on 
silica gel (20% EtOAc in hexanes) to yield the title compound (44 mg, 86%) as a pale 
off-white solid. IR(Film): 3307, 2963, 2868, 1672, 1630, 1497, 1424, 1367, 1211, 1140, 
1058, 998, 908, 881, 815, 740, 684 cm-1; 1H NMR: (300 MHz, CDCl3): 8.55 (d, 1H, 
C=CNH, J = 1.8 Hz), 7.75-6.70 (m, 14H, Ar-H, OCHNH and CONH), 5.68 (br d, 1H, J 
= 9.0 Hz, NHBoc), 4.90, (m, 1H, CONHCH), 4.78 (m, 1H, CHNHBOC), 4.06 (d, 1H, J = 
3.6 Hz, CHOTIPS), 3.52 (s, 3H, CO2Me), 2.95 (m, 2H, CH2Ar), 2.16 (m, 1H, 
NHCHCH(CH3)2), 1.83 (m, 1H, OCHCH(CH3)2), 1.45 (br s, 9H, Boc),  0.98 (m, 27H, 
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TIPS and NHCHCH(CH3)2), 0.74 (d, 3H, J = 6.9 Hz, OCHCH(Me)Me); 0.67 (d, 3H, J = 
6.9 Hz, CH(Me)Me); 13C NMR: (75 MHz, CDCl3) δ 172.6, 171.8, 163.6, 158.4, 155.9, 
152.0, 149.4, 148.6, 141.3, 136.5, 133.5, 130.9, 130.0, 129.5, 128.0, 126.6, 125.6, 124.1, 
123.1, 121.8, 121.6, 121.1, 121.0, 119.8, 116.7, 112.0, 110.7, 104.9, 103.1, 80.2, 78.4, 
60.3, 54.8, 52.6, 52.3, 38.6, 33.9, 33.0, 31.8, 29.9, 28.6, 18.9, 18.6, 18.2, 18.1, 17.9, 12.5; 
19F NMR: (75 MHz, CDCl3) δ –73.5 (s, 3F, CF3); HRMS: (FAB+) exact mass calculated 
for [M+H] (C56H70N6O12F3SiS) requires m/z 1135.449, found m/z 1135.449; 
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25  = -
10.74 (c = 0.94 CHCl3). 
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Biaryl 50: 49 (5 mg, 0.005 mmol) was dissolved in degassed CH3CN/TFE/Et3N (3:1:0.1, 
2.0 mL) in a Pyrex flask under argon.  This solution was exposed to 350 nm UV light 
(Hitachi UVA lamps, Luzchem 10 lamp photoreactor) with stirring for 2 h. At this time 
the solvents were concentrated in vacuo, and the resulting oil was purified on silica gel 
(50% EtOAc in hexanes) to yield the title compound (1.9 mg, 38%) as a pale off-white 
solid. IR(Film): 3312, 2961, 2927, 2868, 1715, 1673, 1592, 1493, 1456, 1367, 1259, 
1210, 1172, 1095, 1016, 914, 882, 803, 739, 685 cm-1; 1H NMR: (300 MHz, CDCl3): 8.71 
(s, 1H, C=CNH), 7.71-6.75 (m, 12H, Ar-H, CONH), 6.32 (s, 1H, OCHNH), 5.71 (br d, 
1H, J = 9.6 Hz, NHBoc), 5.03, (m, 1H, CONHCH), 4.78 (m, 1H, CHNHBOC), 4.11 (d, 
1H, J = 3.6 Hz, CHOTIPS), 3.71 (s, 3H, CO2Me), 3.15 (m, 2H, CH2Ar), 2.14 (m, 1H, 
NHCHCH(CH3)2), 1.81 (m, 1H, OCHCH(CH3)2), 1.48 (br s, 9H, Boc),  1.06-0.77 (m, 
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33H, TIPS, NHCHCH(CH3)2, and OCHCH(Me)Me); HRMS: (FAB+) exact mass 
calculated for [M+H] (C55H69N6O9Si) requires m/z 985.4895, found m/z 985.4897; 
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D
25  = 
-28.03 (c = 0.1, CHCl3). 
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Acid 54: To a solution of 53 (9.50 g, 11.98 mmol) in THF/MeOH/H2O (130 mL, 10:2:1) 
was added LiOH•H2O (2.01 g, 47.9 mmol) with stirring. After the reaction was judged 
complete by TLC analysis (4 h), the reaction mixture was diluted with 300 mL of diethyl 
ether, acidified with 1N HCl to pH = 2, and washed with 100 mL of brine. The organic 
portion is dried over sodium sulfate and concentrated in vacuo. These crude extracts were 
purified by column chromatography (40% EtOAc/Hexanes with 1% AcOH) to yield the 
title compound (8.96 g, 96%) as a white amorphous solid. IR (Film): 3402, 2944, 2867, 
1723, 1641, 1613, 1572, 1513, 1454, 1385, 1248, 1209, 1176, 1063, 909, 882, 821, 732 
cm-1; 1H NMR: (300 MHz, CDCl3) δ 7.35-6.73 (m, 17H, ArH and NH); 5.57 (s, 2H, 
OCH2Ph), 5.13 (s, 2H, OCH2-pMeOPh), 4.89 (dd, 1H, J = 7.2, 12.9 Hz, CHCO2H), 4.16 
(d, 1H, J = 3.3 Hz, CHOTIPS); 3.76 (s, 3H, ArOMe); 3.17 (dd, 1H, J = 5.4, 14.7 Hz, 
CH2Ar); 3.05 (dd, 1H, J = 7.2, 14.4 Hz, CH2Ar); 1.92 (m, 1H, CHMe2); 1.04-0.98 (m, 
21H, TIPS); 0.83 (d, 3H, J = 6.9 Hz, CH(Me)Me); 0.74 (d, 3H, J = 6.9 Hz, CH(Me)Me); 
13C NMR: (300 MHz, CDCl3) δ 175.8, 173.5, 158.8, 152.6, 146.9, 136.7, 131.3, 131.1, 
129.2, 129.1, 128.6, 128.2, 128.0, 127.8, 127.2, 126.5, 121.3, 120.9, 115.6, 113.9, 112.7, 
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110.9, 104.5, 78.0, 70.4, 55.2, 52.6, 52.1, 37.0, 33.9, 18.0, 17.9, 17.6, 17.2, 12.3; HRMS 
(FAB+) exact mass calculated for [M+•] (C46H58N2O7Si) requires m/z 778.4013, found 
m/z 778.4034 
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25  = -28.48 (c = 0.53, CHCl3) 
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Thioester 55: To a solution of 300 mL of 60:7:2:1 CH2Cl2/TFA/Me2S/H2O under argon 
was added 40 (7.0 g, 22 mmol).  After 12 h the solution was concentrated.  The resulting 
oil was purified by column chromatography (10% MeOH/CH2Cl2) to yield the title 
compound as a white crystalline solid in 90% yield (6.24 g). IR(Thin Film): 2972, 2941, 
1668, 1471, 1202, 1181, 1137, 971, 838, 799, 722 cm-1; 1H NMR: (300 MHz, CD3OD) δ 
4.28 (d, 1H, J = 17.4 Hz, NHCH2), 4.06 (d, 1H, J = 17.4 Hz, NHCH2), 3.77 (d, 1H, J = 
5.7 Hz, CHNH2), 2.91 (q, 2H, J = 7.5 Hz, SCH2), 2.25 (m, 1H, CHMe(Me)), 1.23 (t, 3H, 
J = 7.5 Hz, SCH2CH3), 1.10 (d, 3H, J = 6.9 Hz,  CHMe(Me)), 1.07 (d, 3H, J = 6.9 Hz,  
CHMe(Me)); 13C NMR: (75 MHz, CD3OD) δ 196.8, 169.0, 156.2, 58.5, 30.3, 22.7, 17.7, 
16.6, 13.9; HRMS: (FAB+) exact mass calculated for [M+H] (C9H19N2O2S) requires m/z 
219.1167, found m/z 219.1171; 
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25  = -0.95 (c = 1.0 MeOH) 
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Thioester 56: To a solution of 54 (8.96 g, 11.5 mmol) and 55 (4.71 g, 15.0 mmol) in 
DMF (120 mL) was added HOBt (2.02 g, 15.0 mmol), EDC•HCl (2.87 g, 15.0 mmol) 
and NaHCO3 (3.86 g, 46.0 mmol) with stirring. After the reaction was judged complete 
by TLC analysis (7 h), the reaction mixture was diluted with 500 mL of diethyl ether and 
washed with 200 mL of saturated NH4Cl, H2O, and brine. The organic portion was dried 
over sodium sulfate and concentrated in vacuo. These crude extracts were purified by 
column chromatography (40% EtOAc/hexanes) to yield the title compound (10.7 g, 95% 
yield) as a white amorphous solid. IR (Film): 3288, 2962, 2943, 2868, 1642, 1612, 1513, 
1455, 1385, 1262, 1248, 1209, 1176, 1064, 909, 882, 823, 732 cm-1; 1H NMR: (300 MHz, 
CDCl3) δ 7.35-6.49 (m, 19H, ArH and NH); 5.57 (s, 2H, OCH2Ph); 5.15 (s, 2H, OCH2-
pMeOPh); 4.62 (dd, 1H, J = 7.2, 12.9 Hz, CH2CHCONH); 4.30 (dd, 1H, J = 5.6, 8.6 Hz, 
NHCHCHMe2); 4.16 (d, 1H, J = 3.0 Hz, CHOTIPS); 3.98 (t, 2H, J = 4.8 Hz, NHCH2); 
3.76 (s, 3H, ArOMe); 3.08 (m, 2H, CH2Ar); 2.82 (q, 2H, J = 7.5 Hz, SCH2); 2.21 (m, 1H, 
NHCHCHMe2); 1.92 (m, 1H, OCHCHMe2); 1.19 (t, 3H, J = 7.5 Hz, SCH2CH3); 1.04-
0.98 (m, 21H, TIPS); 0.89-0.83 (m, 9H, OCHCH(Me)Me, NHCHCH(Me)Me); 0.74 (d, 
3H, J = 6.9 Hz, OCHCH(Me)Me); 13C NMR: (300 MHz, CDCl3) δ 196.9, 173.8, 171.0, 
170.9, 158.8, 152.5, 146.9, 136.7, 131.2, 131.0, 128.9, 128.6, 128.3, 128.1, 127.8, 127.7, 
126.5, 121.7, 120.9, 115.7, 113.9, 112.7, 110.8, 104.6, 78.0, 70.4, 58.5, 55.2, 54.8, 52.2, 
48.9, 37.2, 34.0, 29.8, 23.0, 19.4, 18.0, 17.5, 17.0, 14.5, 12.4; HRMS (FAB+) exact mass 
calculated for [M+•] (C55H74N4O8SiS) requires m/z 978.4996, found m/z 978.4966; 
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= –17.13 (c = 2.18, CHCl3). 
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Aldehyde 57: (2R,5R)-2-tert-butyl-5-benzyl-3-methylimidazolidin-4-one•TFA (1.03 g, 
2.86 mmol) and phenol 56 (8.0 g, 8.17 mmol) are dissolved in 40 mL of dichloromethane 
and 2 mL of MeOH. This mixture is cooled to -50 °C. To this cold solution is added 
freshly distilled acrolein (5.51 mL, 81.7 mmol). The reaction is left at –50 °C for 48 
hours before being diluted with 50 mL of pH 7 buffer. The layers were separated and the 
organic portions were washed with brine and dried over sodium sulfate. Following 
concentration in vacuo, the crude reaction extracts were purified by flash chromatography 
(80% Et2O in pentane) to afford the title compound as an amorphous white solid (7.9 g, 
93%).  IR (Film): 3408, 3300, 2962, 2942, 2868, 1720, 1648, 1512, 1495, 1466, 1386, 
1247, 1175, 1100, 1065, 915, 882, 822, 733, 683 cm-1; 1H NMR: (300 MHz, CDCl3) δ 
9.45 (s, 1H, CHO); 7.36-6.44 (m, 15H, Ar-H); 5.80 (s, 1H, OCHN); 5.33 (d, 1H, J = 15.6 
Hz, NCH2-pMeOPh); 5.01 (m, 2H, OCH2Ph); 4.60 (m, 2H, CHNHCO); 4.47 (d, 1H, J = 
15.6 Hz, NCH2-pMeOPh); 4.26-3.94 (m, 3H, CHOTIPS, NHCH2); 3.78 (s, 3H, ArOMe); 
3.11-2.80 (m, 4H, CH2Ar, SCH2); 2.29-1.84 (m, 6H, NHCHCHMe2, OCHCHMe2, 
CH2CH2CHO); 1.21 (t, 3H, J = 7.5 Hz, SCH2CH3); 1.09-0.68 (m, 33H, TIPS, 
OCHCH(Me)Me, NHCHCH(Me)Me); 13C NMR: (300 MHz, CDCl3) δ 201.0, 196.6, 
173.9, 173.6, 170.9, 170.8, 170.7, 158.8, 157.8, 152.5, 146.9, 137.0, 136.7, 133.3, 132.5, 
130.1, 130.8, 129.4, 129.3, 129.0, 128.8, 128.6, 128.5, 128.1, 128.0, 127.9, 127.5, 126.5, 
123.6, 121.0, 120.4, 115.6, 114.0, 113.4, 110.7, 109.9, 105.8, 104.6, 78.0, 70.9, 58.5, 
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57.8, 55.3, 54.8, 50.4, 49.0, 39.0, 33.9, 29.9, 29.3, 23.1, 19.2, 18.1, 18.0, 17.6, 17.0, 14.6, 
12.4; HRMS (FAB+) exact mass calculated for [M+H] (C58H78N4O9SiS) requires m/z 
1034.526, found m/z 1034.528; 
! 
["]
D
25  = -35.94 (c = 1.0, CHCl3). 
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Aldehyde 58: To a solution of aldehyde 57 (5.73 g, 5.53 mmol) in 70 mL of THF at 
room temperature was added PhSeNEt2 (1.47 mL, 7.65 mmol). After stirring for one hour 
the reaction was judged complete by TLC. The reaction mixture was concentrated in 
vacuo and the crude extracts were purified by flash chromatography (33% EtOAc in 
hexanes). The product was thus obtained as a yellow oil in a 3:3:1:1 mixture of 
diastereomers as judged by 1H-NMR. This product was then taken up in 42 mL of THF, 
21 mL of methanol, and 21 mL of water. To this solution was added sodium periodate 
(2.06 g, 9.62 mmol) in a single portion. After 12 hours the reaction mixture was 
concentrated in vacuo to remove the methanol and THF, diluted with ethyl acetate and 
washed with water. After separation of the layers the organic portions were washed with 
brine and dried over sodium sulfate. Concentration of the resulting solution gave a yellow 
oil which could be purified by column chromatography (33% EtOAc in hexanes) to give 
the title compound as an amorphous off-white solid (4.81 g, 84%). IR (Film): 3409, 3300, 
2962, 2942, 2868, 1692, 1648, 1512, 1494, 1466, 1385, 1248, 1175, 1100, 1064, 973, 
911, 882, 822, 733, 683 cm-1; 1H NMR: (300 MHz, CDCl3) δ 9.45 (d, 1H, J = 7.5 Hz, 
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CHO); 7.33-6.72 (m, 16H, Ar-H, CH=CHCHO); 6.46 (d, 1H, J = 8.1 Hz, CONH); 5.93 
(s, 1H, OCHN); 5.88 (dd, 1H, J = 15.9, 7.8 Hz, CH=CHCHO); 5.22 (d, 1H, J = 15.3 Hz, 
NCH2-pMeOPh); 5.01 (m, 2H, OCH2Ph); 4.59-4.46 (m, 3H, CHNHCO, NCH2-
pMeOPh); 4.23 (dd, 1H, J = 8.2, 5.8 Hz, NHCH2); 4.15 (d, 1H, J = 3.3 Hz, CHOTIPS); 
4.03 (dd, 1H, J = 5.8, 1.0 Hz, NHCH2); 3.76 (s, 3H, ArOMe); 3.11-2.82 (m, 4H, CH2Ar, 
SCH2); 2.18 (m, 1H, NHCHCHMe2); 1.95 (m, 1H, OCHCHMe2); 1.22 (t, 3H, J = 7.5 Hz, 
SCH2CH3); 1.05 (m, 21H, TIPS); 0.90-0.83 (m, 9H, OCHCH(Me)Me, 
NHCHCH(Me)Me); 0.71 (d, 3H, J = 6.9 Hz, OCHCH(Me)Me); 13C NMR: (300 MHz, 
CDCl3) δ 196.8, 196.6, 193.3, 173.8, 173.4, 171.0, 170.7, 158.9, 158.1, 155.3, 152.5, 
146.9, 145.2, 137.3, 136.6, 136.5, 133.0, 131.8, 131.2, 130.3, 129.9, 129.7, 129.2, 129.0, 
128.3, 128.0, 127.8, 127.5, 126.5, 121.7, 121.3, 121.0, 116.9, 115.7, 114.0, 113.9, 113.6, 
112.7, 110.8, 110.3, 107.0, 104.6, 78.0, 70.8, 70.4, 61.6, 58.5, 55.2, 54.8, 51.1, 49.0, 37.5, 
33.9, 30.3, 23.1, 19.3, 18.1, 17.5, 17.0, 14.6; HRMS (FAB+) exact mass calculated for 
[M+H] (C58H77N4O9SiS) requires m/z 1033.518, found m/z 1033.518; 
! 
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D
25  = -46.19 (c = 
1.20, CHCl3). 
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Amine 58a: To a vigorously stirred solution of aldehyde 58 (4.8 g, 4.64 mmol) in a 1:1 
mixture of dichloromethane and pH 7 buffer (75 mL each) at 0 °C was added freshly 
recrystallized DDQ (2.10 g, 9.29 mmol). The resulting dark heterogeneous reaction 
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mixture is allowed to warm to ambient temperature over the course of two hours after 
which time it is diluted with ethyl acetate and washed with a saturated solution of 
Na2SO3, followed by a saturated solution of NaHCO3 and brine. The layers were 
separated and the aqueous layer wash washed with three times with 50 mL of ethyl 
acetate. The combined organic layer was washed with brine and dried over sodium 
sulfate. Purification by flash chromatography on silica gel (35%-40% EtOAc in hexanes) 
gave the desired product as an amorphous off-white solid in 84% yield (3.54 g). IR 
(Film): 3301, 2962, 2942, 2868, 1691, 1648, 1498, 1466, 1387, 1206, 1058, 975, 882, 
823, 749, 683 cm-1; 1H NMR: (300 MHz, CDCl3) δ 9.61 (d, 1H, J = 7.5 Hz, CHO); 7.41-
6.67 (m, 12H, Ar-H, CH=CHCHO); 6.56 (d, 1H, J = 8.7 Hz, CONH); 6.24 (d, 1H, J = 
2.4 Hz, OCHN); 6.14 (dd, 1H, J = 15.6, 7.5 Hz, CH=CHCHO); 5.04 (s, 2H, OCH2Ph); 
4.59 (m, 1H, CONHCHCH); 4.24 (dd, 1H, J = 8.6, 5.6 Hz, NHCH2); 4.14 (m, 1H, 
CONHCHCH2); 4.03 (d, 1H, J = 5.7 Hz, CHOTIPS); 3.93 (m, 1H, NHCH2); 3.15-2.80 
(m, 4H, CH2Ar, SCH2); 2.17 (m, 1H, NHCHCHMe2); 1.92 (m, 1H, OCHCHMe2); 1.22 
(t, 3H, J = 7.5 Hz, SCH2CH3); 1.05 (m, 21H, TIPS); 0.90-0.82 (m, 9H, OCHCH(Me)Me, 
NHCHCH(Me)Me); 0.72 (d, 3H, J = 6.9 Hz, OCHCH(Me)Me); 13C NMR: (300 MHz, 
CDCl3) δ 196.6, 193.5, 173.3, 170.7, 170.4, 158.2, 155.4, 137.1, 136.6, 133.1, 130.2, 
129.7, 129.5, 129.4, 129.3, 129.2, 128.6, 128.1, 127.6, 125.0, 121.0, 116.4, 112.3, 110.4, 
103.0, 78.0, 70.4, 63.7, 58.5, 54.6, 49.0, 37.5, 33.9, 30.3, 23.1, 19.0, 18.1, 18.0, 17.9, 
17.5, 17.0, 14.6, 12.4; HRMS (FAB+) exact mass calculated for [M+H] (C50H69N4O8SiS) 
requires m/z 913.4605, found m/z 913.4632; 
! 
["]
D
25  = -61.30 (c = 3.08, CHCl3). 
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Aldehyde 59: To a solution of amino aldehyde 58a (3.54 g, 3.87 mmol), pyridine (0.78 
mL, 9.68 mmol) and DMAP (165 mg, 1.35 mmol) in 77 mL of dichloromethane at 0 °C 
was added trifluoroacetic anhydride (0.82 mL, 5.81 mmol) dropwise by syringe under 
argon. After 30 minutes the reaction was diluted with 200 mL of ethyl acetate and 
washed with 60 mL of saturated sodium bicarbonate solution. The layers were separated 
and the organic fraction was washed with brine and dried over sodium sulfate. 
Purification by flask chromatography on silica gel (40% ethyl acetate in hexanes) gave 
the title compound product as an amorphous yellow solid in 87% yield (354 mg). IR 
(Film): 3406, 3306, 2962, 2868, 1731, 1695, 1650, 1492, 1463, 1387, 1292, 1204, 1183, 
1154, 1058, 981, 882, 823, 738, 684 cm-1; 1H NMR: (300 MHz, CDCl3) δ 9.65 (d, 1H, J = 
7.2 Hz, CHO); 7.47-6.54 (m, 13H, Ar-H, CH=CHCHO, OCHN); 6.24 (dd, 1H, J = 15.9, 
7.2 Hz, CH=CHCHO); 5.19 (dd, 2H, J = 18.6, 6.4 Hz, OCH2Ph); 4.59 (m, 1H, 
CONHCHCH); 4.24-4.03 (m, 4H, NHCH2, CHOTIPS, CONHCHCH2); 3.12-2.86 (m, 
4H, CH2Ar, SCH2); 2.13 (m, 1H, NHCHCHMe2); 1.95 (m, 1H, OCHCHMe2); 1.23 (t, 
3H, J = 7.5 Hz, SCH2CH3); 1.05 (m, 21H, TIPS); 0.90-0.86 (m, 9H, OCHCH(Me)Me, 
NHCHCH(Me)Me); 0.75 (d, 3H, J = 6.6 Hz, OCHCH(Me)Me); 13C NMR: (300 MHz, 
CDCl3) δ 196.2, 192.7, 173.2, 170.5, 170.1, 157.3, 151.6, 149.6, 136.3, 135.2, 131.0, 
130.8, 129.2, 128.6, 128.2, 128.0, 127.0, 124.9, 116.3, 114.4, 110.5, 100.4, 78.0, 70.8, 
63.3, 58.5, 54.4, 49.0, 37.6, 33.9, 30.6, 23.1, 18.9, 18.1, 18.0, 17.5, 17.1, 14.6, 12.4; 19F 
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NMR: (75 MHz, CDCl3) δ –70.0 (s, 3F, CF3); HRMS (FAB+) exact mass calculated for 
[M+H] (C52H68N4O9F3SiS) requires m/z 1009.443, found m/z 1009.444; 
! 
["]
D
25  = -133.69 (c 
= 0.37, CHCl3). 
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Aldehyde 53: A stream of ozone is passed through a solution of α, β-unsaturated 
aldehyde 59 (601 mg, 0.59 mmol) in 14 mL of dichloromethane and 1.4 mL of methanol 
at –78 °C for 45 minutes. The solution was bubbled through with oxygen for ten minutes 
and then quenched by the addition of triphenylphospine (0.44 g, 1.67 mmol). After 
warming to room temperature overnight the reaction mixture was concentrated in vacuo 
and loaded directly onto a silica gel column. Elution with 35% ethyl acetate in hexanes 
gives 517 mg of title product (88%) as an amorphous white solid. IR (Film): 3301, 2963, 
2868, 1729, 1649, 1492, 1464, 1406, 1292, 1252, 1204, 1182, 1159, 985, 882, 823, 738, 
684 cm-1; 1H NMR: (300 MHz, CDCl3) δ 10.1 (s, 1H, CHO); 7.46-6.42 (m, 12H, Ar-H, 
OCHN); 5.18 (dd, 2H, J = 17.7, 12.0 Hz, OCH2Ph); 4.59 (m, 1H, CONHCHCH); 4.24-
3.96 (m, 4H, NHCH2, CHOTIPS, CONHCHCH2); 3.14-2.87 (m, 4H, CH2Ar, SCH2); 
2.14 (m, 1H, NHCHCHMe2); 1.92 (m, 1H, OCHCHMe2); 1.24 (t, 3H, J = 7.5 Hz, 
SCH2CH3); 1.04 (m, 21H, TIPS); 0.93-0.84 (m, 9H, OCHCH(Me)Me, 
NHCHCH(Me)Me); 0.69 (d, 3H, J = 6.6 Hz, OCHCH(Me)Me); 13C NMR: (300 MHz, 
CDCl3) δ 196.4, 191.7, 173.4, 170.6, 170.4, 156.7, 149.5, 136.2, 132.1, 131.4, 130.7, 
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129.0, 128.5, 128.0, 127.0, 125.2, 124.0, 115.7, 115.0, 114.0, 110.8, 100.0, 78.0, 70.8, 
58.6, 54.4, 49.0, 37.5, 33.9, 30.4, 23.2, 19.2, 18.0, 17.9, 17.8, 17.5, 17.0, 14.6, 12.3; 19F 
NMR: (75 MHz, CDCl3) δ –70.3 (s, 3F, CF3); HRMS (FAB+) exact mass calculated for 
[M+H] (C50H66N4O9F3SiS) requires m/z 983.4272, found m/z 983.4238; 
! 
["]
D
25  = -93.42 (c 
= 0.47, CHCl3). 
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Alcohol 52: A flame-dried 1000 mL flask is charged with 53 (2.1 g, 2.14 mmol) and 
MgBr2•Et2O (1.65 g, 6.41 mmol) under Ar.  To this flask is added THF (425 mL) 
followed by Et3N (2.98 mL, 21.4 mmol) and TMSCl (0.68 mL, 5.34 mmol) with stirring.  
After 75 min 1N HCl (100 mL) is added and stirred for 10 min.  The solution was diluted 
with EtOAc and pH 7 buffer, and washed with brine. The organic fractions were 
concentrated and the resulting oil purified by column chromatography to afford 1.49 g of 
the title compound (71%) as an off-white solid.  IR (Film): 3401, 2962, 2868, 1732, 
1681, 1644, 1490, 1462, 1288, 1204, 1181, 1160, 1125, 1099, 1057, 982, 881, 832, 752, 
736, 684 cm-1; 1H NMR: (300 MHz, CDCl3) δ 7.50-6.86 (m, 10H, Ar-H); 6.77 (d, 1H, J = 
8.4 Hz, Ar-H); 6.63 (s, 1H, OCHN); 5.36 (d, 1H, J = 10.2 Hz, CONH); 5.16 (dd, 2H, J = 
17.7, 12.3 Hz, OCH2Ph); 4.89 (d, 1H, J = 9.3 Hz, CHC(O)SEt); 4.48 (d, 1H, J = 6.0 Hz, 
CHOH); 4.36 (m, 1H, CONHCHCH); 4.18-4.10 (m, 2H, CHOTIPS, CONHCHCH2); 
3.04 (dd, 1H, J = 12.3, 4.6 Hz, CH2Ar); 2.85 (q, 2H, J = 7.5 Hz, SCH2CH3); 2.65 (t, 1H, J 
= 12.3 Hz, CH2Ar); 2.05 (m, 1H, NHCHCHMe2); 1.92 (m, 1H, OCHCHMe2); 1.20 (t, 
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3H, J = 7.5 Hz, SCH2CH3); 1.06-0.94 (m, 30H, TIPS, OCHCH(Me)Me, 
NHCHCH(Me)Me); 0.84 (d, 3H, J = 6.6 Hz, OCHCH(Me)Me); 13C NMR: (300 MHz, 
CDCl3) δ 199.8, 172.3, 170.4, 169.9, 158.6, 149.4, 136.7, 136.4, 129.8, 129.7, 128.5, 
128.4, 128.3, 127.9, 127.3, 127.1, 126.4, 126.2, 117.9, 114.2, 110.9, 97.8, 77.9, 72.5, 
70.8, 64.6, 58.9, 55.8, 40.2, 33.8, 30.1, 23.9, 19.3, 18.2, 18.0, 17.9, 17.8, 17.6, 17.5, 14.2, 
12.2; 19F NMR: (75 MHz, CDCl3) δ –69.7 (s, 3F, CF3); HRMS (FAB+) exact mass 
calculated for [M+H] (C50H66N4O9F3SiS) requires m/z 983.4272, found m/z 983.4243; 
! 
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25  = –129.17 (c = 0.27, CHCl3). 
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Ketone 52a: To a solution of 52 (46 mg, 0.047 mmol) in 1.0 mL of CH2Cl2 was added 
Dess-Martin periodinane (59 mg, 0.14 mmol). After 30 min the solution was diluted with 
EtOAc and washed with a saturated solution of NaHCO3. The organic fractions were 
concentrated and the resulting oil purified by column chromatography to afford 37 mg of 
the title compound (80%) as an off-white solid. IR (Film): 3408, 3272, 2925, 2868, 1735, 
1651, 1516, 1492, 1465, 1293, 1204, 1184, 1163, 1057, 967, 881, 737, 682 cm-1; 1H 
NMR: (300 MHz, CDCl3) δ 7.56-6.78 (m, 12H, Ar-H, OCHN); 5.76 (m, 2H, CONH, 
CHC(O)SEt); 5.16 (dd, 2H, J = 18.3, 12.3 Hz, OCH2Ph); 4.45 (m, 1H, CONHCHCH); 
4.18 (d, 1H, J = 3.3 Hz, CHOTIPS); 4.02 (m, 1H, CONHCHCH2); 2.95-2.75 (m, 4H, 
CH2Ar, SCH2CH3); 2.05 (m, 1H, NHCHCHMe2); 1.92 (m, 1H, OCHCHMe2); 1.20 (t, 
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3H, J = 7.5 Hz, SCH2CH3); 1.06 (m, 24H, TIPS, NHCHCH(Me)Me); 1.01-0.95 (m, 6H, 
OCHCH(Me)Me, NHCHCH(Me)Me); 0.88 (d, 3H, J = 6.3 Hz, OCHCH(Me)Me); 13C 
NMR: (300 MHz, CDCl3) δ 196.3, 195.9, 172.4, 170.9, 169.8, 158.6, 149.0, 136.4, 132.2, 
131.2, 130.3, 128.5, 128.4, 128.3, 128.2, 127.9, 127.0, 125.0, 124.2, 118.0, 114.5, 111.4, 
96.7, 78.0, 73.7, 70.8, 61.8, 59.2, 55.2, 39.2, 33.8, 29.9, 23.8, 19.1, 18.4, 18.1, 18.0, 17.7, 
17.5, 14.1, 12.4; 19F NMR: (75 MHz, CDCl3) δ –70.0 (s, 3F, CF3); HRMS (FAB+) exact 
mass calculated for [M+H] (C50H64N4O9F3SiS) requires m/z 981.4115, found m/z 
981.4107; 
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25  = -179.88 (c = 0.30, CHCl3). 
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Oxazole 51: To a solution of 52a (125 mg, 0.127 mmol) in benzene (11 mL) was added 
DAST (1.1 mL) dropwise by syringe. The solution was stirred at room temperature for 3 
h before being diluted with EtOAc a saturated solution of NaHCO3. The layers were 
separated and the aqueous layer was washed with ethyl acetate 3 x 50 mL. The combined 
organics were washed with brine and concentrated. The resulting oil was purified on 
silica gel (20% EtOAc in hexanes) to yield the title compound (99 mg, 81%) as a pale 
yellow solid. IR(Film): 3405, 3286, 2926, 2868, 1739, 1656, 1494, 1463, 1291, 1251, 
1201, 1157, 990, 879 cm-1; 1H NMR: (300 MHz, CDCl3): δ 7.63 (d, 1H, J = 1.5 Hz, Ar-
H), 7.40-7.26 (m, 5H, Ar-H), 7.18-7.08 (m, 2H, Ar-H), 6.99-6.93 (m, 2H, Ar-H), 6.84 (s, 
1H, OCHN), 6.78 (d, 1H, J = 8.4 Hz, Ar-H), 5.26-5.11 (m, 3H, OCH2Ph, CONHCHCH), 
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4.71 (m, 1H, CONHCHCH2), 3.96 (d, 1H, J = 3.0 Hz, CHOTIPS), 3.42 (t, 1H, J = 12.3 
Hz, CH2Ar), 2.99-2.75 (m, 2H, SCH2CH3), 2.64 (dd, 1H, J = 12.3, 3.3 Hz, CH2Ar), 2.43 
(m, 1H, NHCHCH(CH3)2), 1.72 (m, 1H, OCHCH(CH3)2),  1.18 (t, 3H, J = 7.5 Hz, 
SCH2CH3), 1.07 (m, 24H, TIPS and NHCHCH(CH3)2), 0.91-0.87 (m, 6H, 
NHCHCH(CH3)2, OCHCH(Me)Me), 0.63 (d, 3H, J = 7.2 Hz, OCHCH(Me)Me); 13C 
NMR: (75 MHz, CDCl3) δ 186.2, 172.4, 171.7, 160.8, 156.8, 150.2, 149.7, 136.8, 136.2, 
134.0, 130.4, 130.2, 129.4, 129.2, 128.8, 128.7, 128.6, 128.1, 127.6, 127.4, 115.0, 114.6, 
110.7, 100.3, 77.9, 71.0, 60.9, 55.3, 53.5, 39.0, 34.0, 28.9, 23.0, 19.8, 18.3, 18.2, 18.0, 
17.5, 17.0, 14.4, 12.6; HRMS: (FAB+) exact mass calculated for [M+H] (C50H62 
F3N4O8SiS) requires m/z 963.4010, found m/z 963.3998; 
! 
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25  = -61.01 (c = 0.55, CHCl3).   
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Acid 60: To a solution of 51 (84 mg, 0.087 mmol) in THF/MeOH/H2O (4.4 mL, 10:2:1) 
was added LiOH•H2O (36.5 mg, 0.87 mmol) with stirring. After the reaction was judged 
complete by TLC analysis (2 h), the reaction mixture was diluted with 50 mL of diethyl 
ether, acidified with 1N HCl to pH = 2, and washed with 20 mL of brine. The organic 
portion was dried over sodium sulfate and concentrated in vacuo. These crude extracts 
were purified by column chromatography (50% EtOAc/Hexanes to 10% MeOH in 
CH2Cl2) to yield the title compound (71 mg, 99%) as a white amorphous solid. IR (Film): 
3405, 2917, 2849, 1654, 1498, 1464, 1289, 1251, 1209, 1068, 882, 754, 684 cm-1; 1H 
NMR: (300 MHz, CD3OD): δ 7.54-7.26 (m, 6H, Ar-H), 7.18 (dd, 1H, J = 8.2, 1.6 Hz, Ar-
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H), 6.94 (s, 1H, OCHN), 6.87-6.65 (m, 4H, Ar-H), 5.08 (s, 2H, OCH2Ph), 4.93 (m, 1H, 
CONHCHCH), 4.53 (m, 1H, CONHCHCH2), 4.16 (d, 1H, J = 3.9 Hz, CHOTIPS), 3.15 
(t, 1H, J = 12.3 Hz, CH2Ar), 2.85 (dd, 1H, J = 12.3, 3.8 Hz, CH2Ar), 2.36 (m, 1H, 
NHCHCH(CH3)2), 2.05 (m, 1H, OCHCH(CH3)2),  1.09 (m, 24H, TIPS and 
NHCHCH(CH3)2), 1.04-1.01 (m, 6H, NHCHCH(CH3)2, OCHCH(Me)Me), 0.87 (d, 3H, J 
= 6.9 Hz, OCHCH(Me)Me); 13C NMR: (75 MHz, CD3OD) δ 172.7, 172.6, 165.9, 160.0, 
157.2, 154.0, 144.0, 138.3, 137.0, 133.0, 130.6, 130.1, 130.0, 128.7, 128.2, 127.9, 127.6, 
127.4, 127.3, 120.3, 114.9, 112.1, 110.2, 103.9, 70.2, 61.5, 55.6, 53.8, 38.6, 33.8, 28.6, 
19.1, 17.6, 17.5, 17.1, 17.0, 16.6, 12.2; HRMS: (FAB+) exact mass calculated for 
[M+Na] (C46H58N4O8SiNa) requires m/z 845.3921, found m/z 845.3914; 
! 
["]
D
25  = -100.66 
(c = 0.493, CHCl3). 
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Ketoindole 62: To a solution of 60 (36.4 mg, 0.044 mmol) in DMF (2.2 mL) was added 
61 (24 mg, 0.088 mmol), EDC•HCl (10.2 mg, 0.052 mmol), HOBt (7.2 mg, 0.052 mmol), 
and NaHCO3 (14.8 mg, 0.18 mmol). The solution was stirred at room temperature for 12 
h before being diluted with EtOAc and brine. The layers were separated and the aqueous 
was washed with ethyl acetate. The combined organics were washed with brine and 
concentrated. The resulting oil was purified on silica gel (40% EtOAc in hexanes) to 
yield the title compound (28 mg, 68%) as pale white solid. IR(Film): 3404, 3287, 2962, 
2868, 1654, 1500, 1465, 1435, 1289, 1248, 1210, 1119, 1065, 913, 882, 843, 732, 685 
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cm-1; 1H NMR: (300 MHz, CDCl3): δ 9.13 (d, 1H, J = 2.4 Hz, C=CNH), 8.24 (m, 1H, Ar-
H), 7.90 (t, 1H, J = 4.6 Hz, Ar-H), 7.73 (d, 1H, J = 3.3 Hz, Ar-H), 7.58 (d, 1H, J = 1.8 
Hz, Ar-H), 7.28-7.22 (m, 9H, Ar-H), 7.08 (dd, 1H, J = 8.2, 1.6 Hz, Ar-H), 6.89 (t, 1H, J 
= 4.4 Hz, Ar-H), 6.70 (m, 2H, Ar-H, OCHN), 6.31 (br d, 1H, J = 8.4 Hz, CONH), 5.62, 
(s, 1H, CONH), 5.16 (dd, 1H, J = 9.0, 5.6, CONHCHCH), 4.87 (dd, 2H, J = 24.6, 11.4 
Hz, OCH2Ph), 4.54 (t, 2H, J = 4.8 Hz, CH2CO), 4.46 (m, 1H, CONHCHCH2), 4.13 (d, 
1H, J = 3.3 Hz, CHOTIPS), 3.36 (t, 1H, J = 12.0 Hz, CH2Ar), 2.74 (dd, 1H, J = 12.0, 3.3 
Hz, CH2Ar), 2.44 (m, 1H, NHCHCH(CH3)2), 1.97 (m, 1H, OCHCH(CH3)2),  1.09 (m, 
24H, TIPS and NHCHCH(CH3)2), 0.98-0.87 (m, 9H, NHCHCH(CH3)2, OCHCH(Me)2); 
13C NMR: (75 MHz, CDCl3) δ 188.4, 171.9, 160.8, 159.5, 157.2, 153.4, 144.0, 138.1, 
136.8, 136.2, 131.4, 130.9, 130.6, 130.1, 129.6, 128.4, 128.2, 128.0, 127.8, 127.4, 125.1, 
123.9, 122.9, 121.9, 120.6, 115.2, 115.1, 112.0, 111.7, 110.6, 103.7, 77.9, 77.2, 70.0, 
61.4, 56.0, 53.1, 45.9, 38.7, 33.9, 28.5, 19.6, 18.1, 18.0, 17.7, 17.5, 17.2, 12.4; HRMS: 
(FAB+) exact mass calculated for [M+H] (C56H67N6O8Si) requires m/z 979.4789, found 
m/z 979.4765; 
! 
["]
D
25  = -42.44 (c = 0.147, CHCl3). 
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Bisoxazole 63: To a solution of PPh3 (136 mg, 0.52 mmol) in CH2Cl2 (1.8 mL) was 
added C2Cl6 (123 mg, 0.52 mmol). The solution was stirred at room temperature for 10 
min at which time Et3N (0.144 mL, 1.04 mmol) was added dropwise.  The resultant 
solution was stirred for 10 min at which time it was added dropwise via cannula to a 
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stirred CH2Cl2 (2.8 mL) solution of 62 (51 mg, 0.052 mmol) at 0 °C and held at this 
temperature for 10 min, at which point it was allowed to warm to room temperature and 
stirred for an additional 10 min.  The solution was then diluted with a saturated solution 
of NaHCO3. The layers were separated and the aqueous was washed with CH2Cl2 3 x 5 
mL. The combined organics were washed with brine and concentrated. The resulting oil 
was purified on silica gel (40% EtOAc in hexanes) to yield the title compound (47.7 mg, 
95%) as a pale amorphous solid. IR(Film): 3405, 3289, 2961, 2868, 1655, 1498, 1460, 
1288, 1254, 1207, 1116, 1096, 1061, 917, 882, 738, 685 cm-1; 1H NMR: (300 MHz, 
CDCl3): δ 8.12 (s, 1H, C=CNH), 7.68-6.56 (m, 18H, Ar-H, OCHN), 5.41 (s, 1H, 
CONH), 5.06-4.86 (m, 3H, CONHCHCH, OCH2Ph), 4.67 (m, 1H, CONHCHCH2), 4.09 
(d, 1H, J = 3.3 Hz, CHOTIPS), 3.34 (t, 1H, J = 12.0 Hz, CH2Ar), 2.77 (dd, 1H, J = 12.0, 
3.3 Hz, CH2Ar), 2.38 (m, 1H, NHCHCH(CH3)2), 1.95 (m, 1H, OCHCH(CH3)2),  1.07 (m, 
24H, TIPS and NHCHCH(CH3)2), 0.96 (d, 3H, J = 6.9 Hz, NHCHCH(CH3)2), 0.90 (d, 
3H, J = 6.9 Hz, OCHCH(Me)Me), 0.84 (d, 3H, J = 6.9 Hz, OCHCH(Me)Me); 13C NMR: 
(75 MHz, CDCl3) δ 172.1, 172.0, 161.8, 157.5, 152.5, 149.9, 148.3, 143.7, 137.9, 137.4, 
136.3, 130.4, 130.1, 129.7, 129.2, 129.0, 128.8, 128.5, 128.1, 127.6, 124.0, 123.1, 122.9, 
121.6, 121.2, 121.1, 119.8, 115.9, 112.4, 111.8, 110.9, 105.3, 103.3, 78.1, 70.2, 62.1, 
55.8, 54.4, 39.0, 34.1, 29.5, 19.8, 18.3, 18.2, 17.6, 17.5, 12.5; HRMS: (FAB+) exact mass 
calculated for [M+H] (C56H65N6O7Si) requires m/z 961.4687, found m/z 961.4682; 
! 
["]
D
25  = 
–115.47 (c = 0.187, CHCl3). 
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Phenol 63a: To a solution of 63 (47.5 mg, 0.049 mmol) in THF (5 mL) was added 
Pd(OH)2/C (120 mg). The solution was sparged with H2 for 20 min and kept under a H2 
atmosphere for 7 h.  At this time the solution was filtered through a silica plug, 
concentrated, and the resulting oil was purified on silica gel (40%-60% EtOAc in 
hexanes) to yield the title compound (38.0 mg, 88%) as a pale amorphous solid. 
IR(Film): 3287, 2962, 2868, 1652, 1496, 1458, 1292, 1254, 1191, 1099, 1061, 917, 882, 
738, 683 cm-1; 1H NMR: (300 MHz, CD3OD): δ 8.67 (d, 1H, J = 7.2 Hz, C=CNH), 7.64 
(m, 1H, Ar-H), 7.49-7.41 (m, 3H, Ar-H), 7.21-7.13 (m, 4H, Ar-H), 7.04 (d, 1H, J = 1.8 
Hz, Ar-H), 6.84-6.80 (m, 2H, Ar-H), 6.57 (dd, 1H, J = 6.0, 2.7 Hz, Ar-H), 6.39 (m, 2H, 
Ar-H, OCHN), 4.69 (t, 1H, J = 7.2 Hz, CONHCHCH), 4.55 (m, 1H, CONHCHCH2), 
4.15 (d, 1H, J = 3.9 Hz, CHOTIPS), 3.06 (t, 1H, J = 12.0 Hz, CH2Ar), 2.85 (dd, 1H, J = 
12.0, 4.0 Hz, CH2Ar), 2.17-2.00 (m, 2H, NHCHCH(CH3)2, OCHCH(CH3)2),  1.10-0.96 
(m, 33H, TIPS, NHCHCH(CH3)2, OCHCH(Me)2); 13C NMR: (75 MHz, CD3OD) δ 172.8, 
172.3, 162.6, 157.6, 151.7, 151.2, 149.6, 142.0, 137.0, 136.7, 131.2, 129.7, 129.0, 128.9, 
128.4, 127.8, 123.7, 123.6, 121.9, 120.3, 120.0, 119.2, 118.8, 115.0, 113.4, 111.4, 110.1, 
103.7, 103.2, 78.1, 61.9, 55.6, 55.5, 38.1, 33.8, 29.8, 18.4, 18.0, 17.2, 17.1, 16.7, 12.2; 
HRMS: (FAB+) exact mass calculated for [M+H] (C49H58N6O7Si) requires m/z 870.4136, 
found m/z 870.4132; 
! 
["]
D
25  = -102.52 (c = 0.173, CHCl3). 
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Triflate 64: To a solution of 63a (38 mg, 0.044 mmol) in CH2Cl2 (4.3 mL) was added 
PhNTf2 (39 mg, 0.109 mmol) and Et3N (30.4 µL, 0.218 mmol). The solution was stirred 
under argon for 30 min and then diluted with brine.  The aqueous layer was washed with 
EtOAc, and the combined organics were dried over Na2SO4. After concentration of the 
solvents in vacuo, the resulting oil was purified on silica gel (30% EtOAc in hexanes) to 
yield the title compound (30 mg, 67%) as a pale yellow-orange amorphous solid. 
IR(Film): 3287, 2962, 2869, 1652, 1496, 1471, 1424, 1213, 1139, 1062, 916, 882, 812, 
742, 668 cm-1; 1H NMR: (300 MHz, CD3OD): δ 7.68 (m, 1H, Ar-H), 7.48-7.42 (m, 2H, 
Ar-H), 7.26-7.02 (m, 7H, Ar-H), 6.85 (m, 2H, Ar-H, OCHN), 6.52 (dd, 1H, J = 7.5, 6.6 
Hz, Ar-H), 4.69 (d, 1H, J = 7.2 Hz, CONHCHCH), 4.56 (dd, 1H, J = 14.2, 3.9 Hz, 
CONHCHCH2), 4.16 (d, 1H, J = 3.9 Hz, CHOTIPS), 3.07 (t, 1H, J = 12.0 Hz, CH2Ar), 
2.87 (dd, 1H, J = 12.0, 3.9 Hz, CH2Ar), 2.19-2.00 (m, 2H, NHCHCH(CH3)2, 
OCHCH(CH3)2),  1.12-0.99 (m, 33H, TIPS, NHCHCH(CH3)2, OCHCH(Me)2); 13C NMR: 
(75 MHz, CD3OD) δ 172.7, 172.2, 162.8, 157.7, 151.4, 150.0, 149.5, 141.5, 136.8, 133.3, 
131.8, 130.3, 129.9, 129.1, 128.8, 128.1, 123.7, 123.0, 122.2, 122.1, 121.2, 120.7, 120.1, 
119.7, 119.2, 118.8, 116.5, 111.5, 110.4, 103.3, 103.2, 78.1, 61.2, 55.4, 38.0, 33.8, 29.8, 
18.4, 18.0, 17.2, 17.1, 16.7, 12.2; 19F NMR: (75 MHz, CD3OD) δ –75.6 (s, 3F, CF3); 
HRMS: (FAB+) exact mass calculated for [M+H] (C50H58N6O9F3SiS) requires m/z 
1003.371, found m/z 1003.369; 
! 
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25  = -119.34 (c = 0.126 CHCl3). 
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Phenol 65: To a solution of 60 (110 mg, 0.133 mmol) in THF (7 mL) was added 
Pd(OH)2/C (150 mg). The solution was sparged with H2 for 20 min and kept under a H2 
atmosphere for 64 h.  At this time the solution was filtered through a silica plug, 
concentrated, and the resulting oil was purified on silica gel (10% MeOH in CH2Cl2) to 
yield the title compound (82 mg, 83%) as a pale amorphous solid.  IR (Film): 3406, 2962, 
2868, 1652, 1601, 1493, 1414, 1295, 1251, 1184, 1097, 1063, 914, 882, 815, 758, 682 
cm-1; 1H NMR: (300 MHz, CD3OD): δ 7.52 (d, 1H, J = 8.7 Hz, Ar-H), 7.32 (s, 1H, Ar-
H), 7.15 (dd, 1H, J = 8.4, 1.5 Hz, Ar-H), 7.02 (s, 1H, Ar-H), 6.78-6.54 (m, 4H, Ar-H, 
OCHN), 4.98 (m, 1H, CONHCHCH), 4.56 (m, 1H, CONHCHCH2), 4.16 (d, 1H, J = 3.9 
Hz, CHOTIPS), 3.15 (t, 1H, J = 12.0 Hz, CH2Ar), 2.85 (dd, 1H, J = 12.3, 3.2 Hz, 
CH2Ar), 2.40 (m, 1H, NHCHCH(CH3)2), 2.04 (m, 1H, OCHCH(CH3)2),  1.10 (m, 21H, 
TIPS), 1.02-0.98 (m, 9H, NHCHCH(CH3)2, OCHCH(Me)Me), 0.81 (d, 3H, J = 6.3 Hz, 
OCHCH(Me)Me); 13C NMR: (75 MHz, CD3OD) δ 172.8, 172.6, 171.6, 167.0, 159.8, 
157.3, 153.2, 142.1, 137.0, 134.0, 131.2, 129.9, 129.8, 129.2, 127.8, 120.4, 114.7, 113.4, 
110.0, 103.9, 78.0, 61.4, 60.1, 55.6, 53.7, 38.4, 33.8, 28.5, 18.8, 17.2, 17.1, 16.7, 16.3, 
12.2; HRMS: (FAB+) exact mass calculated for [M+Na] (C39H52N4O8SiNa) requires m/z 
755.3452, found m/z 755.3467; 
! 
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25  = -112.44 (c = 0.285, CH3OH). 
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Bismacrocycle 67: A Schlenk vial was charged with 66 (15 mg, 0.013 mmol), K3PO4 
(5.5 mg, 0.0040 mmol) and Pd(PPh3)4 (4.6 mg, 0.0040 mmol).  To this vial was added 
degassed dioxane/H2O (5:1, 3.3 mL). The resulting solution was warmed to 70 °C for 5 h.  
At this time the solution was diluted with EtOAc, and Na2SO4 was added to precipitate 
remaining palladium.  This solution was filtered through florisil, concentrated, and the 
resulting oil was purified by prep TLC (100:25:4 CH2Cl2:Hexanes:MeOH) to yield the 
title compound (4.3 mg, 38%) as a pale amorphous solid.  1H NMR: (300 MHz, CD3OD): 
δ 10.56 (s, 1H, C=CNH), 8.66 (d, 1H, J = 7.8 Hz, Ar-H), 7.54 (d, 1H, J = 9.0 Hz, Ar-H), 
7.41 (d, 1H, J = 8.1 Hz, Ar-H), 7.24-7.15 (m, 4H, Ar-H), 6.99 (d, 1H, J = 7.2 Hz, Ar-H), 
6.90 (t, 1H, J = 7.5 Hz, Ar-H), 6.75 (d, 1H, J = 8.1 Hz, Ar-H), 6.20 (s, 1H, OCHN), 4.73 
(m, 1H, CONHCHCH), 4.59 (m, 1H, CONHCHCH2), 4.16 (d, 1H, J = 3.9 Hz, 
CHOTIPS), 4.04 (m, 1H, CH2CH2NHCO), 3.23 (t, 1H, J = 12.0 Hz, CH2Ar), 2.85 (m, 
2H, CH2Ar, CH2CH2NHCO), 2.68 (m, 1H, NHCHCH(CH3)2), 2.08 (m, 2H, 
OCHCH(CH3)2, CH2CH2NHCO), 1.86 (dd, 1H, J = 15.3, 6.0 Hz, CH2CH2NHCO), 1.11 
(m, 21H, TIPS), 1.05-0.98 (m, 9H, NHCHCH(CH3)2, OCHCH(Me)Me), 0.91 (d, 3H, J = 
6.6 Hz, OCHCH(Me)Me); HRMS: (FAB+) exact mass calculated for [M+Na] 
(C49H61N6O6Si) requires m/z 857.4422, found m/z 857.4397. 
 
 
